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Background: Researchers sometimes undertake qualitative research with randomised controlled trials
(RCTs) of health interventions.
Objectives: To systematically explore how qualitative research is being used with trials and identify ways
of maximising its value to the trial aim of providing evidence of effectiveness of health interventions.
Design: A sequential mixed methods study with four components.
Methods: (1) Database search of peer-reviewed journals between January 2008 and September 2010 for
articles reporting the qualitative research undertaken with speciﬁc trials, (2) systematic search of database
of registered trials to identify studies combining qualitative research and trials, (3) survey of 200 lead
investigators of trials with no apparent qualitative research and (4) semistructured telephone interviews
with 18 researchers purposively sampled from the ﬁrst three methods.
Results: Qualitative research was undertaken with at least 12% of trials. A large number of articles
reporting qualitative research undertaken with trials (n = 296) were published between 2008 and 2010.
A total of 28% (82/296) of articles reported qualitative research undertaken at the pre-trial stage and
around one-quarter concerned drugs or devices. The articles focused on 22 aspects of the trial within ﬁve
broad categories. Some focused on more than one aspect of the trial, totalling 356 examples.
The qualitative research focused on the intervention being trialled (71%, 254/356), the design and
conduct of the trial (15%, 54/356), the outcomes of the trial (1%, 5/356), the measures used in the trial
(3%, 10/356), and the health condition in the trial (9%, 33/356). The potential value of the qualitative
research to the trial endeavour included improving the external validity of trials and facilitating
interpretation of trial ﬁndings. This value could be maximised by using qualitative research more at the
pre-trial stage and reporting ﬁndings with explicit attention to the implications for the trial endeavour.
During interviews, three models of study were identiﬁed: qualitative research as peripheral to the trial,
qualitative research as an ‘add-on’ to the trial and a study with qualitative research and trial as essential
components, with the third model offering more opportunity to maximise the value of the qualitative
research. Interviewees valued the use of qualitative research with trials and identiﬁed team structures and
wider structural issues which gave more value to the trial than the qualitative research as barriers to
maximising the value of the qualitative research.v
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ABSTRACT
viConclusion: A large number of articles were published between 2008 and 2010, addressing a wide range
of aspects of trials. There were examples of this research affecting the trial by facilitating interpretation of
trial ﬁndings, developing and reﬁning interventions for testing in the trial and changing the measures used
in the trial. However, researchers were not necessarily maximising the value of qualitative research
undertaken with trials to the endeavour of generating evidence of effectiveness of health interventions.
Researchers can maximise value by promoting its use at the pre-trial stage to ensure that the intervention
and trial conduct is optimised at the main trial stage, being explicit about the conclusions for the trial
endeavour in peer-reviewed journal articles reporting the qualitative research and valuing the contribution
of the qualitative research as much as the trial. Future recommendations for researchers include: plan the
qualitative research, design and implement studies not trials, use qualitative research at the feasibility and
pilot stage of trials, be explicit in publications about the impact of the qualitative research on the trial
and implications for the trial endeavour, undertake in-depth qualitative research, allow qualitative research
to take a challenging role and develop a learning environment around the use of qualitative research
and trials.
Funding: This project was funded by the Medical Research Council (MRC) as part of the MRC-National
Institute for Health Research Methodology Research programme.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Plain English summary
Researchers use randomised controlled trials (RCTs) to test whether or not new health services andtreatments work. Sometimes researchers use qualitative research (e.g. interviews, focus groups,
observation) alongside these trials and a common reason is to help to understand why these services and
treatments do or do not work. We looked at how researchers have done this type of qualitative research
and how to make the best use of it. We found 296 papers, published in academic journals, which
reported this type of qualitative research during 2008–10. We found that it was used to explore 22
different aspects of trials and qualitative research had the potential to make more efﬁcient use of research
money by being used before a trial to make sure that the service or treatment was designed to give it the
best chance of working. It could also help the trial researchers to be more sensitive to the needs of people
joining or working in a trial. We also interviewed experienced researchers to ﬁnd out whether or not they
felt the qualitative research had been of value and how best to carry it out. These researchers valued the
qualitative research because it could improve the treatment and the trial and help to understand how to
use the trial results in the real world. They felt that the best way to do this work was to undertake
high-quality qualitative research and for team members to plan, in the early stages of the research, how to
use the ﬁndings to produce the best evidence about the treatment.xvii
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Researchers sometimes undertake qualitative research with randomised controlled trials (RCTs) of health
interventions, particularly when evaluating the effectiveness of complex interventions.Objectives
To systematically explore how qualitative research is being used with trials and identify ways of maximising
its value to the trial endeavour of providing evidence of effectiveness of health interventions.Design
A sequential mixed methods study with four components: a systematic mapping review of peer-reviewed
journal articles reporting qualitative research undertaken with speciﬁc trials, a review of studies combining
qualitative research and trials, a survey of lead investigators of trials which appeared not to use
qualitative research and an interview study of researchers sampled from these articles and studies.Methods
1. Database search of peer-reviewed journals between January 2008 and September 2010 for articles
reporting the qualitative research undertaken with speciﬁc trials: MEDLINE, PreMEDLINE, EMBASE,
The Cochrane Library, Health Technology Assessment (HTA), PsycINFO, CINAHL, British Nursing Index,
Social Sciences Citation Index and Applied Social Sciences Index and Abstracts. Full articles were
assessed to identify the focus of the qualitative research in relation to the trial. Data extraction from a
sample of articles was undertaken to identify its potential value to the trial endeavour, good practice
and ways of maximising value.
2. Systematic search of the metaRegister of Controlled Trials (mRCT) database of registered trials to
identify studies combining qualitative research and trials, followed by a review of the proposals
and ﬁnal reports of these studies to consider how qualitative research is presented in key
study documentation.
3. Survey of 200 lead investigators of trials with no apparent qualitative research to identify ‘invisible’
qualitative research.
4. Semistructured telephone interviews with 18 researchers purposively sampled from the ﬁrst three
methods to explore their perceptions of undertaking this work and how to maximise its value for the
speciﬁc trial.Results
Qualitative research was undertaken with at least 12% of trials on the mRCT database in the 2000s.
A large number of articles reporting qualitative research undertaken with trials (n = 296) were published
between 2008 and 2010. These articles had a wide international authorship and a total of 28% (82/296)
of articles reported qualitative research undertaken at the pre-trial stage, that is, as part of a pilot,
feasibility or early-phase trial or study in preparation for the main trial. The majority related to trials of
complex interventions and approximately one-quarter to trials of drugs or devices.xix
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SCIENTIFIC SUMMARY
xxThe articles focused on 22 aspects of the trial within ﬁve broad categories. Some articles focused on more
than one aspect of the trial, totalling 356 examples. The qualitative research focused on the intervention
being trialled (71%, 254/356), the design, process and conduct of the trial (15%, 54/356), the outcomes
of the trial (1%, 5/356), the measures used in the trial (3%, 10/356), and the target condition for the trial
(9%, 33/356). All the subcategories are described and illustrated with examples in the report. The largest
subcategory focused on exploring the feasibility and acceptability of the intervention in practice (23%).
There were eight types of potential value of the qualitative research to the trial endeavour. These included
making trials more efﬁcient by improving recruitment rates, improving the ethics of trials by helping
triallists to be sensitive to human beings participating in trials and improving informed consent procedures,
improving the internal and external validity of trials, facilitating implementation of trial results by facilitating
replicability of interventions in the real world and transferability of trial results to other settings, and
facilitating interpretation of trial ﬁndings.
We identiﬁed a number of ways of maximising value to the trial endeavour, including by using qualitative
research more at the pre-trial stage and reporting ﬁndings with explicit attention to the implications for
the trial endeavour. We developed guidance to help researchers to improve how they report this work,
QUAlitative Research with Trials: Excellent Reporting (QUARTER), and guidance for researchers and
commissioners on writing proposals for qualitative research and trials.
During interviews, three models of study were identiﬁed: qualitative research as peripheral to the trial,
qualitative research as an ‘add-on’ to the trial and a study with qualitative research and trial as essential
components, with the third model offering more opportunity to maximise the value of the qualitative
research. Interviewees valued the use of qualitative research with trials and identiﬁed team structures
and wider structural issues within health research as barriers to maximising the value of qualitative
research. If impact on the trial was important to the research lead, this shaped the team structure, team
communication, resources and dissemination strategy. There was also an indication that impact of the
qualitative research on the trial occurred within some studies in ways that were invisible to others owing to
structural constraints such as publishing norms, limiting its value to other researchers working on similar
interventions or in similar environments.Conclusion
A large number of articles were published between 2008 and 2010 reporting the ﬁndings of qualitative
research undertaken with trials. They addressed a wide range of aspects of trials and there were examples
of this research affecting the trial by facilitating interpretation of trial ﬁndings, developing and reﬁning
interventions for testing in the trial and changing the measures used in the trial. However, researchers are
not necessarily maximising the value of qualitative research undertaken with trials. Researchers can
maximise value by promoting its use at the pre-trial stage to ensure that the intervention and trial conduct
is optimised at the main trial stage, being explicit about the conclusions for the trial endeavour in
peer-reviewed journal articles reporting the qualitative research and valuing the contribution of the
qualitative research as much as the trial, particularly for complex interventions and health interventions
delivered in complex environments. Wider structural issues such as publishing norms will also need to be
addressed. Future recommendations for researchers include: plan the qualitative research, design and
implement studies not trials, use qualitative research at the feasibility and pilot stage of trials, be explicit
in publications about the impact of the qualitative research on the trial and implications for the trial
endeavour, undertake in-depth qualitative research, allow qualitative research to take a challenging role
and develop a learning environment around the use of qualitative research and trials.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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If qualitative research is undertaken with speciﬁc trials, we would expect that research to impact on that
trial in some way by optimising the intervention or trial conduct, explaining trial ﬁndings or facilitating
transferability of trial ﬁndings in the real world. This may not be occurring and we make the following
recommendations to maximise the value of this endeavour:Researchers
Plan the qualitative research
It is not possible or necessary to use qualitative research to address all the aspects identiﬁed in our
framework in the context of a single trial. Researchers will need to think about the problems
and challenges their planned trial is likely to face and design the qualitative research to address these,
while allowing for a degree of openness and ﬂexibility to address possible emerging issues as the
trial progresses.Design and implement studies not trials
Some lead researchers we interviewed identiﬁed the qualitative research as essential to their desire to
produce evidence relevant to the real world, whereas others described it as an addition to the trial and
even as peripheral to the trial. If it was perceived as essential to the trial, the impact on the trial was
central to the team’s thinking.Use qualitative research at the feasibility and pilot stage of randomised
controlled trials
Qualitative research undertaken at the feasibility or pilot phases of a RCT can impact on the main trial by
optimising the intervention, improving the conduct of the trial or identifying the appropriate outcomes and
measures. This can result in successful and efﬁcient trials, which, we would argue, would be more likely to
have positive results if shown to be feasible. At the pre-trial stage, the research can be iterative, feeding
into the feasibility trial and seeing improvements in recruitment or the intervention during this time.Think about the impact on the trial and implications for the trial endeavour
One of the most problematic things we came across here was the lack of explicit articulation of the effect
of the qualitative research on the trial or the lessons for that trial or future trials. We do not think that the
qualitative research and the trial have to be published in the same article for this to happen. Some authors
show that these lessons can be articulated in the qualitative article. There is an issue about the timing of
the two components working against this and a related ﬁnding was researcher concern about the
contamination of the experiment by the qualitative research, with concern that some intensive techniques
such as diary keeping and interviews can offer a therapeutic effect. This requires thought at the planning
stage so that intensive qualitative data collection on a large proportion of the trial participants can be
undertaken after the collection of important outcome data. There is also the potential for bias for some
endeavours, for example using qualitative research to study variation of outcomes when the outcomes are
already known. Again, the potential for this bias can be considered at the planning stage. There is some
evidence in the wider literature that the qualitative research can take on procedures associated with trials
such as having a published protocol for the process evaluation or qualitative research, which would ensure
planning and thinking about contamination and bias and how to minimise these in the context of a
speciﬁc study.Undertake in-depth qualitative research
Descriptive qualitative research has utility for health-care practice; however, some research questions
required an explanatory approach with in-depth analysis (e.g. asking why the trial ﬁnding was null or
positive) and this could be lacking. We found some undermining of the epistemological roots of qualitative
research in which some researchers described implicit pressure to undertake large samples and structured
interviews. We recommend that researchers engage expertise in qualitative research and resource thexxi
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SCIENTIFIC SUMMARY
xxiiqualitative research in terms of the time, money and stafﬁng required. There is a lot of activity in this ﬁeld
yet researchers present their ﬁndings without necessarily building on learning in the ﬁeld. The approach to
building a conceptual framework from existing qualitative research can help learning from disparate
qualitative research undertaken with trials and there may be other opportunities to develop such models or
make use of existing ones.Allow qualitative research to take a challenging role
We identiﬁed qualitative research as describer, explainer and translator of evidence, with some evidence
also as challenger of current practices.Develop a learning environment about this issue
Some researchers have developed considerable expertise in undertaking qualitative research with trials and
could share this expertise by running training courses and writing about how to undertake this work well.
Researchers new to the ﬁeld of combining qualitative research and trials, both qualitative researchers and
triallists, would beneﬁt from attending these courses and reading some of the exemplars we identify in
this report.Funders
Funding application forms could include requirements for the detail of the qualitative research, for example
specifying the rationale for its use and detail of methods, sample size, analysis and resources required.Ethics committees
Ethics committees could recognise the need for qualitative research to evolve throughout studies without
the need for submission of substantial amendments.Journal editors
Journal editors could consider the importance of applied qualitative research to their readership and,
where it is undertaken with a trial, request that the lessons for trials are made explicit. Electronic
publication, with its associated longer article length, may facilitate this.Funding
This project was funded by the Medical Research Council (MRC) as part of the MRC-National Institute for
Health Research Methodology Research programme.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The use of qualitative research with randomised controlled trials (RCTs) in the health ﬁeld is not new.There are excellent examples and discussions published in the 1990s.1,2 In the 2000s, the Medical
Research Council (MRC) framework for the development and evaluation of complex interventions,
although focusing on neither qualitative research nor trials, highlighted the utility of using a variety of
methods at different phases of the evaluation process, including qualitative research.3–5The contribution of qualitative research to randomised
controlled trialsResearchers have internationally described the contribution qualitative research can make to trials in the
health ﬁeld.2,6–8 These include general statements about ‘harnessing the beneﬁts of trials’ as well as more
speciﬁc contributions around explaining outcomes or variation in outcomes, verifying outcomes from
standardised instruments, explaining how mechanisms work in a theoretical model, developing good
recruitment and consent procedures, understanding how an intervention works in practice, drawing
attention to outcomes important to patients and practitioners, communicating ﬁndings, helping to
interpret the trial results, understanding why an intervention was or was not successful, optimising the
implementation of an intervention in a pilot trial and challenging the underlying theory of the intervention.
Researchers have also described detailed examples of some of these contributions; explicitly showing the
value of the qualitative research to the speciﬁc trial it was undertaken with.1,9Complex interventions
There is an increasing understanding that many of the interventions evaluated in the health ﬁeld are
complex, requiring focus on the ﬁdelity and quality of implementation of the intervention, clariﬁcation of
the causal mechanisms and exploration of any variation in outcomes.5 Thus, qualitative research is likely to
be essential at some stage of developing or evaluating complex interventions. It may also be useful for
simpler interventions such as those in drug trials for which the complexity may not be related to the
intervention itself but to the lives of the people who will take the drug or the environment in which the
trial of that drug operates.Context
There is increasing reference in the literature on interventions and trials to the importance of
understanding the effect of the context in which an intervention is delivered within a trial10 and the role of
qualitative research in facilitating this understanding.7,11 Those designing interventions need to understand
the context in which they will operate and when reporting trials, researchers need to describe the context
in which the intervention was evaluated so that users of that research can transfer ﬁndings to their own
context.4 Indeed, Hawe et al.12 describe a ‘process and context evaluation’. Wells et al.10 explore the role
of context in trials rather than the role of qualitative research per se; nonetheless, their study is highly
relevant to the role of qualitative research with trials. Through the use of multiple case studies of trials of
complex interventions, they identiﬁed that context is important to understanding the mechanism and
generalisability of complex interventions, for instance, context may shape the intervention and ﬁdelity to
the intervention, the scale of the problem the intervention seeks to address may be context speciﬁc and
practitioners’ enthusiasm for the intervention may affect the quality of the trial as well as the intervention.
They also point out that some of the assumptions underpinning trials may be compromised owing to
tensions between the ideal of a trial and the reality of implementing it in the real world and propose that
the concept of reﬂexivity would encourage more realistic accounts of trials which may ultimately lead to
better understanding of effectiveness studies. This highlights the utility of qualitative research not simply
for trials of complex interventions but trials and interventions operating in complex environments.1
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INTRODUCTION
2Process evaluations
Process evaluations have been conducted since the mid-1980s to improve understanding of applied
interventions and in particular to consider conditions under which the intervention is effective, for whom it
is effective and the key mechanisms by which the intervention works.13 Linnan and Steckler13 propose that
process evaluations can be used for both positive and negative trials to understand which components of
the intervention contributed to its effectiveness or to understand why the trial was unsuccessful. They list
seven key components of a process evaluation: context, reach, dose delivered, dose received, ﬁdelity,
implementation and recruitment. Oakley et al.14 list a similar range of issues that process evaluations can
address alongside trials, including understanding implementation of the intervention, contextual factors
that affect an intervention, dose of intervention, variation in outcomes and interpretation of the trial
ﬁndings. These issues overlap with the contribution qualitative research can make to trials when the
qualitative research occurs during rather than before or after the trial. However, it is important to
understand that process evaluations can be fully quantitative, fully qualitative or mixed methods, drawing
on combinations of surveys, documents, observation and interview and, therefore, they should not be
conﬂated with qualitative research.14 Because qualitative research can be a key component of process
evaluations, and, indeed, Oakley et al.14 argue that process evaluations should be both qualitative and
quantitative, it was important to consider process evaluations when assessing the contribution of
qualitative research to trials.The rationale for the QUAlitative Research in Trials study
(maximising the value of QUAlitative Research with Trials)Researchers have identiﬁed the potential value of undertaking qualitative research with trials and there are
examples of its application in the literature.1,9 However, there is a need to take stock of this whole
endeavour and consider how qualitative research is being used in practice and whether or not its potential
is being maximised. The impetus for the QUAlitative Research in Trials (QUART) study came from a sense
that there were problems with gaining value from this work. A member of our team had participated in
the commissioning of trials in health care in the UK and raised concerns about how useful the planned
qualitative research would be for the trial with which it was being commissioned because researchers
sometimes failed to be explicit about the work the qualitative research was doing for the speciﬁc trial. For
example, qualitative research with the aim of ‘exploring patients’ and health professionals’ experiences of
the intervention’ raised the question of how this would enhance, add value or impact on the speciﬁc trial it
was being commissioned with. This prompted the development of the QUART study, with the aim of
assessing the contribution qualitative research undertaken with trials makes to the speciﬁc trial. The
concern was related to our team’s more general interest in maximising the potential of mixed methods
research.15 However, our perspective in the QUART study was different because, rather than being
interested in the whole mixed methods study of a RCT and qualitative research, we were interested in
maximising the value of the qualitative research for the speciﬁc trial. Our focus was on the utility of the
qualitative research,16 viewing qualitative research within an ‘enhancement model’,17 whereby we were
interested in how qualitative research enhances the trial, rather than how it makes an independent
contribution to knowledge. Flemming et al.7 describe this as ‘enhancing evidence from trials’.Existing frameworks for the use of qualitative research with randomised
controlled trials
Researchers have described a variety of contributions of qualitative research to trials and intervention
studies. Frameworks are useful because they can help novice researchers to learn about these
contributions and more experienced researchers to select from the full range of contributions when
designing studies. We found two existing frameworks of the use of qualitative research with trials:
l A temporal framework of the contribution of qualitative research before, during and after a trial.2,6,8
These authors offer a list of contributions of qualitative research at these three time points of a trial.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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has been used by Jansen et al.11 to document the contribution of qualitative research to the
development of community-based interventions in primary care.
Flemming et al.7 do not put forward a framework but structure their consideration of how mixed methods
research can generate evidence for palliative care around study planning, recruitment, conduct and
implementation. This draws on a combination of the two frameworks presented above. These frameworks
were based on the authors’ research experience, practical examples of the use of qualitative research and
trials, and the authors’ perceptions of the potential contribution of qualitative research to trials. We
wanted to develop a framework inductively, based on empirical evidence of the contribution made,
recognising that the most appropriate framework might be one of the two already in existence.Focus on specific trials
Qualitative research can be undertaken to explore trials in general. For example, qualitative interviews can
be undertaken with key trial stakeholders about strategies to improve recruitment to trials generally. This
can be a useful endeavour but was not the focus of the QUART study, for which the interest was the value
of qualitative research undertaken with speciﬁc trials.Defining value
In the QUART study, we deﬁne the value of qualitative research undertaken with a speciﬁc trial as the
‘work’ the qualitative research does for, or the ‘impact’ it has on, that trial. For example, it contributes to
optimising the intervention prior to the main trial or it explains the trial ﬁndings. However, when we
undertook the ﬁrst component of the QUART study – the systematic mapping review of journal articles
reporting the qualitative research – few articles described the impact of the qualitative research on the
speciﬁc trial. Instead, the authors described the conclusions of the qualitative research, sometimes explicitly
articulating the value of the qualitative research for the speciﬁc trial or sometimes for future trials or the
work that trials are engaged in, namely the provision of evidence of effectiveness of health interventions
(we call this ‘the trial endeavour’ within this report). So, although the QUART study focus was on the value
of the qualitative research to the speciﬁc trial, we had to widen our deﬁnition of value when assessing
articles reporting the qualitative research. In addition, as the authors of these articles did not necessarily
articulate the value for the speciﬁc trial or the trial endeavour, or that any value was attained in practice,
we sometimes found ourselves having to make a subjective assessment of the ‘potential value’ of that
qualitative research.Maximising value
Jansen et al.11 identiﬁed how the value of qualitative research may not currently be maximised in practice.
They studied 33 trials in which qualitative research was used to develop an intervention and identiﬁed that
it was rarely used to improve or tailor interventions to ﬁt with primary care, so that interventions were
delivered as planned rather than adjusted to local circumstances. We took a similar approach to
Jansen et al.11 by considering what researchers were doing and reporting in practice and considering
any gaps in this practice that would allow those producing and applying research ﬁndings to maximise
the value of this qualitative research. We took this approach because there is no agreed consensus on the
value that should be attained from undertaking qualitative research with trials.The boundaries of the QUAlitative Research in Trials study
The QUART study focused on:
l RCTs in health rather than in other ﬁelds such as social or educational research
l qualitative research undertaken in the context of speciﬁc trials rather than the body of research for
which qualitative research is used to explore trials as a social process or to explore an aspect of trials
more generally3
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INTRODUCTION
4l the qualitative research component rather than the whole study or the trial
l all interventions, including complex interventions
l research published in English.Aims and objectives
Aim
To identify the range of ways qualitative research is used with speciﬁc trials and how to maximise its value
to the speciﬁc trial.Objectives1. To map and quantify the range of ways qualitative research is used with trials.
2. To identify good practice and ways of maximising the value of the qualitative research in this context.
3. To explore researchers’ perspectives on the current practice of combining qualitative research and trials.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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study with four components. First, a systematic mapping review of peer-reviewed journal articles reporting
qualitative research undertaken with speciﬁc trials; second, a review of the documentation of studies
which combined trials and qualitative research; third, a survey of lead investigators of trials that appeared
not to have used qualitative research, and these three components were followed by a fourth component
of a qualitative interview study of researchers identiﬁed from these articles and studies.Methods
Systematic mapping review of published journal articles
We undertook a database search of peer-reviewed journals between January 2008 and September 2010
for articles reporting qualitative research undertaken with speciﬁc trials. The aim was to map the range of
contributions of the qualitative research to the speciﬁc trial and identify good practice and ways of
maximising value.Review of studies
Not all qualitative research undertaken with trials is published in peer-reviewed journals.8 We undertook a
systematic search of the metaRegister of Controlled Trials (mRCT), a database of registered trials, to
identify trials funded in the UK and ongoing between 2001 and 2010 that reported the use of qualitative
methods on the trial database. The aim was to explore the potential contribution of the qualitative
research to the speciﬁc trial and consider good practice in terms of how it was presented in proposals and
reports. This also offered insights into recent practice because some studies started in 2010, whereas
studies in the mapping review started much earlier than this.Survey of lead investigators
We anticipated that qualitative research undertaken with trials would not necessarily be described on the
mRCT database. Therefore, we undertook a survey of lead investigators of trials with no apparent
qualitative research on the mRCT database of registered trials funded in the UK. The aim was to identify
‘invisible’ qualitative research and its contribution to the speciﬁc trial.A qualitative interview study with researchers
We undertook a semistructured telephone interview study with researchers purposively sampled from the
ﬁrst three components of the study. The aim was to explore researchers’ perceptions of how to maximise
the value of qualitative research with trials and the facilitators and barriers to this.Report structureWe report the methods, ﬁndings and discussions of each component in separate chapters (Figure 1).
Then we integrate these in Chapter 7 and discuss the integrated ﬁndings in Chapter 8.5
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Mapping review of published articles
Chapter 4
Studies of RCT and qualitative research
Chapter 5
Survey to identify invisible qualitative
research
Chapter 6
Qualitative interview study
with researchers
FIGURE 1 Mixed methods design as reported in separate chapters.
DESIGN AND OVERVIEW OF METHODS
6Public and patient involvement
We held a meeting with two members of the public as part of our public and patient involvement (PPI) for
the QUART study. Both were identiﬁed because they had been PPI representatives on trials. One person
had been an active PPI member of a mixed methods pilot trial and another a PPI member of a drug trial
and, it transpired, had also recruited participants into trials as part of their job. We met during the early
stages of the mapping review and asked them to read two articles reporting qualitative research
undertaken with trials and discuss the content of these articles with the QUART team. They were
extremely positive about the need to include qualitative research with trials because, for them, the
qualitative research paid attention to the views and needs of people, bringing to the fore the human
beings that recruit to, or participate within, trials. This meeting shaped our understanding of the value of
the qualitative research and highlighted the need for our team to ensure that we paid full attention to the
positive aspects of the research we read.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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published qualitative research undertaken with
speciﬁc randomised controlled trialsAimWe undertook a review of peer-reviewed journal articles reporting the qualitative research undertaken with
a speciﬁc trial in order to map the contribution of aspects of trials addressed by the qualitative research.
We then sought to identify good practice and missed opportunities within articles to understand how to
maximise the value of qualitative research undertaken with speciﬁc trials when reporting the qualitative
research in a journal article.
We identiﬁed problems with our intended approach early in this process. We had assumed that these
articles would explicitly state the contribution the qualitative research had made to the speciﬁc trial, for
example optimised recruitment processes or explained trial ﬁndings. However, we found that this rarely
occurred and that the contribution was often directed at future trials and the trial endeavour of generating
evidence of effectiveness of health interventions. We also found that authors did not necessarily articulate
the contribution and we had to draw this out ourselves. As there was rarely evidence that this value had
occurred, we refer to potential value throughout this chapter. In this chapter we address two issues:
1. the aspect of the trial addressed by the qualitative research
2. its potential value.
First, we identiﬁed the aspect of the trial addressed by the qualitative research by considering the stated
aim of the qualitative research in the article. This was often general rather than speciﬁc so we discarded
this approach and considered the actual focus of the journal article. For example, a stated aim might be
‘to interview participants who have experienced the intervention in a pilot trial to explore their views of the
intervention’ but the focus of the article was ‘identifying problems with the feasibility of the intervention’.
Second, we considered the potential value ﬁrst in relation to the trial and then we attempted to abstract
this to consider value to the trial endeavour. For example, the impact on a trial of identifying problems
with the feasibility of an intervention might be the intervention was reﬁned for use in the main trial and its
abstracted potential value might be ‘optimising the intervention for the main trial’ and ‘saving money by
not undertaking a large expensive trial of a suboptimal intervention’.Methods
Systematic mapping review
We undertook a ‘mapping review’ or ‘systematic map’ of published journal articles reporting qualitative
research undertaken with speciﬁc RCTs.19 The aim of this type of review is to map out and categorise
existing literature on a particular topic, with further review work expected. Formal quality appraisal is not
expected and synthesis is graphical or tabular. We called our review a ‘systematic mapping review’
because labels for different types of reviews are not consistent.19 This review involved a systematic search
for published articles reporting qualitative research undertaken with speciﬁc trials and categorisation of the
uses made of qualitative research into an inductively developed framework. This was followed by detailed
synthesis of articles within each category to identify the potential value and ways in which value had been
maximised, followed by synthesis of these issues across all categories. We did not aim to synthesise
ﬁndings from these studies.7
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SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
8Mapping review search strategy
Our plan was to search for articles published between 2001 and September 2010, which was the last full
month prior to our search. We searched the following databases: MEDLINE, PreMEDLINE, EMBASE, The
Cochrane Library, Health Technology Assessment (HTA), PsycINFO, CINAHL, British Nursing Index, Social
Sciences Citation Index and Applied Social Sciences Index and Abstracts. We used two sets of search
terms, one to identify RCTs and one to identify qualitative research, searching for journal articles that
included both sets of terms. The search terms for RCTs are well documented. We adapted The Cochrane
Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE.20 The search terms for
qualitative research were more challenging. We started with a qualitative research ﬁlter21 but this returned
many articles that were irrelevant to our study. We made decisions about the terms to use for the ﬁnal
search in an iterative manner, balancing the need for comprehensiveness and relevance.20 We tested a
range of terms in MEDLINE and held team discussions about the speciﬁcity and sensitivity of different
terms. The ﬁnal search strategy is reported in Appendix 2. We identiﬁed 15,208 references, which was
reduced to 10,822 after electronic removal of duplicates. We downloaded these references to a data
management software program Endnote X5.0.1 for windows (Thomson Reuters, CA, USA).Mapping review inclusion and exclusion criteria
Our inclusion criteria were English-language articles published between 2001 and September 2010
reporting the ﬁndings of empirical qualitative research studies undertaken before, during or after a speciﬁc
RCT in the ﬁeld of health. These could include qualitative research reported within a mixed methods
article. Our exclusion criteria were:
l not a journal article (e.g. conference proceedings, book chapter)
l no abstract available
l not a speciﬁc RCT (e.g. qualitative research about hypothetical RCTs or RCTs in general)
l not qualitative research
l not health related
l not a report of ﬁndings of empirical research (e.g. published protocol, methodological paper, editorial)
l not reported in English
l not human research.Screening references and abstracts for the mapping review
We applied the exclusion criteria electronically to the 10,822 references and abstracts. The numbers of
references identiﬁed increased each year (Figure 2). We do not report 2010 in Figure 2 because we did not
search the full year.
Owing to the large number of references identiﬁed, we made the decision to focus on articles published
between January 2008 and September 2010. The rationale was that the most recently published articles
would offer the most useful insights to future researchers. This resulted in 3745 references and abstracts,
with 739 excluded by electronic application of exclusion criteria (Table 1). One of the research team (SJD)
read the abstracts of the remaining 3006 references and excluded a further 2506. The most common
reasons for exclusion were that the abstract did not refer to a RCT, did not use qualitative research or did
not report empirical research (Figure 3 and see Table 1). There were 500 abstracts after this screening
process. Two members of the research team (KJT and AO) reviewed a sample of 100 excluded abstracts to
check the reliability of the exclusion process. Each read 50 abstracts and placed them into the exclusion
categories. Of the 100 abstracts reviewed, all were categorised as exclusions. There was some
disagreement about which exclusion category was most appropriate for 16 abstracts. These disagreements
were resolved with discussion between team members. Further screening was undertaken on full articles
(see Categorisation based on full articles).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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FIGURE 2 Numbers of references identified in an electronic search for qualitative research undertaken with RCTs
between 2001 and 2009.
TABLE 1 Reasons for exclusion of articles from the mapping review
Criterion
Electronic screening
of 3745 references
Screening of abstracts
of 3006 articles
Screening of
500 full articles
Duplicates 0 8 17
Not a journal article 29 2 0
No abstract 65 0 –
Not RCT 2 1102 60
Not qualitative research 1 609 89
Not health related 2 69 0
Not empirical 640 708 31
Other: not English, not human,
full article not found
0 8 7
Total exclusions 739 2506 204
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10Preliminary categorisation of abstracts using the stated aim
of the qualitative research
We did not set out with a plan of how we would develop our map or framework. As we proceeded, we
realised that the approach we were taking was similar to the ﬁve stages of ‘framework analysis’, an
approach to analysing qualitative data.22 The stages of framework analysis are ‘familiarisation’ with the
data, ‘identifying a thematic framework’, ‘indexing’ by applying the framework systematically to the data,
‘charting’ by putting data related to a theme together and ‘mapping and interpretation’ to think about the
meaning of the ﬁndings in relation to original purpose of the research.
As a starting point for the categorisation of qualitative research we undertook the ﬁrst three stages of
‘framework analysis’. We familiarised ourselves with the articles by reading a small set of abstracts
(n = 122). We identiﬁed a thematic framework by using the stated aim of the qualitative research within
the abstract to identify categories and subcategories of a ‘preliminary framework’. We also considered the
potential of the temporal framework6,8 and the MRC framework for the evaluation of complexNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38interventions3 as our overarching framework. We found that the information given in the abstracts did not
include details necessary for mapping onto these frameworks. After team discussions, we ﬁnalised our
preliminary framework and one team member (SJD) ‘indexed’ by applying it to the stated aim of the
qualitative research in our 500 abstracts, open to emergent categories which were then added to
the framework (Table 2). The purpose of this initial categorisation was to create meaningful categories to
enable a second, more in-depth, process of categorisation at a later stage.TABLE 2 Preliminary categorisation of 500 abstracts
Category Subcategory Numbers of abstracts
Intervention Patient views of intervention in RCT 114
Professional views of intervention in RCT 35
Develop the intervention 94
Build explanatory model of how intervention works 12
Factors inﬂuencing intervention delivery 19
Evaluation of intervention 38
Design and conduct Recruitment for RCT 50
Being part of trial 25
Would patients participate in trial? 19
Trial design (acceptability of some designs) 11
Outcomes Variation in outcomes 14
Accuracy of outcome measures 15
Additional outcomes following trial 22
Outcome tool development 18
Disease Patient views of disease 20
Professional views of disease 5
Dissemination Dissemination of trial results 4
Unclassiﬁable Do not know 10Categorisation based on full articles
We obtained copies of full articles for the 500 included abstracts. All members of the team read articles
from across the categories before selecting a category to lead on and engaging in a process similar to
framework analysis:
Step 1: familiarisation – we read the full articles in the category, including those that had been moved
from another category by other team members.
Step 2: further exclusion – we excluded some articles on further reading, for example those that did not
report qualitative research. Application of exclusion criteria became challenging and these challenges
are discussed in Challenges applying the framework. We excluded another 204 articles at this stage
(see Table 1 and Figure 3).11
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12Step 3: identiﬁcation of a thematic framework through recategorisation and development of
categories and subcategories – we recategorised any articles that, after full reading, did not appear to
ﬁt into the allocated category or subcategory. We considered whether subcategories were right and
changed their titles, their order in the category and added or collapsed subcategories. We held in-depth
discussions about a number of articles to help us deﬁne the unique characteristics of a particular
subcategory. At this stage we felt that the preliminary categorisation based on the stated aim of the
article did not necessarily describe the focus actually taken by the qualitative research presented in the
article. For example, articles that were originally categorised as ‘patient view of intervention’ were put into
new categories such as identifying the ‘perceived value and beneﬁts of intervention’. This recategorisation
stage required a considerable amount of discussion between team members, with all members reading
abstracts and articles, and discussing disagreements in terms of allocating articles to categories.
Step 4: ‘indexing’ or allocation of articles – each article was allocated mainly to one subcategory but
some had more than one focus and were categorised into two or more subcategories.
Step 5: data extraction or ‘charting’ – we undertook formal data extraction for up to six articles from
each subcategory. For subcategories with more than six articles, we randomly selected articles with the
exception of the ‘intervention’ category. Because this category had very large subcategories, we undertook
purposive sampling to ensure we displayed the range of articles within each subcategory. During data
extraction, we described authorship, the qualitative methods, the RCT, the intervention, the stated aim of
the qualitative research, the aspect of the trial addressed by the qualitative research and the potential
value of the qualitative research for the trial endeavour (see Step 6). Reﬂections on good practice and ways
in which the value of the qualitative research for RCTs could have been maximised were largely based on
these data extractions of six articles per subcategory. However, these reﬂections were also informed by our
wider reading of all the articles within that subcategory. This step was similar to the ‘charting’ stage of
framework analysis for which data within a theme are studied in depth. Matrices of subthemes and
interviewees are created in the standard approach to framework analysis. We created ﬁgures based on
descriptive data and display them in the ﬁndings.
Step 6: identifying potential value for articles in the data extraction – we had intended to extract
the value of the qualitative research to the speciﬁc trial. During team discussions, we identiﬁed that the
value of the qualitative research was not necessarily explicitly articulated within the articles. When it was
not explicit, we made a subjective assessment of potential value based on reading the article and our own
subjective assessment of issues we had identiﬁed in background reading in Chapter 1. In practice, authors
of these articles implicitly discussed value through how they framed the article in the introduction and the
issues they alluded to in the discussion. We considered these to be potential value rather than actual value
because authors rarely evidenced impact that occurred in practice. We developed a tick box set of values
for the data extraction form but mainly used a free text box to record potential value.
Step 7: identifying exemplars – for each subcategory, we attempted to identify an article that we
judged as undertaking that type of work well. Key considerations were how explicit authors were about
the impact of the qualitative research on the speciﬁc trial or the message for the wider trial endeavour and
the depth of insights described in the article.
Step 8: describing the type of intervention – ﬁnally, two members of the team worked together to
categorise the intervention for articles in the data extraction (AO and KJT). Each independently categorised
the intervention into ‘drug or device’ or ‘complex intervention’. This was a crude categorisation based on a
brief description of an intervention in the qualitative article. Our approach was to identify RCTs of drugs
and devices (including surgery and acupuncture) and then categorise any others as complex interventions
because of the lack of detail required to classify an intervention as complex with any conﬁdence. We then
compared our categorisations and discussed disagreements to reach consensus.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Challenges applying the framework
We met four key challenges during this categorisation process and resolved them during team discussions
as follows.Maintaining perspective
Qualitative research generates knowledge and has value outside the context of RCTs. As stated earlier,
our goal was to categorise the contribution of qualitative research to the trial endeavour. This felt
uncomfortable at times because we were ignoring the strengths and value of qualitative research in its
own right. We resolved this difﬁculty by ensuring that we were transparent about the perspective we
were taking.Defining ‘specific randomised control trial’
We met three challenges here. First, some trials were referred to as a ‘clinical trial’ or ‘trial’ and it was not
clear if they were RCTs; therefore, we took a generous approach to including these articles. Second,
sometimes the qualitative research was undertaken regarding a set of trials rather than a speciﬁc trial, for
example a programme of trials on asthma in a single medical centre involved in trial recruitment. We did
not want to include the vast literature for which qualitative research is used to explore different aspects of
trials in general but decided to include articles based on sets of trials about a speciﬁc disease or patient
group, for example undertaken in a neonatal trials unit, because of the possibility that the qualitative
research could impact on that set of trials. Third, we were clear that hypothetical trials were excluded
but made an explicit decision to include any hypothetical trials we identiﬁed in our two ‘in principle’
subcategories in which there was evidence of a commitment to undertake a trial if the intervention or trial
design were acceptable (Table 3 shows ﬁnal categories including ‘acceptability of the intervention in
principle’ and ‘acceptability of the trial in principle’). Therefore, there was some blurring of our boundaries
and in data extraction we identiﬁed these as ‘grey’ articles.
Defining ‘qualitative research’
We could not rely on the article authors’ use of the term ‘qualitative research’; for example, some authors
called surveys a qualitative method. We deﬁned qualitative research as qualitative data collection
(interviews, focus groups, observation, documents) and analysis (textual analysis, usually supported by
quotes). We found many articles based on open questions in surveys or unstructured interviews reduced to
quantitative ﬁndings reported as percentages. We generally excluded these but found it difﬁcult to decide
on this boundary for some articles. For example, an open question on a survey resulted in a detailed
textual analysis so we included it. Again, there was some blurring of our boundaries and in data extraction
we identiﬁed these as ‘grey’ articles.Distinguishing the contribution of the qualitative research from other
methods and approaches
Some articles reported mixed methods research and we had to work hard to distinguish ﬁndings based on
the qualitative rather than the quantitative research. We felt we were generally successful but that it was
much harder to distinguish the contribution of qualitative research within articles reporting participatory
action research.Quality appraisal
Quality appraisal is not essential for mapping reviews.19 We stated in our proposal that we would consider
quality but our aim was not to judge the quality of the qualitative research. However, we did commit to
explicitly reviewing our exemplars using accepted quality criteria. We revisited this during the study and
discussed the beneﬁts of either applying a quality assessment checklist to all articles or to only those we
selected as exemplars. We identiﬁed the Critical Appraisal Skills Programme checklist for the appraisal of
qualitative research as a simple and well-regarded checklist.23 We decided not to apply it to all 296 articles
for two reasons. First, the methodological quality of these types of articles has already been assessed for
30 qualitative studies undertaken with RCTs.8 That study found that there was not sufﬁcient information in
one-third of these 30 studies to assess methodological quality and considerable weaknesses were13
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14found for the rest, including inadequate description of sampling and analysis. Second, our interest was
different – we wanted to assess quality deﬁned as the contribution the qualitative research made to the
trial endeavour and identify quality issues speciﬁc to this. We decided not to apply quality criteria to our
exemplars because we wanted the keep the focus on quality in terms of the impact of the qualitative
research on the speciﬁc trial or the message for the wider trial endeavour.Synthesis within and across subcategories
We identiﬁed good practice and ways of maximising value within each subcategory by reading the articles
and identifying issues that were present in some articles and missing from others. Then we asked
questions within the whole subcategory: why did researchers do the qualitative research? Did it seem like
a useful thing to do? What did some researchers do that felt helpful? What could have been done to
improve the value of the research for the trial endeavour? Finally, we identiﬁed commonly occurring
themes across the subcategories. This was similar to the ﬁnal stage of framework analysis, ‘mapping and
interpretation’, in which researchers consider relationships between themes in the context of the original
research question.FindingsWe present the ﬁndings in four sections:
l framework of the use of qualitative research with trials
l detailed description of framework subcategories with examples
l the potential value of qualitative research with trials
l the rationale for the QUART study (maximising the value of QUAlitative Research with Trials).Framework of the use of qualitative research with trials
Size and characteristics of the evidence base
We identiﬁed 296 articles published between January 2008 and September 2010. The references of these
articles are listed in Appendix 3. There was no evidence of increasing numbers per year in this short time
period: 113 articles in 2008, 105 in 2009 and 78 in the ﬁrst nine months of 2010 (equivalent to 104 in a
full year).
Most of the ﬁrst authors were based in the USA (107 articles) and the UK (97 articles), with others based
in Scandinavian countries (21 articles), Australia (20 articles), Canada (15 articles), South Africa
(seven articles), New Zealand (ﬁve articles), Spain (ﬁve articles) and a range of other countries in Africa
(six articles), Asia (six articles) and Europe (seven articles). The journals these articles were published in are
listed in Appendix 4.Framework of the focus of the qualitative research
As we read the full articles and discussed the content within the team, the framework presented in Table 2
developed into ﬁve broad categories related to:
l the intervention being tested
l the trial design and conduct
l outcomes
l measures used within the trial
l the condition studied in the trial.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Subcategories also developed further; for example, the subcategories of ‘patient views of the intervention’
and ‘professional views of the intervention’ disappeared because we were interested in the insights offered
by these views for the trial. For example, we developed a subcategory of ‘acceptability of the intervention
in principle’ that was always based on exploring the views of patients and/or professionals. At this stage,
some articles were reclassiﬁed to a different category when the focus of the full article conﬂicted with the
focus described in the abstract. Some articles were classiﬁed into two or more subcategories, usually
within the same category. We identiﬁed 22 discrete subcategories within the ﬁve broad categories and
identiﬁed 356 incidents of these within the 296 articles (Table 3).TABLE 3 Framework of how qualitative research was used with speciﬁc trials in 296 articles
Category Subcategory n (%)
Intervention content and delivery 254 (71)
Intervention development 48 (13)
Intervention components 10 (3)
Models, mechanisms and underlying theory development 23 (6)
Perceived value and beneﬁts of intervention 42 (12)
Acceptability of intervention in principle 32 (9)
Feasibility and acceptability of intervention in practice 83 (23)
Fidelity, reach and dose of intervention 12 (3)
Implementation of the intervention in the real world 4 (1)
Trial design, conduct and processes 54 (15)
Recruitment and retention 11 (3)
Diversity of participants 7 (2)
Trial participation 4 (1)
Acceptability of the trial in principle 5 (1)
Acceptability of the trial in practice 4 (1)
Ethical conduct 16 (4)
Adaptation of trial conduct to local context 2 (1)
Impact of trial on staff, researchers or participants 5 (1)
Outcomes 5 (1)
Breadth of outcomes 1 (< 1)
Variation in outcomes 4 (1)
Measures 10 (3)
Accuracy of measures 7 (2)
Completion of measures 1 (< 1)
Development of measures 2 (1)
Condition Experience of the disease, behaviour or beliefs 33 (9)
Total uses 356 (100)
15
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16Distribution within subcategories
The majority of the articles focused on the intervention (66%, 196/296), with few articles focusing on
measures and outcomes (see Table 3). This imbalance between categories may reﬂect practice or may be
due to some activities undertaken in relation to trials not being published or not being identiﬁed by our
search strategy. The subcategories that each of the 296 articles were allocated to are shown in Appendix 3
at the end of each reference.Timing of the qualitative research
A total of 28% (82/296) of articles reported qualitative research undertaken at the pre-trial stage, i.e. as
part of a pilot, feasibility or early-phase trial or study in preparation for the main trial. Some activities
would be expected to occur only prior to the main trial, such as intervention development, and all of these
articles were undertaken pre-trial. However, others that may also be expected to occur prior to the trial,
such as ‘acceptability of the intervention in principle’, occurred frequently during the main trial. This is
discussed in more detail in the next section on the individual subcategories (see Detailed description of
framework subcategories with examples).
It was not possible to categorise articles using the temporal framework before, during and after the trial6,8
because it was unclear in many articles when the data collection for the qualitative research was
undertaken in terms of during or after the trial. Sometimes data collection was undertaken after the
intervention ended, after the last outcome was measured, or after the trial ﬁndings were known.
Sometimes the data analysis was undertaken at these different stages based on data collected during
the trial. Often it was not clear precisely when the data collection or analysis was undertaken.Detailed description of framework subcategories with examples
In this section we explore each of the 22 subcategories identiﬁed in Table 3 in detail. We based this on
reading all the articles and the detailed data extraction on up to six articles per subcategory and extracting
data on 104 articles in total. These subcategory assessments were subjective, inductive and emergent,
shaped by the articles we found and by our values and interests. Within each subcategory we:
l describe the subcategory
l give examples of articles within it (see the relevant table within each subcategory)
l identify which of the examples focused on drugs or devices and which on complex interventions (see
the relevant table within each subcategory)
l indicate an exemplar in the ﬁgure of examples
l explore the potential value of using qualitative research to this purpose
l offer suggestions for good practice.Category 1: content and delivery of the trial intervention
The ﬁrst category focused on the intervention being tested in the trial and was by far the largest category,
accounting for 254 of the 356 uses of the qualitative research (71%). Qualitative research was used to
explore eight aspects of the content and delivery of trial interventions from development through
to implementation in the real world (see Table 3):
1. intervention development
2. intervention components
3. models, mechanisms and underlying theory development
4. perceived value and beneﬁts of intervention
5. acceptability of intervention in principle
6. feasibility and acceptability of intervention in practice
7. ﬁdelity, reach and dose of intervention
8. implementation of the intervention in the real world.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Development of the trial intervention
Qualitative research to support intervention development may be undertaken as part of a formal
evaluation framework that advocates the use of theoretical and feasibility modelling prior to testing an
intervention in a trial,3 or it may be undertaken without a formal framework, with the clear intention to
create, or reﬁne, all or part of an intervention for testing within a trial. Our criterion for including studies in
this subcategory was that the qualitative ﬁndings reported substantive development of the intervention
content or delivery. We expected these interventions to be complex interventions involving behavioural
aspects of care delivery or receipt. We identiﬁed 48 articles, all of which included qualitative research
undertaken prior to a planned main trial. Many of these studies used mixed methods research and some
described other pre-trial work in conjunction with the intervention development, such as testing possible
outcome measures for use in the full trial and trial design issues such as recruitment and retention. We
selected six examples purposively to include a range of interventions: clinical, educational and professional.
These are described in Table 4. The focus of the qualitative research was always clearly related to the
speciﬁc trial and the qualitative methods included interviews, focus groups and non-participant
observation. The research subjects were drawn from members of the public, potential trial participants and
professionals involved in the delivery of the proposed intervention.Potential value of using qualitative research to develop interventions
Intervention development undertaken in a pre-trial context can strengthen the relevance of a trial by
optimising the intervention and/or its delivery from the perspective of recipients and providers. The
rationale for this use of qualitative research fell into three categories:
1. The need to optimise an existing intervention that has some clinical or practice history in order to
ensure that the ‘best’ intervention is tested in the trial. Multiple versions of an existing intervention may
be in use with no identiﬁable ‘gold standard’ and the problem may be presented as needing to develop
an optimised intervention.
2. The need to adapt an existing intervention for use in a different context:
– A new clinical or practice context, for example a similar programme of care for a different patient
group or a hospital service delivered in primary care.
– A different geographical context for which the goal is to adapt a successful intervention developed
in one country for use in another country where health services and health-care delivery differ
(e.g. Gulbrandsen’s ‘Four Habits’25).
– A different cultural context that may require adapting a mainstream intervention for use with a
speciﬁc minority group or subgroup of a clinical population (e.g. Nagel’s Torres Strait Islanders28 or
Marciel’s adolescents with cystic ﬁbrosis27).3. The need to develop a ‘de novo’ intervention, based on perceived clinical or practice need and, often, a
theoretical understanding of the nature of the required intervention.26,29
The driver for undertaking qualitative research in this context was not clinical appropriateness, but
rather the need to explore the intervention as part of a matrix of health-related social behaviour on the
part of patients, carers, health professionals or communities. That is to say, articles described participants
in terms of their social and behavioural characteristics and explore experiences and beliefs from the
perspective of a community of recipients or carers, a community of professionals delivering the
intervention, or a particular context of delivery (primary care, community care, web-based care). Key to this
was the way in which the research participants were deﬁned and the issues particular to the group that
were predicted to be relevant. Examples of this included women living with human immunodeﬁciency virus
(HIV) who were also fulﬁlling the role of mothers,24 people with mental health problems who were also
part of a minority indigenous group with speciﬁc cultural characteristics,28 or physicians who delivered care
within the context of a particular national culture and its health-care system.2517
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SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
20In order to achieve the research goal of identifying the best possible (or most appropriate) intervention for
testing in a full trial, the need to attend to the health-related behaviours and beliefs of relevant groups (to
be accessed via their experiences and perspectives) was the starting point and rationale for most of the
qualitative research undertaken in this subcategory, whether the intervention was being designed de novo,
being optimised or being adapted for use in a new context. In addition, some studies reported the
importance of qualitative research in the development phase of a trial in terms of the opportunity to
engender ‘stakeholder support’ for the trial process.26–28 This was described as operating both at an
individual level (patient and professional) and at a community level.26–28
Suggestions for good practice and maximising value (for intervention development):
i. Be clear that changes were made to the intervention
l In some cases, the qualitative ﬁndings resulted in a demonstrated change being made to the
intervention content or delivery. In others, conﬁrmation of acceptability was the real objective of
the study. Good practice would entail making a clear distinction between these two aims
within articles.
ii. Ensure changes to the intervention are grounded in the data
l When the aim of the qualitative research was to develop the intervention for a planned trial, it was
important for researchers to demonstrate the mechanisms by which the qualitative data inﬂuenced
the ﬁnal intervention design. For this to happen it was necessary for the changes to be convincingly
grounded in the data. This did not always occur, perhaps owing to limited article word count
because in papers reporting the development of the intervention alongside the trial results, very
little space was allocated to the qualitative component and its impact was usually reported rather
than demonstrated.
iii. Place within an evaluative framework
l The MRC framework for the development and evaluation of complex interventions offers
endorsement for the practice of undertaking qualitative research to support intervention
development.3 A conceptual framework for the qualitative research, such as the MRC framework,
was not used in the majority of articles in this subcategory. One advantage of using such a
framework may be to raise the proﬁle and status of the qualitative research contributing to
intervention development and to ensure that its contribution is documented. For example,
referencing and using the MRC framework, the authors of one paper were able to claim that their
goal was the development of ‘the deﬁnitive risk-factor management intervention’.29Describing the trial intervention and elaborating its components
In this subcategory, the qualitative research supported a description of a trial intervention, or one or more
components of a complex intervention. We included articles for which qualitative methods were employed
to generate essential data for the description, usually taking into account recipients’ experiences during
the trial. These descriptive accounts could be based on mixed methods research, combining qualitative
data about patients’ experiences with quantitative data relating to satisfaction measures. We identiﬁed 10
articles, all undertaken at the full trial stage. Some of them also reported qualitative research undertaken
to meet other objectives such as assessing the acceptability of the intervention. We selected six examples
purposively to include a range of interventions: clinical, educational and professional (Table 5). The
qualitative methods included interviews and audio recordings of consultations. The research subjects were
drawn from members of the public, intervention recipients, and professionals involved in the delivery of
the intervention.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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A lot of space may be needed within a report to describe in detail the components of a complex or
multifaceted intervention delivered to recipients. This may not be possible within the structure of a
conventional trial report, or valued enough to ensure that a limited word count includes intervention
description. The MRC framework for complex interventions3 supports this process at an early stage of
evaluation, but all 10 articles undertook this description alongside the main trial (see Table 5). Qualitative
research undertaken alongside a trial can provide a rich account of elements of the intervention in detail,
enhancing understanding of how the intervention plays out in the experimental delivery context of the
trial. In the articles reviewed here, there were two main reasons for using qualitative research:
1. to describe and make available an unfamiliar or complex intervention using the experiences and
perspectives of trial participants35
2. to increase understanding of individual components of a complex intervention and make them available
for further exploration or testing.30,32–34
Researchers chose to focus on a particular component of a complex intervention for a number of reasons.
Macpherson and Thomas32 focused on an underexplored component, looking at acupuncture practitioners’
intention to deliver self-care advice alongside needling. This article raised a question regarding the integral
nature of this aspect of the intervention as delivered and the implications of this for future trials of
acupuncture care. Romo et al.34 explored patient and family experiences of receiving prescription heroin in
a hospital setting, and identiﬁed the perceived medicalisation of addiction (in contrast to criminalisation)
as a component of the intervention in its own right. In contrast, Foster et al.30 focused on an element of
the intervention that was common to both arms of the trial (the use of medication companions) and
highlighted the fact that this ‘taken-for-granted‘ component was integral to both home- and facility-based
delivery of antiretroviral therapy and that its mechanisms of action would beneﬁt from further research.
Qualitative research was also used to explore components of complex interventions relating to what might
be described as generic strategies, such as ‘shared-decision making’ in the context of advising about
different cancer screening options within a consultation33 or the way health behaviour advice is
‘packaged’, rather than its speciﬁc content.31
Accounts of complex interventions used in trials run the risk of reﬂecting the research protocol, rather than
what was delivered in practice. Quantitative research methods may be employed to verify measurable
elements of delivery, but qualitative methods, such as non-participant observation or in-depth interviews,
can provide rich descriptive accounts of how the intervention was delivered on the ground during the trial,
from the perspectives of recipients or providers. This descriptive function may form part of what is
described as a ‘process evaluation’, although none of the articles we describe here used that term.
In each of our examples, the qualitative research appeared to provide an opportunity to focus attention on
one or more components of a complex intervention, the signiﬁcance of which might otherwise remain
hidden or over-looked in a pragmatic trial. Although some of these articles discussed their ﬁndings in
terms of possible mechanisms of action, the main purpose was to provide a rich and detailed account of
different components of the intervention, based on the participants’ experiences. Using qualitative research
data in this way is sometimes seen as ‘poor’ qualitative research because it does not extend itself into
interpretive analysis or theory building. However, this tendency to undervalue the potential contribution of
rich description has been recognised,36 especially in terms of its ability to ‘challenge taken-for-granted
assumptions about the nature of the setting or group under study’.3723
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24Suggestions for good practice and maximising value (describing the intervention components)
i. Be clear about the origin of the research question
l In our sample of articles, the genesis of the qualitative research question was sometimes unclear.
The stronger articles gave a clear account of the reason for the focus on particular components and
indicated whether this was an emergent issue or one that was identiﬁed as a research focus early
in the trial.
ii. Place within an evaluative framework
l Describing, elucidating and highlighting hidden or overlooked components of a complex
intervention using qualitative methods is a useful research output that has value for future
intervention development, but many of the articles lacked a wider framework for presenting this
type of analysis. Use of the MRC framework for the development and evaluation of complex
interventions was rare and it may be that this framework could help provide this type of research
with a useful rationale and contextual reference point.
iii. Consider ﬁndings in relation to mechanisms of action
l Descriptive accounts developed through qualitative data may also lend themselves to further
development relating to an exploration of mechanisms of action or the explicit development of
theoretical concepts underpinning interventions. Some of these articles moved towards this type of
analysis, but this was not their aim.
iv. Make explicit links to the main trial
l Links to the main trial tended to be limited to the background and methods sections of articles,
with little or no attempt to link this research back to the trial in the discussion or conclusion. This
raised concerns about whether or not the research had any impact on the trial and also limited its
utility for future trials.Models, mechanisms and underlying theory development of the intervention
This subcategory was distinguished from the ‘intervention components’ focus described above by going
one step further and attempting to develop underlying concepts and behavioural theories, as well as
exploring mechanisms of action. Articles in this subcategory described an explicit aim to develop the
conceptual thinking behind the intervention, using the rich data provided by the experience of delivering
an intervention within a trial context. In practice, a few articles sat between this subcategory and the
previous one, making some reference to theory or mechanisms of action, but falling short of developing
these ideas using the qualitative data collected. This subcategory was also distinguished from the next
subcategory Exploring perceived value and benefits of the trial intervention, which identiﬁes additional
(unmeasured) beneﬁts from the perspective of the trial participants. When articles in this subcategory
identify unmeasured beneﬁts, they go on to explore their role as (sometimes hidden) mechanisms for
change, and locate these ﬁndings in a theoretical framework, thus attempting to integrate any such
additional beneﬁts into an explanatory model of the mechanism of action of the intervention.
We identiﬁed 23 articles in this subcategory, with only one undertaken at the pre-trial stage. We selected
six examples purposively to include examples of the range of topics: treatment, process and context
mechanisms. The six articles focused on a range of interventions: clinical, educational and professional
(Table 6). The qualitative methods used in these six examples included interviews, focus groups and
observation, and the research subjects included trial participants and wider stakeholders.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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underlying theory
Qualitative research with this focus appeared to be motivated by a desire to acknowledge the role of
complexity in many interventions being trialled, owing either to the multifaceted nature of the intervention
or to the complex social structures and contexts in which interventions took place. The qualitative research
was intrinsically evaluative and entailed an exploration of the intervention using the perspective of the
participants and wider stakeholders. When the goal was an explanatory model of the intervention,38,39
the qualitative research was part of a broader mixed methods approach. Alternatively, the focus was on
‘generic’ mechanisms rather than on those deemed to be speciﬁc to the trial intervention, in which case
the message was less for the trial itself and more for a ‘class’ of intervention, such as ‘self-management’43
or ‘placebo effects’.41 Additionally, the research was sometimes designed to address a recognised body of
theoretical work, such as theories of behavioural change. Researchers undertaking research in this
subcategory reported a number of related reasons for doing so:
1. To unpick the complexity of an intervention and develop a theoretically informed model of
mechanisms of action by modelling the relationship between the elements.
2. To reﬁne interventions by identifying the most ‘effective’ components from participants’ accounts,
with reference to underlying theories from the social sciences.
3. To create conceptual clarity around an aspect or element of the intervention (e.g. patient-centred
care).
4. To develop a theoretically informed model of treatment effects from a patient perspective.
5. To better understand elements of the process of care (e.g. modelling the conditions for
‘well-functioning teams’).
6. To develop empirically based and theoretically grounded explanations of wider treatment effects,
especially those related to beliefs and behaviour (e.g. placebo effects).
7. To evaluate existing theories of mechanisms of action and develop new insights or models.
8. To develop existing theories of the mechanisms by which generic outcomes (e.g. ‘self-efﬁcacy’) are
achieved through the intervention as a whole or through speciﬁc elements of the intervention.
9. To identify mediating factors and ‘hidden mechanisms’ relating to the intervention. The work of Ray
Pawson was frequently referenced in relation to this type of work.44
10. To create explanatory models of the impact of the intervention using a mixed methods approach
showing how the context and the complex social systems within which an intervention occurs can be
an important mechanism of change.
Research in this subcategory ranged from simple linking of existing theories to the accounts given by
participants, to the development of sophisticated and complex models of mechanisms of action that may
encompass treatment, process and context. Understanding the impact of ‘context’ on the outcomes of an
intervention could have particular relevance to the transferability of the results or the external validity of
the trial. The value to the original trial was high, especially where unexpected outcomes were observed, or
where measured outcomes were uniformly negative but patient satisfaction with the intervention or the
process of care was high. The work by Hoddinott et al.39 was particularly interesting as the intention to
develop an explanatory model of the intervention incorporating contextual effects was designed at the
outset of the trial in anticipation of expected context-driven variation in outcomes in the different cluster
sites in which the intervention was delivered. This work was therefore able to directly inform the
interpretation of the trial results. Alternatively, this research was sometimes reported with little reference in
the discussion or conclusions of the trial in which the data were collected, with the key message from the
article being directed to clinical practice or to the body of literature that would form the theoretical basis
of intervention development in the future.27
© Queen’s Printer and Controller of HMSO 2014. This work was produced by O’Cathain et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
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28Suggestions for good practice and maximising value (models, mechanisms and underlying theory)
i. Be explicit about messages for transferability of trial ﬁndings
l Successful research in this subcategory was able to generate new knowledge that had the potential
for deepening our understanding of how interventions achieve the results observed in the context of
a particular trial and how these lessons may be transferred to other contexts. When appropriate, a
commitment to taking a wider view by incorporating aspects of delivery and context would help this
type of research to contribute substantially to our understanding of the transferability of the trial
ﬁndings and identify likely barriers to the successful roll-out of practice based on the trial results.
ii. Extend current thinking by challenging as well as endorsing theories
l Research addressing underlying generic concepts and theories underpinning interventions have the
potential to inform a wide range of possible interventions in different contexts. Weaker articles
missed the opportunity to extend current thinking because external constructs, concepts or theories
were employed more for the purposes of referencing or endorsing the ﬁndings than for challenging
existing ideas or developing new knowledge.Exploring perceived value and benefits of the trial intervention
Articles in this subcategory focused on experiences of giving or receiving the intervention. They were
different from articles related to the acceptability or feasibility of an intervention (subcategory Feasibility and
acceptability of the trial intervention in practice) in that they were not seeking to assess the viability of the
intervention but rather to capture important aspects of the range of outcomes experienced and to
understand the ways in which these outcomes were valued by the providers or recipients of an intervention.
Judgements about value were part of a process that might include the assessment of alternatives and
context. Some of the beneﬁts may be described as indirect beneﬁts, derived from the processes associated
with the intervention delivery. In some cases, the value of the wider beneﬁts identiﬁed was linked to their
role as mechanisms of desired behavioural change within a complex intervention (see earlier subcategory
Models, mechanisms and underlying theory development of the intervention). In other cases, perceived
beneﬁts were tangential or unrelated to the target outcome (e.g. increased self-esteem or conﬁdence in
self-management of long-term conditions), presented as examples of ‘added-value’ for the trial
intervention. There was some overlap between this subcategory and a later subcategory on the breadth of
outcomes used in a trial (see Breadth of outcomes to be measured in the trial).
We identiﬁed 42 articles in this subcategory, only 7% of which reported qualitative research undertaken
at the pre-trial stage (3/42). We undertook detailed data extraction on six of them, which were selected
purposively to include examples of the different research subject perspectives (intervention recipients
and/or intervention providers). They focused on a range of interventions: clinical, educational and
professional (Table 7). The qualitative methods used included interviews, focus groups and content analysis
of diaries completed as part of the intervention itself. The research subjects included intervention recipients
and intervention providers.
Potential value of qualitative research for exploring perceived value and benefits
Articles were largely focused on complex interventions with behavioural and/or psychological components.
Although often not stated, the rationale for conducting the qualitative research appeared to be a desire to
understand the experiences of trial participants in terms of the perceived value of the intervention and its
beneﬁts, with an underlying assumption that the quantitative measures employed in the trial outcomes
were likely to fail to capture some aspect(s) of the intervention valued by patients or participants. This
allowed some researchers to identify beneﬁts that were not anticipated at the outset of the trial (and,
therefore, not measured) and others to explore beneﬁts that were anticipated but not measured, either
because they were not amenable to measurement or because they were considered peripheral to theNIHR Journals Library www.journalslibrary.nihr.ac.uk
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DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38primary outcome. For example, Morone et al.50 undertook a qualitative study expecting to ﬁnd beneﬁts
relating to the intervention that were broader than the trial’s primary outcome of pain reduction. For other
researchers, a rich account of the meaning of the experience, which allows them to explore why the
intervention is valued by participants, may be used to support the case for further research or the adoption
of an intervention in practice. In the article by Dowrick et al.,46 the exploration of the perceived beneﬁts
relating to the management of medically unexplained symptoms identiﬁed its potential value as a
transferable skill in the management of chronic illness. In the article by Lipman et al.,48 the exploration of
beneﬁts was understood in the context of the lives of the trial participants (lone mothers), the qualitative
work undertaken during the trial therefore had the potential to increase understanding of the needs of
this group. Finally, data collected relating to the ways in which participants experience beneﬁts from a trial
intervention may be used to illustrate quantitative ﬁndings and give them more immediacy, or they may be
used to explore contradictory ﬁndings in the trial outcomes, such as high satisfaction scores alongside
small changes in other measured outcomes.
Suggestions for good practice and maximising value (exploring perceived value and benefits)
i. Consider using qualitative research at the pilot phase
l This research was most frequently conducted with the main trial rather than as part of any formal
pre-trial or piloting work. This restricted the potential impact of the research on the trial itself. If
undertaken pre-trial, unexpected beneﬁts could then be considered as candidates for formal outcome
measurement (see subcategory on outcomes Breadth of outcomes to be measured in the trial).
ii. Give more consideration of ﬁndings in relation to trial results
l Because most of this research was conducted during the main trial phase, impact was more likely
to be achieved in terms of giving the trial results a ‘human context’, making recommendations for
future research or suggestions for clinical practice. Opportunities appeared to be missed within
these articles for using the ﬁndings of the qualitative research to support the interpretation or
presentation of the trial results.
iii. Give more consideration to messages for implementation in the real world
l Researchers could have been more explicit about the utility of their ﬁndings for encouraging take-up
or implementation of an intervention following positive trial results, especially when the intervention
was perceived as novel or involved the active collaboration of health staff or patients in its delivery.Gauging the ‘in principle’ acceptability of the trial intervention
We distinguish between acceptability in principle (this subcategory) and acceptability in practice (the next
subcategory Feasibility and acceptability of the trial intervention in practice). Acceptability in principle is
about beliefs held by people who will either receive or deliver the intervention, which may impact on their
willingness to co-operate with the intervention process. This is best understood as principles or beliefs held
as standards for guiding or shaping conduct, decisions or choices. We would expect these beliefs to be
formed prior to the trial. In contrast, acceptability in practice is experiential and can only be explored
following an enactment of the intervention delivery. In order to be classiﬁed in this subcategory, articles
had to demonstrate that clear ‘in principle’ beliefs about the intervention or aspects of its delivery were
being explored, beyond the experience of receiving the intervention.
We identiﬁed 32 articles in this subcategory. Only one-quarter reported qualitative research undertaken at
the pre-trial stage (8/32). About half of the articles considered patients’ views, slightly fewer considered
professionals’ views and some explored both viewpoints in the same study. We purposively selected
six examples to include a range of interventions: clinical, educational and professional (Table 8).31
© Queen’s Printer and Controller of HMSO 2014. This work was produced by O’Cathain et al. under the terms of a commissioning contract issued by the Secretary of State for
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provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
TA
B
LE
8
Ex
am
p
le
s
o
f
th
e
u
se
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
to
g
au
g
e
th
e
‘in
p
ri
n
ci
p
le
’
ac
ce
p
ta
b
ili
ty
o
f
th
e
tr
ia
li
n
te
rv
en
ti
o
n
Pa
p
er
C
o
u
n
tr
y
Tr
ia
l
A
im
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
Q
u
al
it
at
iv
e
m
et
h
o
d
s
an
d
sa
m
p
le
V
al
u
e
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
fo
r
tr
ia
l
an
d
th
e
tr
ia
l
e
n
d
e
a
v
o
u
r
A
ve
ry
et
al
.
20
08
5
1
U
K
Pr
ot
ec
T:
a
pr
im
ar
y
ca
re
-b
as
ed
pr
ag
m
at
ic
tr
ia
lt
o
ev
al
ua
te
th
e
ef
fe
ct
iv
en
es
s
an
d
co
st
-e
ff
ec
tiv
en
es
s
of
sc
re
en
in
g
an
d
tr
ea
tm
en
t
fo
r
m
en
at
ris
k
of
lo
ca
lis
ed
pr
os
ta
te
ca
nc
er
(C
)
To
ex
pl
or
e
(a
ct
ua
la
nd
po
te
nt
ia
l)
in
te
rv
en
tio
n
re
ci
pi
en
ts
’
de
ci
si
on
-m
ak
in
g
ab
ou
t
sc
re
en
in
g,
in
cl
ud
in
g
bi
op
sy
an
d
ho
w
be
lie
fs
in
ﬂ
ue
nc
e
he
al
th
be
ha
vi
ou
r
58
in
te
rv
ie
w
s
w
ith
m
en
ac
ce
pt
in
g
sc
re
en
in
g,
no
t
re
sp
on
di
ng
to
in
vi
ta
tio
n
fo
r
sc
re
en
in
g,
ha
vi
ng
re
ce
iv
ed
a
pr
os
ta
te
bi
op
sy
or
re
fu
si
ng
bi
op
sy
Id
en
tiﬁ
ed
go
od
pr
ac
tic
e
in
in
fo
rm
ed
de
ci
si
on
-m
ak
in
g
fo
r
cl
in
ic
al
pr
ac
tic
e
Bu
zz
a
et
al
.
20
10
5
2
U
SA
RC
T
of
th
re
e
pa
tie
nt
ac
tiv
at
io
n
st
ra
te
gi
es
(in
fo
rm
at
io
n,
ﬁ
na
nc
ia
l
in
ce
nt
iv
es
an
d
ph
on
e
co
nt
ac
t)
to
en
co
ur
ag
e
di
sc
us
si
on
of
ap
pr
op
ria
te
pr
es
cr
ib
in
g
w
ith
th
ei
r
pr
ov
id
er
(C
)
To
ex
pl
or
e
pr
ov
id
er
at
tit
ud
es
to
th
e
in
te
rv
en
tio
n
fo
llo
w
in
g
a
po
si
tiv
e
tr
ia
l(
in
cl
ud
es
bo
th
ac
ce
pt
ab
ili
ty
in
pr
in
ci
pl
e
an
d
in
pr
ac
tic
e)
Te
le
ph
on
e
in
te
rv
ie
w
s
w
ith
21
pr
ov
id
er
s
in
vo
lv
ed
in
th
e
tr
ia
l
M
ay
sh
ap
e
si
m
ila
r
in
te
rv
en
tio
n
fo
r
di
ff
er
en
t
ta
rg
et
be
ha
vi
ou
rs
in
fu
tu
re
tr
ia
ls
.
Fi
nd
in
gs
re
ga
rd
in
g
ac
ce
pt
ab
ili
ty
m
ay
al
so
ha
ve
va
lu
e
fo
r
di
ss
em
in
at
io
n/
up
ta
ke
of
th
e
po
si
tiv
e
tr
ia
lr
es
ul
ts
.
In
cr
ea
se
s
lik
el
ih
o
o
d
o
f
u
p
ta
ke
o
f
in
te
rv
en
ti
o
n
in
th
e
re
al
w
o
rl
d
M
ih
ay
lo
v
et
al
.
20
08
5
3
U
K
ST
oo
L:
pr
ag
m
at
ic
fa
ct
or
ia
l
m
ul
tic
en
tr
ed
RC
T
to
in
ve
st
ig
at
e
th
e
cl
in
ic
al
an
d
co
st
-e
ff
ec
tiv
en
es
s
of
st
ep
pe
d
la
xa
tiv
e
m
an
ag
em
en
t
st
ra
te
gi
es
fo
r
ch
ro
ni
c
co
ns
tip
at
io
n
in
ol
de
r
pe
op
le
(C
)
A
n
‘a
dd
-o
n
’
st
ud
y
to
ex
pl
or
e
th
e
m
ea
ni
ng
of
th
e
ta
rg
et
co
nd
iti
on
an
d
be
lie
fs
ab
ou
t
ap
pr
op
ria
te
tr
ea
tm
en
t
am
on
gs
t
in
te
rv
en
tio
n
re
ci
pi
en
ts
an
d
ca
re
pr
ov
id
er
s
In
-d
ep
th
in
te
rv
ie
w
s
w
ith
24
po
te
nt
ia
li
nt
er
ve
nt
io
n
re
ci
pi
en
ts
an
d
ni
ne
G
P
pr
ov
id
er
s,
an
d
gr
ou
p
in
te
rv
ie
w
s
w
ith
17
nu
rs
e
pr
ov
id
er
s
Th
e
RC
T
cl
os
ed
ea
rly
ow
in
g
to
lo
w
re
cr
ui
tm
en
t
an
d
th
e
qu
al
ita
tiv
e
re
se
ar
ch
de
m
on
st
ra
te
d
po
or
ac
ce
pt
ab
ili
ty
of
th
e
in
te
rv
en
tio
n
to
re
ci
pi
en
ts
an
d
lo
w
pr
io
rit
y
am
on
gs
t
pr
ov
id
er
s
in
th
e
co
nt
ex
t
of
cu
rr
en
t
be
lie
fs
an
d
pr
ac
tic
es
.
Ex
p
la
in
s
tr
ia
l
fa
ilu
re
an
d
w
h
y
si
m
ila
r
tr
ia
ls
w
ill
fa
il
in
th
e
fu
tu
re
SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
32
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Pa
p
er
C
o
u
n
tr
y
Tr
ia
l
A
im
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
Q
u
al
it
at
iv
e
m
et
h
o
d
s
an
d
sa
m
p
le
V
al
u
e
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
fo
r
tr
ia
la
n
d
th
e
tr
ia
l
e
n
d
e
a
v
o
u
r
O
ck
le
fo
rd
et
al
.
20
08
5
4
U
K
D
ES
M
O
N
D
:
pr
im
ar
y
ca
re
-b
as
ed
cl
us
te
r
RC
T
of
a
st
ru
ct
ur
ed
gr
ou
p
ed
uc
at
io
n
pr
og
ra
m
m
e
fo
r
ne
w
ly
di
ag
no
se
d
di
ab
et
ic
pa
tie
nt
s
vs
.
us
ua
lc
ar
e
(C
)
To
ex
pl
or
e
ex
pe
rie
nc
e
of
be
in
g
di
ag
no
se
d
w
ith
di
ab
et
es
an
d
its
im
pa
ct
on
th
e
ac
ce
pt
ab
ili
ty
of
a
be
ha
vi
ou
ra
li
nt
er
ve
nt
io
n
In
-d
ep
th
in
te
rv
ie
w
s
w
ith
19
in
te
rv
en
tio
n
re
ci
pi
en
ts
an
d
17
co
nt
ro
lg
ro
up
pa
rt
ic
ip
an
ts
K
ey
m
es
sa
ge
re
la
te
d
di
re
ct
ly
to
cl
in
ic
al
pr
ac
tic
e
ra
th
er
th
an
to
tr
ia
ls
Re
id
et
al
.
20
08
5
5
U
K
C
an
ce
r
pa
in
m
an
ag
em
en
t
RC
T
co
m
pa
rin
g
tw
o
pa
in
re
lie
f
re
gi
m
es
,
on
e
in
cl
ud
in
g
op
io
id
s
be
in
g
of
fe
re
d
fo
r
th
e
ﬁ
rs
t
tim
e
(C
)
To
ex
pl
or
e
fa
ct
or
s
in
ﬂ
ue
nc
in
g
in
te
rv
en
tio
n
re
ci
pi
en
ts
’
de
ci
si
on
s
to
ac
ce
pt
or
re
je
ct
m
or
ph
in
e
w
he
n
ﬁ
rs
t
of
fe
re
d
as
pa
in
re
lie
f
w
ith
in
th
e
tr
ia
l
In
-d
ep
th
in
te
rv
ie
w
s
w
ith
17
tr
ia
l
pa
rt
ic
ip
an
ts
an
d
12
pa
tie
nt
s
w
ho
w
er
e
in
vi
te
d
bu
t
de
cl
in
ed
to
en
te
r
th
e
tr
ia
l
Tr
ia
lw
as
an
op
po
rt
un
ity
to
ex
pl
or
e
th
e
be
lie
fs
of
ca
nc
er
pa
tie
nt
s
w
ho
w
er
e
be
in
g
of
fe
re
d
op
io
id
s,
an
d
as
se
ss
th
e
in
pr
in
ci
pl
e
ac
ce
pt
ab
ili
ty
of
dr
ug
s
in
th
is
co
nt
ex
t.
Th
e
ke
y
m
es
sa
ge
w
as
fo
r
cl
in
ic
al
pr
ac
tic
e
ra
th
er
th
an
th
e
tr
ia
l
Zh
an
g
et
al
.
20
10
5
6
C
hi
na
/U
SA
C
om
m
un
ity
-b
as
ed
RC
T
of
re
du
ct
io
n
of
ris
k
of
di
ab
et
es
th
ro
ug
h
lo
ng
-t
er
m
di
et
ar
y
ch
an
ge
fr
om
w
hi
te
to
br
ow
n
ric
e
(C
)
Pr
e-
tr
ia
lt
o
ex
pl
or
e
cu
ltu
ra
l
ac
ce
pt
ab
ili
ty
an
d
pr
io
r
be
lie
fs
ab
ou
t
br
ow
n
ric
e
co
ns
um
pt
io
n
am
on
gs
t
po
te
nt
ia
li
nt
er
ve
nt
io
n
re
ci
pi
en
ts
M
ix
ed
m
et
ho
ds
st
ud
y
w
ith
fo
cu
s
gr
ou
ps
of
32
no
n-
tr
ia
lp
ar
tic
ip
an
ts
Id
en
tiﬁ
ed
th
e
be
lie
fs
he
ld
ab
ou
t
br
ow
n
ric
e
th
at
m
ad
e
it
an
un
ac
ce
pt
ab
le
in
te
rv
en
tio
n.
Re
su
lts
pr
ov
id
ed
va
lu
ab
le
in
si
gh
ts
to
gu
id
e
th
e
de
si
gn
of
pa
tie
nt
in
fo
rm
at
io
n
fo
r
th
e
pl
an
ne
d
tr
ia
l.
Im
p
ro
ve
s
vi
ab
ili
ty
o
f
tr
ia
l
C
,
co
m
p
le
x
in
te
rv
en
ti
o
n
;
D
ES
M
O
N
D
,
D
ia
b
et
es
Ed
u
ca
ti
o
n
an
d
Se
lf
M
an
ag
em
en
t
fo
r
O
n
g
o
in
g
an
d
N
ew
ly
D
ia
g
n
o
se
d
;
G
P,
g
en
er
al
p
ra
ct
it
io
n
er
;
Pr
o
te
cT
,
Pr
o
st
at
e
Te
st
in
g
fo
r
C
an
ce
r
an
d
Tr
ea
tm
en
t;
ST
oo
L,
St
ep
pe
d
Tr
ea
tm
en
t
of
ol
de
r
ad
ul
ts
on
La
xa
tiv
es
.
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38
33
© Queen’s Printer and Controller of HMSO 2014. This work was produced by O’Cathain et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
34The qualitative research focus was always clearly related to the trial. The qualitative methods used included
interviews and diaries. The research subjects were drawn from members of the public, trial participants,
trial decliners and professionals involved in the delivery of the proposed intervention.
Potential value of qualitative research for gauging the ‘in principle’ acceptability of the
trial intervention
The authors of these articles offered a range of reasons for conducting research into the in principle
acceptability of the trial intervention. Some started with this as a purpose but for others it emerged as an
issue during the main trial and it then became the focus of the article. In each latter case, the statement
supporting the need to undertake the study indicated that there was reason to believe that the idea of the
intervention might not be received entirely positively by the recipients or the providers. The given rationale
for exploring the in principle acceptability of a trial intervention tended to fall into one of three trial-related
categories:
1. The need to explore the impact of individual and wider cultural beliefs on behaviours, such as the likely
take-up of a trial intervention by participants.
2. The need to explore the potential impact of individual and wider profession/cultural beliefs on the
optimal delivery of the trial intervention.
3. The opportunity to understand changes in existing beliefs about acceptability that emerge during the
course of the trial and their implications for the trial results and/or for future clinical practice. In these
cases, retrospectively reported acceptability in principle may be contrasted with reported acceptability
in practice.
The qualitative research aimed to understand the relationship between beliefs and behaviour or choices
made prior to, or during, the trial. A minority of the 32 articles explored this issue in isolation and prior to
the trial itself and these articles focused on patients or the general population rather than professionals
involved in the delivery of the intervention. They were characterised by a cultural distance between the trial
organisers and the recipients of the intervention. An example is Zhang et al.,56 in which the trial lead was
based in the USA and the trial intervention was in China.
The potential impact of this use of qualitative research on the trial itself is likely to depend on its timing.
When a concern exists about the acceptability of an intervention to be trialled, doing this work prior to the
main trial may impact on trial recruitment, long-term participation or adherence to the intervention, as well
as the effective or optimal delivery of the intervention in the context of the trial. An example of this is
provided by Zhang et al.56 who explored the acceptability of dietary changes in advance of a planned trial
and found strongly held negative beliefs about the acceptability of brown rice in terms of beliefs about
taste and quality. They were able to identify nutritional messages that could increase acceptability and
encourage participation in the trial, but these did not change the intervention itself. This highlights why
this subcategory differs from what we have called ‘intervention development’ because here it is beliefs
about the intervention that are important. In the 32 articles, pre-trial work was relatively rare, with most
studies being conducted after commencement of the full trial. This may be due in part to our study
inclusion criteria, which required the qualitative research to be linked explicitly to a planned or
ongoing trial.
The qualitative research was undertaken alongside the main trial for many of our articles. These explored
acceptability in principle alongside acceptability in practice and some also addressed the perceived value
and beneﬁts of the intervention as part of a broadly speciﬁed rationale for the qualitative research such as
‘to explore the experiences of patients participating in the trial’. This limited the potential impact of the
research on the trial because it could not shape the intervention delivered in the trial. However, it did have
the potential to relate the qualitative ﬁndings to the outcome of the trial, poor implementation of the
intervention or low recruitment.53 Mihaylov et al.53 were able to explain the failure to recruit in a trial of
constipation treatment according to the strongly held beliefs about appropriate or favourite existing
treatment and a reluctance to change behaviour as required by entering the trial. Buzza et al.52 describedNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38how negative prior beliefs that existed about some aspects of the intervention (e.g. patient activation seen
as a threat to professional autonomy) did not appear to impact on behaviour during the trial. Ockleford
et al.54 were able to demonstrate important relationships between acceptance of a diabetic diagnosis and
willingness to engage with self-management groups. They suggested that engagement with the
intervention programme might help some trial participants who were struggling with accepting this
change to their identity.
Many articles concluded with messages for clinical practice, without reference to the trial ﬁndings. The trial
appeared to present an opportunity to explore issues relating to beliefs and acceptability relevant to clinical
care, some relating to the likely success of the intervention in a real-world context, others making explicit
suggestions for improving the intervention or its delivery in practice. For example, Reid et al.55 concluded
with the need to address the ‘in principle’ fears and beliefs about opioid analgesics among cancer patients
in order to improve clinical care. In this case, the trial was identiﬁed as an opportunity to interview patients
who were being offered opioids for the ﬁrst time and found that patients strongly associated them with
end-stage care and death and therefore discounted them as helpful pain relief at earlier stages of
treatment. A few articles took their discussion beyond the immediate clinical or public health interventions
that were the subject of the trial, raising issues about the transferability of the lessons learnt to other
clinical contexts requiring behavioural interventions with similar underpinnings and principles for success,
for example patient activation strategies.52
Suggestions for good practice and maximising value (in principle acceptability of intervention)
i. Consider the timing of the qualitative research in relation to the trial
l When a concern exists about the acceptability of an intervention to be trialled, qualitative research
is best used prior to the main trial to allow it to impact on trial recruitment, long-term participation
or adherence to the intervention, as well as the effective or optimal delivery of the intervention in
the context of the trial. If the qualitative research is undertaken within an ongoing trial, the obvious
limitation is that, once in the trial, participants have already made a decision that reﬂects some
degree of acceptance and the sample will reﬂect this range of beliefs. Some designs overcame this
problem by exploring in principle acceptability among those invited but declining to participate in
the trial.51,55
ii. Be clear about messages for the trial
l Research in this subcategory had the potential to produce messages of relevance to the trial and
beyond in clinical practice or the delivery of population-based public health programmes. Overall,
we found a considerable divorce between the trial itself and the qualitative ﬁndings. This may have
been due to the qualitative articles being published in advance of the trial ﬁndings but sometimes
the main trial results article did not reference the qualitative research (e.g. Ockleford et al.54).Feasibility and acceptability of the trial intervention in practice
In this subcategory, the focus of the qualitative research was the feasibility and acceptability in practice of
the intervention itself or its mode of delivery within a trial context. Feasibility and acceptability in practice
were often considered together, with acceptability treated as a component of feasibility. However, for
clarity, it is worth considering them separately at a conceptual level. The feasibility of an intervention
depends on a number of factors and includes two distinct perspectives: those involved in delivery of the
intervention and those receiving it. From the perspective of those delivering the intervention, feasibility
includes the ability to do so in an effective manner that is compatible with their personal skills and work
practice, individual and team-based workloads, managerial and contextual constraints and prevailing
cultural norms. From the perspective of those in receipt of the intervention, data may be obtained from
patients, trial participants, caregivers and other involved parties in order to explore the practical35
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36consequences of engaging with the intervention in terms of the demands made on those involved,
especially those in addition to the demands imposed on patients and carers by the illness itself. If feasibility
asks the question ‘Can it be done within existing contextual constraints?’, acceptability asks the question
‘Are the “costs” of doing it such that people are willing to play their part in the effective delivery or
receipt of the intervention?’.
This subcategory contained a large number of articles (83), accounting for over one-ﬁfth of the 356
different uses of qualitative research (23%). Almost one-quarter of the articles (20/83) reporting the use of
qualitative research were undertaken at the pre-trial stage. All but one article presented the analysis of data
collected from either the providers of the trial intervention or recipients of the trial intervention or control.
The exception collected data from managerial staff in the local sites who did not deliver the intervention
itself, but who contributed to the context in which the intervention took place. Intervention providers
included health professionals, public health practitioners, and teachers. Intervention recipients included
patients, carers and members of the public (for public health/prevention trials). Occasionally, the distinction
between these two groups was blurred when carers (especially parents) were asked to deliver the trial
intervention, or when health-care providers were the recipients of a trial intervention (usually one designed
to change their professional behaviour). Complex interventions frequently required intervention recipients
to engage in behaviour change, such that they were, in some sense, ‘providers’ of their own intervention.
We present the details of six articles, selected purposively to include examples of the range of research
subjects (intervention recipients and providers) and the timing of the data collection (i.e. pre-trial, during
the trial). They focused on a range of interventions: clinical, educational and professional (Table 9).
The qualitative methods used included interviews, focus groups, diaries and observation, and the
research subjects reﬂected the range of research questions being drawn from members of the public,
trial participants, carers and parents and the health professionals involved in the delivery of the
proposed intervention.
Potential value of qualitative research for exploring intervention feasibility and acceptability
in practice
The potential value of this use of qualitative research depended on when it was undertaken in relation to
the trial. We discussed its potential value at the pre-trial and full trial stages. First, feasibility and
acceptability in practice can be explored as part of a pre-trial pilot or feasibility study with the explicit aim
of impacting on the way the intervention is delivered in the main trial. For example, the rationale for using
qualitative research at this stage was that members of the intervention group were required to make
substantial changes to their sexually related behaviour in order to comply with the intervention57 and the
use of theoretically informed, but untested, interventions gave rise to practical concerns about the
feasibility of delivering them optimally within the context of the rehabilitation clinic.59 The potential value
to the trial endeavour was scope for radical redesign of the intervention, or its mode of delivery, or to raise
concerns about the design or value of the main trial being conducted. In this sense, these studies had
something in common with those aimed at intervention development; however, intervention development
was not an explicit research aim. Second, feasibility and acceptability in practice can be explored during
the main trial and indeed the majority of the 83 articles focused on this stage. The impetus for this was
not always clear. The initial qualitative research question was ‘to capture the experiences of the
participants’ stemming from the recognition that the intervention was either complex or novel or both. In
some articles, the focus of the analysis was broad and diffuse whereas in others, the data collected under
the banner of ‘participant experiences’ were used selectively in the analysis to address a particular issue
arising from the trial conduct or the trial results. The qualitative research was used to describe the
intervention itself or introduce it to a clinical community that would not get a full picture of its potential
impact on recipients or providers from the main trial results alone. Potential value also lay in providing
evidence of acceptability of an effective, but controversial, intervention.61
A subset of articles presented ﬁndings on feasibility and acceptability as part of a broader ‘process
evaluation’ that sought to capture and evaluate a range of contextual and behavioural issues relating toNIHR Journals Library www.journalslibrary.nihr.ac.uk
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DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38the trial conduct and intervention process. Two articles reported qualitative research undertaken after the
trial results were known to understand low or variable intervention adoption rates within a trial.
The importance of this issue was only identiﬁed as the trial progressed.58,60Suggestions for good practice and maximising value (intervention feasibility and acceptability
in practice)
i. Identify a speciﬁc research question.
l The research question was very broad in many articles in this subcategory. The apparent lack of
focus of some articles may have reﬂected an underlying methodological tension between a
perceived need to identify a priori questions for the qualitative research and a desire to allow
emergent issues to be identiﬁed during data collection and analysis. However, articles could be
strengthened by having a clearer rationale for the analysis, rather than an assumption that patient
experiences are important, per se.
ii. Be explicit about the message for trials.
l There was a clear sense that it was important to gain an understanding of the way an intervention
was received and/or delivered in practice, but not why this deeper understanding was important to
the trial itself. Articles with a narrower, trial-linked focus to the analysis carried a stronger message
than those trying to present a broad brush analysis of all the factors (positive and negative) that
constituted the experience of delivering or receiving an intervention under trial conditions.
iii. Consider the timing of qualitative research in relation to the trial.
l Surprisingly few studies looked at delivery issues at the pre-trial stage. There is scope for more work
to be carried out at that early stage to shape the practical delivery of the intervention and to ensure
that the main trial is not jeopardised by a failure to implement the intervention optimally.Intervention fidelity, reach and dose
In this subcategory of work relating to the trial intervention, the qualitative research supported assessment
of the degree to which an intervention was delivered or implemented as planned during a trial, as well as
reasons for any variation or deviation. This included issues relating to both provider delivery and recipient
adherence or compliance, including intervention quality, dose received, and population reach of the
intervention within the trial, as well as local variations in implementation in cluster trials. Because it was
often part of a mixed methods process evaluation, we noted how and why the qualitative research was
added and what it contributed beyond the output of any quantitative measures employed.
We identiﬁed 12 articles in this subcategory, accounting for 3% of the 356 uses of qualitative research,
none of which were undertaken pre-trial. We selected six for detailed data extraction (Table 10). The six
articles covered a range of interventions: clinical, educational and professional. The qualitative data
collection methods used included interviews, focus groups and observation, and the research subjects
were drawn from members of the public, trial participants and professionals involved in the delivery of the
proposed intervention.
Potential value of qualitative research for exploring intervention fidelity, reach and dose
The most direct impact of this qualitative research on the trial was interpretation of the trial results. If an
intervention was not delivered with adequate integrity (i.e. as planned), the results of that trial could
reﬂect the quality of the intervention as delivered and produce false-negative results. Triallists can use
quantitative measures of intervention ﬁdelity, dose and reach, but these articles showed the utility of
qualitative methods such as observation and interviews in gauging the way an intervention was delivered39
© Queen’s Printer and Controller of HMSO 2014. This work was produced by O’Cathain et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
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TA
B
LE
10
Ex
am
p
le
s
o
f
th
e
u
se
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
in
ex
p
lo
ri
n
g
ﬁ
d
el
it
y,
re
ac
h
an
d
d
o
se
o
f
th
e
in
te
rv
en
ti
o
n
in
th
e
tr
ia
l
Pa
p
er
C
o
u
n
tr
y
Tr
ia
l
A
im
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
Q
u
al
it
at
iv
e
m
et
h
o
d
s
an
d
sa
m
p
le
V
al
u
e
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
fo
r
tr
ia
l
an
d
th
e
tr
ia
l
e
n
d
e
a
v
o
u
r
Fe
rg
us
on
et
al
.
20
09
6
3
M
al
aw
i
O
pe
n-
la
be
l
co
m
m
un
ity
-b
as
ed
RC
T
of
pr
og
ra
m
m
e
to
pr
ev
en
t
m
ot
he
r-
to
-c
hi
ld
tr
an
sm
is
si
on
of
H
IV
(C
)
To
ex
pl
or
e
pr
ot
oc
ol
im
pl
em
en
ta
tio
n
(ﬁ
de
lit
y
an
d
re
ac
h)
re
la
tin
g
to
br
ea
st
fe
ed
in
g
co
un
se
lli
ng
el
em
en
t
of
pr
og
ra
m
m
e
D
ire
ct
ob
se
rv
at
io
n
of
12
3
co
un
se
lli
ng
se
ss
io
ns
;
in
te
rv
ie
w
s
w
ith
6
nu
rs
e
co
un
se
llo
rs
af
te
r
ob
se
rv
at
io
ns
co
m
pl
et
ed
.
Pa
rt
of
m
ix
ed
m
et
ho
ds
pr
oc
es
s
ev
al
ua
tio
n
O
bs
er
va
tio
n
us
ed
to
ge
ne
ra
te
qu
an
tit
at
iv
e
m
ea
su
re
of
ad
he
re
nc
e.
In
lig
ht
of
hi
gh
ad
he
re
nc
e,
in
te
rv
ie
w
da
ta
id
en
tiﬁ
ed
re
qu
es
ts
fo
r
m
or
e
tr
ai
ni
ng
an
d
be
tt
er
pa
tie
nt
–
co
un
se
llo
r
ra
tio
s.
Ex
p
lo
re
s
w
ay
s
o
f
b
u
ild
in
g
o
n
su
cc
es
sf
u
l
im
p
le
m
en
ta
ti
o
n
in
fu
tu
re
cl
in
ic
al
p
ra
ct
ic
e
H
ol
lid
ay
et
al
.
20
09
6
4
U
K
Sc
ho
ol
s-
ba
se
d
pr
ag
m
at
ic
cl
us
te
r
RC
T
of
st
op
sm
ok
in
g
in
te
rv
en
tio
n
us
in
g
pe
er
su
pp
or
te
rs
(C
)
To
id
en
tif
y
ho
w
th
e
in
te
rv
en
tio
n
w
as
ad
ap
te
d
to
m
ee
t
ch
al
le
ng
es
su
ch
as
la
ck
of
tim
e
an
d
th
e
co
ns
eq
ue
nc
es
of
an
y
va
ria
tio
ns
fo
r
in
te
gr
ity
(ﬁ
de
lit
y)
of
th
e
in
te
rv
en
tio
n
21
di
re
ct
no
n-
pa
rt
ic
ip
an
t
ob
se
rv
at
io
n
se
ss
io
ns
an
d
po
st
in
te
rv
en
tio
n
se
m
is
tr
uc
tu
re
d
in
te
rv
ie
w
s
w
ith
11
tr
ai
ne
rs
re
sp
on
si
bl
e
fo
r
de
liv
er
in
g
in
te
rv
en
tio
n.
Pa
rt
of
m
ix
ed
m
et
ho
ds
‘n
es
te
d
pr
oc
es
s
ev
al
ua
tio
n’
Id
en
tiﬁ
ed
ex
am
pl
es
of
va
ria
tio
n
in
ﬁ
de
lit
y
of
im
pl
em
en
ta
tio
n,
in
cl
ud
in
g
st
ud
en
t
re
cr
ui
tm
en
t
an
d
re
as
on
s
fo
r
th
is
ha
pp
en
in
g
ac
ro
ss
si
te
s.
Ex
p
lo
re
s
an
ti
ci
p
at
ed
va
ri
at
io
n
s
in
in
te
rv
en
ti
o
n
im
p
le
m
en
ta
ti
o
n
in
a
cl
u
st
er
tr
ia
l.
In
th
e
lig
h
t
o
f
p
o
si
ti
ve
tr
ia
l
re
su
lt
s,
id
en
ti
fi
es
w
ay
s
to
sa
fe
g
u
ar
d
ag
ai
n
st
av
o
id
ab
le
an
d
u
n
ac
ce
p
ta
b
le
va
ri
at
io
n
d
u
ri
n
g
im
p
le
m
en
ta
ti
o
n
M
cN
am
ar
a
et
al
.
20
09
6
5
N
ew
Ze
al
an
d
RC
T
w
ith
cr
os
so
ve
r
de
si
gn
of
tw
o
hu
m
id
iﬁ
ca
tio
n
te
ch
ni
qu
es
ap
pl
ie
d
by
pa
re
nt
s
in
th
e
ca
re
of
ch
ild
re
n
w
ith
tr
ac
he
os
to
m
ie
s
(D
D
)
To
ex
pl
or
e
ex
pe
rie
nc
es
of
pa
re
nt
s
w
ith
st
ro
ng
ex
pr
es
se
d
pr
ef
er
en
ce
s
fo
r
on
e
tr
ea
tm
en
t
an
d
th
os
e
w
ho
w
ith
dr
ew
fr
om
th
e
tr
ia
l
ow
in
g
to
co
nc
er
ns
w
ith
ei
th
er
tr
ea
tm
en
t
Se
m
is
tr
uc
tu
re
d
in
te
rv
ie
w
s
w
ith
ni
ne
m
ot
he
rs
an
d
fo
ur
nu
rs
es
Fo
un
d
ev
id
en
ce
of
no
n-
ad
he
re
nc
e
ow
in
g
to
pr
ef
er
en
ce
s.
Th
es
e
w
er
e
se
en
as
ac
tiv
e
de
ci
si
on
s
by
ca
re
gi
ve
rs
to
im
pr
ov
e
th
ei
r
ow
n
co
pi
ng
an
d
th
e
ca
re
of
th
e
ch
ild
.
Ex
p
lo
re
s
w
ay
s
o
f
b
u
ild
in
g
o
n
su
cc
es
sf
u
l
im
p
le
m
en
ta
ti
o
n
in
fu
tu
re
cl
in
ic
al
p
ra
ct
ic
e
SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
40
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Pa
p
er
C
o
u
n
tr
y
Tr
ia
l
A
im
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
Q
u
al
it
at
iv
e
m
et
h
o
d
s
an
d
sa
m
p
le
V
al
u
e
o
f
q
u
al
it
at
iv
e
re
se
ar
ch
fo
r
tr
ia
l
an
d
th
e
tr
ia
l
e
n
d
e
a
v
o
u
r
a
M
uk
om
a
et
al
.
20
09
6
6
So
ut
h
A
fr
ic
a/
N
or
w
ay
Sc
ho
ol
s-
ba
se
d
cl
us
te
r
RC
T
of
H
IV
ed
uc
at
io
n
pr
og
ra
m
m
e
to
de
la
y
on
se
t
of
se
xu
al
in
te
rc
ou
rs
e
an
d
in
cr
ea
se
ap
pr
op
ria
te
co
nd
om
us
e
(C
)
To
ex
pl
or
e
w
he
th
er
or
no
t
th
e
in
te
rv
en
tio
n
w
as
im
pl
em
en
te
d
as
pl
an
ne
d,
to
as
se
ss
qu
al
ity
an
d
va
ria
tio
n
of
in
te
rv
en
tio
n
at
a
lo
ca
ll
ev
el
an
d
to
ex
pl
or
e
th
e
re
la
tio
ns
hi
p
be
tw
ee
n
ﬁ
de
lit
y
of
im
pl
em
en
ta
tio
n
an
d
ob
se
rv
ed
ou
tc
om
es
D
ire
ct
cl
as
sr
oo
m
ob
se
rv
at
io
ns
(2
6
in
13
in
te
rv
en
tio
n
sc
ho
ol
s)
,
25
se
m
is
tr
uc
tu
re
d
in
te
rv
ie
w
s
w
ith
te
ac
he
rs
(in
te
rv
en
tio
n
de
liv
er
er
s)
an
d
12
fo
cu
s
gr
ou
ps
w
ith
pu
pi
ls
(r
ec
ip
ie
nt
s)
.
Pa
rt
of
‘e
m
be
dd
ed
’
m
ix
ed
m
et
ho
ds
pr
oc
es
s
ev
al
ua
tio
n
Sh
ow
ed
th
at
in
te
rv
en
tio
n
w
as
no
t
im
pl
em
en
te
d
w
ith
hi
gh
ﬁ
de
lit
y
at
m
an
y
sc
ho
ol
s
an
d
th
at
th
e
qu
al
ity
of
de
liv
er
y,
an
d
th
er
ef
or
e
th
e
ex
te
nt
to
w
hi
ch
st
ud
en
ts
w
er
e
ex
po
se
d
to
th
e
in
te
rv
en
tio
n
(d
os
e)
,
va
rie
d
co
ns
id
er
ab
ly
.
O
bs
er
va
tio
n
an
d
in
te
rv
ie
w
da
ta
di
d
no
t
al
w
ay
s
co
nc
ur
w
ith
qu
an
tit
at
iv
e
as
se
ss
m
en
t
of
ﬁ
de
lit
y
(t
ea
ch
er
s’
lo
gs
).
Ex
p
lo
re
s
p
er
ce
p
ti
o
n
s
o
f
fi
d
el
it
y
o
f
im
p
le
m
en
ta
ti
o
n
an
d
re
as
o
n
s
fo
r
n
o
n
-c
o
m
p
lia
n
ce
.
C
re
at
es
th
e
o
p
p
o
rt
u
n
it
y
fo
r
u
n
d
er
st
an
d
in
g
h
o
w
an
d
w
h
y
in
te
rv
en
ti
o
n
s
an
d
tr
ia
l
o
u
tc
o
m
es
m
ay
b
e
re
la
te
d
Pa
lin
ka
s
et
al
.
20
08
6
7
U
SA
RC
T
of
m
an
ua
lis
ed
ev
id
en
ce
-b
as
ed
tr
ea
tm
en
ts
vs
.
us
ua
lc
ar
e
fo
r
an
xi
et
y
an
d
de
pr
es
si
on
in
ch
ild
re
n
(C
)
To
ex
pl
or
e
lo
ng
er
-t
er
m
cl
in
ic
ia
n
in
te
nt
io
ns
to
im
pl
em
en
t
tr
ea
tm
en
ts
O
bs
er
va
tio
n
an
d
se
m
is
tr
uc
tu
re
d
in
te
rv
ie
w
s
w
ith
pr
of
es
si
on
al
s
in
vo
lv
ed
in
de
liv
er
y,
de
sc
rib
ed
as
‘a
n
et
hn
og
ra
ph
ic
st
ud
y
of
im
pl
em
en
ta
tio
n
’
Id
en
tiﬁ
ed
th
re
e
pa
tt
er
ns
re
la
tin
g
to
in
te
nt
io
n
to
su
st
ai
n
tr
ea
tm
en
ts
:
ap
pl
ic
at
io
n
w
ith
ﬁ
de
lit
y,
ab
an
do
nm
en
t
of
tr
ea
tm
en
ts
an
d
pa
rt
ia
la
pp
lic
at
io
n
of
tr
ea
tm
en
ts
.
Ex
pl
or
ed
fa
ct
or
s
re
la
tin
g
to
th
es
e
pa
tt
er
ns
.
Ex
p
lo
re
s
w
ay
s
o
f
b
u
ild
in
g
o
n
su
cc
es
sf
u
l
im
p
le
m
en
ta
ti
o
n
in
fu
tu
re
cl
in
ic
al
p
ra
ct
ic
e
Pl
um
m
er
et
al
.
20
10
6
8
U
K
/T
an
za
ni
a
Pl
ac
eb
o-
co
nt
ro
lle
d
RC
T
of
he
rp
es
su
pp
re
ss
io
n
th
er
ap
y
(D
D
)
To
in
ve
st
ig
at
e
re
as
on
s
fo
r
po
or
pa
tie
nt
ad
he
re
nc
e
to
in
te
rv
en
tio
n
in
a
ne
ga
tiv
e
tr
ia
l,
re
co
gn
is
in
g
th
at
po
or
ad
he
re
nc
e
m
ay
co
nt
rib
ut
e
to
la
ck
of
im
pa
ct
in
H
IV
pr
ev
en
tio
n
tr
ia
ls
In
-d
ep
th
in
te
rv
ie
w
s
w
ith
20
in
te
rv
en
tio
n
an
d
co
nt
ro
l(
pl
ac
eb
o)
pa
rt
ic
ip
an
ts
,
at
ﬁ
na
lo
ut
co
m
e
po
in
t.
Sa
m
pl
e
se
le
ct
ed
ac
co
rd
in
g
to
qu
an
tit
at
iv
e
m
ea
su
re
s
of
ad
he
re
nc
e
(‘u
nd
er
us
er
s’
,
‘g
oo
d
us
er
s’
an
d
‘o
ve
r
us
er
s’
)
Id
en
tiﬁ
ed
a
ra
ng
e
of
ba
rr
ie
rs
to
ad
he
re
nc
e
fo
r
un
de
r-
us
er
s
in
cl
ud
in
g
po
or
un
de
rs
ta
nd
in
g
of
th
e
tr
ia
la
nd
fa
m
ily
cr
is
is
.
Le
ss
su
cc
es
sf
ul
in
ex
pl
ai
ni
ng
‘o
ve
r
us
e’
or
w
hy
so
m
e
pl
ac
eb
o
re
ci
pi
en
ts
ha
d
po
si
tiv
e
la
b
re
su
lts
.E
xp
lo
re
s
re
as
o
n
s
fo
r
n
o
n
-a
d
h
er
en
ce
to
tr
ea
tm
en
t.
R
ec
o
g
n
is
es
th
at
b
io
m
ed
ic
al
in
te
rv
en
ti
o
n
s
al
so
h
av
e
st
ro
n
g
b
eh
av
io
u
ra
l
co
m
p
o
n
en
ts
an
d
th
at
ad
h
er
en
ce
p
at
te
rn
s
m
u
st
b
e
m
ea
su
re
d
an
d
u
n
d
er
st
o
o
d
if
th
e
tr
ia
lr
es
u
lt
s
ar
e
to
b
e
re
lia
b
le
C
,
co
m
pl
ex
in
te
rv
en
tio
n;
D
D
,
dr
ug
or
de
vi
ce
.
a
Ex
em
pl
ar
pa
pe
r
th
at
is
a
go
od
ex
am
pl
e
of
th
e
w
or
k
qu
al
ita
tiv
e
re
se
ar
ch
do
es
in
th
is
su
bc
at
eg
or
y.
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38
41
© Queen’s Printer and Controller of HMSO 2014. This work was produced by O’Cathain et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
42or implemented within a trial. Observational data were used to create a checklist of quantiﬁable actions
that comprised adequate delivery, showing variation or deviation from protocol. In contrast, qualitative
data comprising ﬁrst-hand accounts and observations of delivery in context explored questions relating to
how or why variations and deviations from protocol occurred. Interventions as planned often included a
concrete, measurable element deﬁned in a protocol, but the implementation of this was subject to
external inﬂuences (context) and individual preferences (behaviours and beliefs) on the part of intervention
recipients and/or those delivering the intervention. Using qualitative methods to explore these issues was
identiﬁed as useful in assisting the interpretation of the relationship between implementation and
observed outcomes.66 Cluster trials in particular were seen as vulnerable to a powerful potential context
effect, as local structures and practices were likely to impact on delivery.64,66 Complex interventions
frequently required behavioural changes on the part of recipients and/or those delivering the intervention
which were sensitive to individual preferences, beliefs and circumstances.65 Less complex interventions,
such as biomedical or drug interventions, were also acknowledged to have strong behavioural components
that required attention. The drug trial reported by Plummer et al.68 attempted to measure adherence to
drug therapy among the trial participants, but recognised the limitations of these data for explaining the
observed patterns of adherence. Indeed, the qualitative research raised questions regarding the reliability
of the quantitative measures of adherence.66,68
In a pragmatic trial, it could be argued that some variation in the integrity of intervention delivery would
be found in practice and, therefore, acceptable in terms of the external validity of the trial results.
However, messages for (clinical) practice could emerge as a by-product of assessing ﬁdelity of
implementation that had relevance beyond the trial results in terms of understanding potential moderating
factors and identifying those that may be amenable to local modiﬁcation in order to optimise the
effectiveness of the intervention in practice. Thus, a study by Holliday et al.64 was usefully able to identify
variations that the authors considered to be both ‘unacceptable’ and ‘avoidable’ in the future
implementation of a schools-based smoking cessation intervention, as well as identifying examples of
acceptable, and anticipated, variation.
Suggestions for good practice and maximising value (Intervention fidelity, reach and dose)
i. Link ﬁndings back to the trial.
l Despite a strong case being made for the potential of qualitative research with this focus being
used to aid interpretation of trial results, we found few examples of this in practice in the
qualitative articles here. Some articles announced the intention to do this once the trial results were
known and these trial articles were not included here. However, separate publication strategies
may militate against this happening in practice. When trials assess interventions that are dependent
on successful implementation, building this type of work into the trial design at the outset, with
clear strategies for incorporating ﬁndings into the trial analysis, if appropriate, may increase the
utility of undertaking this type of qualitative research with trials as well as enhance the value of the
trial itself in terms of the dissemination of successful practice.Implementation of the trial intervention in the real world
In this subcategory, the qualitative research focused on issues relevant to the likely success or failure of
future attempts to implement effective interventions, or to embed them in clinical practice. This focused on
what was special or unique about the trial conditions or context (i.e. time, space, participants) and how this
might impact on any attempt to roll out or implement the intervention as trialled. Exploration of the
real-world application of interventions requires that the qualitative data be analysed in conjunction with trial
results in an explicit attempt to identify lessons that can be learned about the likely transferability of the trial
results to a non-experimental setting. To minimise overlap with other subcategories, we only included
articles here for which analysis was undertaken following trial results that supported the roll-out or adoption
of the intervention as delivered in the trial. The lessons to be learned from the qualitative research were
directed at the possible barriers to successful implementation of the (evidence-based) intervention beyondNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38the trial. This was a small subcategory with only four articles, none of which were undertaken at the pre-trial
stage, as was expected. We undertook detailed data extraction on all four articles (Table 11).
Potential value of qualitative research for implementation of the trial intervention in the
real world
Articles here addressed the broad question of how conﬁdent users of research evidence can be
that an intervention delivered successfully in a trial will be transferable outside the experimental trial
setting. They were linked to the emerging discipline of ‘implementation science’, which recognises that
positive trial results will undergo a process of adoption and incorporation into real-world practice.
Murphy et al.37 describe this evidence gap as the result of an inevitable ‘context stripping’ that occurs in
a hypothesis-driven experimental research design. They also suggest that qualitative research is particularly
useful for putting context back into the picture in terms of behaviours, beliefs and local circumstances
that do not form part of the original quantitative trial evidence.
In our examples, the qualitative data were analysed after the results of the trial were known, in order to
identify speciﬁc factors relating to behaviour, beliefs or context that might impact on the future adoption
of the intervention. Cals et al.69,70 demonstrated how qualitative interview data, collected prior to the trial
results being known, were analysed retrospectively and in the light of positive trial ﬁndings to address
explicit issues relating to the likely adoption of the intervention. A particular strength of this work was its
ability to describe the perceived value of the intervention (near-site testing) to a sample of clinicians similar
to those who would be considering its adoption in the future. For Carnes et al.,71 the trial message was
that neither oral nor topical administration of non-steroidal anti-inﬂammatory drugs was superior in
controlling knee pain. However, the choice between them still has to be made in everyday clinical practice
and, using the qualitative research, these researchers were able to describe how prescribing decisions
might be enhanced if patient preferences, and the reasons for these preferences, were incorporated into
the prescribing process.
All the trials here were positive. However, when trial ﬁndings indicated a lack of effectiveness of an
intervention used routinely in clinical practice, qualitative enquiry could be used to explore contextual and
behavioural barriers to cessation of that intervention. We found no examples of this type of enquiry in the
sample of literature reviewed.Suggestions for good practice and maximising value (implementation of the trial intervention
in the real world)
i. Undertake analysis with a clear, trial-related, focus.
l Qualitative research in this subcategory overlapped substantially with that undertaken to explore
the feasibility or acceptability of an intervention and to assess the ﬁdelity of its implementation.
However, the strength of research in this subcategory lay in its ability to address focused and
practical questions relating to the translation of trial ﬁndings into practice.
ii. Be clear about the aim of the analysis in the abstract.
l Articles by Cals et al.69,70 were examples of how abstracts sometimes describe the aims and
objectives of the type of data collected (views and attitudes based on experiences) rather than the
rationale for conducting a particular analysis (to identify factors that may support the process by
which an intervention found to be effective is adopted in practice). In these articles, data were
collected for a process evaluation and then analysed retrospectively to explore particular issues,
given the results of the trial. This fact emerges from reading the full article only. The value of
research in this subcategory would be more apparent and accessible if a distinction was made
between the original (broad) objectives of data collection and the speciﬁc aims of the analysis being
presented throughout the article, including the abstract.43
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SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
46Category 2: trial design, conduct and process
The second broad category of the framework focused on the design, conduct and process of the speciﬁc
trial (see Table 3). We identiﬁed 54 articles with this focus, accounting for 15% of the 356 uses described.
One-ﬁfth of articles in this category were based on qualitative research undertaken at the pre-trial stage
(22%, 12/54). There were eight aspects of the design and conduct of trials addressed by the
qualitative research:
1. recruitment and retention
2. diversity of participants
3. trial participation
4. acceptability of the trial in principle
5. acceptability of the trial in practice
6. ethical conduct
7. adaptation of trial conduct to local context
8. impact of trial on staff, researchers or participants.Trial recruitment and retention
Randomised controlled trials can fail because of poor recruitment, or be suboptimal owing to lack of
statistical power, or cost more money because additional funds are required to address slow recruitment.
There is an evidence base on reasons for poor recruitment to trials, based mainly on quantitative research,73
and an evidence base on the effectiveness of interventions for improving recruitment.74 A survey of trials in
primary care in the UK found inefﬁciency and cost consequences, with trials running past planned
recruitment timetables and additional funds needed to address poor recruitment.75 Within the literature
there is an innovative approach to using qualitative research to improve trial recruitment9 in which a trial is
embedded within qualitative research to identify trial-speciﬁc recruitment issues and take action on them to
increase recruitment rates within that trial. Retention can also be a problem once people are recruited. The
quality of trials can be damaged if there are large numbers of dropouts, particularly if dropout rates are
different for intervention and control arms, leading to concerns about internal validity.
We identiﬁed 11 articles focusing on recruitment or retention, 18% (2/11) of which reported qualitative
research undertaken at the pre-trial stage. Four articles were from the same team that specialises in the
use of qualitative research to increase recruitment for a speciﬁc trial. We selected six articles for full data
extraction: ﬁve unique articles and one from the linked articles. The main method used was interviews,
although there was also use of focus groups, observation and documents in some of the studies.76,77
One article was about recruitment to the intervention rather than the trial itself (Table 12).77
Potential value of qualitative research for trial recruitment and retention
A considerable amount of research has been undertaken about barriers to trial recruitment and this has
been synthesised.73 Most of the studies in the review by Ross et al.73 were quantitative and the articles we
identiﬁed in this subcategory were building on this evidence base. Rather than attempting to identify
barriers as in the review by Ross et al.,73 they focused on strategies for overcoming the barriers,78 ﬁlling
gaps in the knowledge base such as barriers to recruiting health professionals rather than patients,79
focusing on retention as well as recruitment,77,79 considering barriers in new research environments80 and
considering barriers faced by different types of recruiters.81 Most of the articles included here undertook
the qualitative research to help recruitment in future trials. The main goal of De Salis et al.76 was the use
of qualitative research to increase recruitment rates for the speciﬁc trial. These endeavours were extremely
useful because researchers were building on the evidence base and addressing an issue for improving
future trial viability.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
48Suggestions for good practice and maximising value (trial recruitment and retention)
i. Consider the depth of the qualitative research required.
l Some of the qualitative research reported here was descriptive, listing reasons for poor recruitment
or retention as if the data had been obtained from surveys.77,80,81 The authors were able to identify
important issues even when they themselves pointed out the limitation of their content analysis
that did not ‘allow a deeper analytic approach’.78 This raises the issue about whether the strength
of qualitative research to move beyond accounts and identify underlying issues, as opposed to
creating lists of issues, is needed here or whether descriptive qualitative research is enough. There
was also an issue about the labelling of some approaches as qualitative research when in some
articles it read as if researchers took advantage of information collected as part of the recruitment
process to write up about barriers and solutions. This was a useful endeavour but perhaps wrongly
labelled as qualitative research.
ii. Consider including those who do not participate as well as those who do.
l Some authors included in their samples people who had not participated or stayed in the trial as
well as those who had. This was a useful thing to do but more clarity was needed about the
different insights offered by non-participants and participants.
iii. Look beyond interviews.
l Most of the studies included here used interviews. De Salis et al.76 used observation to identify
changes to make to a speciﬁc trial and were able to draw on more than accounts.
iv. Impact on the current trial
l The focus was on learning from current trials to inform future trials. De Salis et al.76 main goal was
the use of qualitative research to increase recruitment rates for the speciﬁc trial. This is an approach
that should be considered more often.Diversity of trial participants
Concerns have been raised about the external validity of trials if an intervention is tested on a narrow
group of individuals who do not reﬂect the population which would receive the treatment in practice.82
We identiﬁed seven articles focused on broadening diversity of participation in trials, with one undertaken
at the pre-trial stage. Two were by the same authors so the six unique ones were selected for data
extraction (Table 13). Methods mainly involved focus groups, with one study making use of observation.85
Potential value of qualitative research for broadening trial participation
Authors of these articles were usually building on the evidence base about barriers to broadening trial
recruitment by focusing on strategies for overcoming the barriers84,88 and understanding how these
barriers impeded diverse recruitment.85 Some of the studies appeared to be driven by the use of
community-based trials,86–88 for which there was a need to include hard-to-reach groups such as those in
rural areas, with low income, or from ethnic minority groups. The qualitative research by Jaspan et al.84
had a high utility for the speciﬁc trial because it was identiﬁed as a way of interacting with the community
and seen as a way of communicating and consulting with the community about the planned trial. There
was an aspect of action research in the study by Velott et al.88 in that they were trying to promote
recruitment for their speciﬁc trial. This endeavour felt extremely useful because it was addressing the
external validity of trials but also the viability of community-based trials. These kinds of articles could also
challenge the interpretation of trial ﬁndings by highlighting problematic recruitment practices.85NIHR Journals Library www.journalslibrary.nihr.ac.uk
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SYSTEMATIC MAPPING REVIEW OF PUBLISHED QUALITATIVE RESEARCH UNDERTAKEN WITH SPECIFIC RCTS
50Suggestions for good practice and maximising value (diversity of trial participation)
i. Consider the depth of the qualitative research required.
l Some of these articles described lists of issues,83 which were useful, but some authors went beyond
this to develop understanding. Russell et al.87 used content analysis but embedded it in known
literature to move beyond a simple list. While one of the authors was an anthropologist and
observation was used, the question was not ‘what are the barriers’ but ‘how do barriers work’,
looking for underlying explanatory rather than descriptive issues.85 These authors identiﬁed the
desire of recruiters to recruit good patients and described how the deﬁnition of a ‘good patient’
in their research setting excluded minority groups. There was also an example here of an approach
which was labelled as qualitative research but was a meeting of recruiters to discuss problems.86
It produced useful insights but there was also lack of credibility owing to lack of detail about who
attended, how many attended and who was able to speak at the meeting.
ii. Do not be tempted to downplay the strength of qualitative research.
l There was some evidence of qualitative research being judged from a quantitative perspective in
the discussion section of some articles.87 For example, references were made to small numbers
affecting generalisability and how obtaining ‘just perceptions’ would need to be validated.87 This
may have been related to the use of content analysis of the qualitative data in this article, but there
is a need to be careful about the inferences drawn from any study and this can be done based on
the strengths of the methodology used. In contrast, Joseph and Dohan85 dealt with this extremely
well. They recognised that what constitutes a ‘good patient’ is likely to depend on context and that
they had studied one context. They attended to the transferability of their ﬁndings by requesting
that future trial leaders articulate what they think is a good patient to recruit and consider its effect
on breadth of recruitment.
iii. Be explicit about learning for trials.
l Russell et al.87 were explicit about the learning for future trials by producing a checklist and being
clear about this in the abstract of the article.
iv. Look beyond interviews and focus groups.
l Focus groups were commonly used in this subcategory. The one study using observation was
extremely insightful.85 This may have been related to the anthropological background of one of the
authors rather than the observation, per se.Trial participation: the experience of being in a trial
The focus of articles in this subcategory was on understanding the challenges people face when in a trial,
particularly during recruitment. Articles with a focus on recruitment or strengthening ethical conduct were
classiﬁed elsewhere. We identiﬁed four articles, two of which were undertaken in the context of a group
of trials and, thus, could have been excluded. We excluded other articles that were in this territory but
appeared to make use of trials as a way of recruiting participants for an interview study rather than
focusing on the trials themselves. We extracted data from all four articles (Table 14). Only one study was
undertaken at the pre-trial stage. The studies used interviews and two also used observation.Potential value of qualitative research for understanding the experience of being in a trial
The articles were about understanding trial participation, focusing on the decision-making processes
people went through when asked to join a trial. They focused on sensitive trial recruitment practices,
such as when parents were asked to put sick infants in a trial89,92 and cancer trials that recruitedNIHR Journals Library www.journalslibrary.nihr.ac.uk
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52patients at the end of their life.90 Their value was in understanding how trials can be more sensitive
to human beings by avoiding misconceptions and improving communication as opposed to improving
ethical procedures.
Suggestions for good practice and maximising value (trial participation)
i. Consider the depth of the qualitative research required.
l This subcategory lent itself to a more in-depth approach to analysis. McCann et al.91 produced a
sophisticated qualitative analysis based on observation and interview to develop the concept of
‘conditional altruism’ rather than simply list themes. Kohara and Inoue90 also provided an in-depth
analysis using a grounded theory approach.
ii. Be explicit about learning for future trials.
l Good practice was stating clearly how the ﬁndings of a study were useful, and to whom, in both
the abstract and body of the article. Some of these articles could have been much more explicit
about how triallists or recruiters could use their research, for example, those recruiting for trials
could understand how to be more sensitive to the journey a parent is on.89,92 This contrasted with
McCann et al.91 who placed emphasis on the utility of their research by including a section in the
discussion on implications for triallists.
iii. Consider including those who do not participate as well as those who do.
l Different insights can be gained about trial participation by including those who did not join, or
who left the trial, as well as those who participated.89,90,92
iv. Consider looking beyond interviews and focus groups.
l The two articles using observation appeared to be more insightful and took an explanatory rather
than a descriptive stance.90,91The ‘in principle’ acceptability of the trial
This subcategory was about trials that researchers or policy-makers wanted to undertake but they were
concerned that the research itself was not acceptable to health professionals or patients, or actual trials
where concerns arose about the trial in principle. We excluded hypothetical trials from our review but
they were relevant to this subcategory when there was a reason for undertaking a speciﬁc trial and
researchers were exploring its acceptability in principle.93 We found ﬁve articles, three of which were
undertaken at the pre-trial stage, and undertook formal data extraction on all of them (Table 15).
Interestingly, studies used content and discourse analysis of newspapers as well as interviews and focus
groups with health professionals and patients.Potential value of qualitative research exploring ‘in principle’ acceptability of a trial
There were two drivers for using qualitative research to explore the acceptability of a trial in principle. The
ﬁrst was concern about the viability of a proposed trial because key service providers or target participants
may be unwilling to participate in a trial which required doing something difﬁcult, for example abstaining
from sex,97 the randomisation of options may be unacceptable93 or the control controversial (Campbell
et al.,94 with placebo surgery). Qualitative research for this purpose seemed extremely useful by saving
time and money and avoiding the low morale that might be involved in setting up a trial that failed.93,94 Of
course, it could be argued that the qualitative research itself cost time and money and that a cost–beneﬁt
comparison may be necessary. However, there was utility of the qualitative ﬁndings beyond the proposed
trial because it identiﬁed why there was a problem so that other researchers could consider the viability ofNIHR Journals Library www.journalslibrary.nihr.ac.uk
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54related trials. There was also explicit consideration of the implications for wider types of trials, for example
placebo trials and surgical trials in general.94 The second driver was the closure of a trial and how media
portrayal inﬂuenced the closure or could inﬂuence the viability of future trials by raising the issue of these
trials being unacceptable in principle.95,96
Suggestions for good practice and maximising value (‘in principle’ acceptability of a trial)
i. Be clear about the research questions.
l Some studies focused only on the acceptability of a trial in principle and offered very clear
ﬁndings.93,94 However, some addressed so many issues concerning both the intervention and the
trial itself that it was difﬁcult to understand the purpose of the study and, therefore, engage with
the ﬁndings.97
ii. Focus on in-depth understanding as well as description.
l The critical discourse analysis by Mack et al.96 stood out as an exemplar of qualitative research used
to understand rather than describe an issue. They offered a sophisticated analysis focusing on how
and why the media coverage was persuasive rather than simply describing the media coverage and
its effect.
iii. Make the implications for different audiences clear.
l Campbell et al.94 offered an exemplary approach to thinking about the implications of their
research for a number of audiences in both the abstract and the conclusion section of their
publication, that is, implications for researchers undertaking trials of surgery and placebo surgery
trials as well as those interested in the speciﬁc trial under consideration. The longer report format
of their publication may have helped by offering more space, which might encourage authors to
consider the wider implications of their work. However they should be given full credit for doing
this in a thorough and clear manner. Others had limited conclusions and reﬂections for trials,
leaving the reader wondering what action triallists might take in response to the ﬁndings.95
iv. Be explicit about the origin of the research question.
l Some researchers were explicit about being driven by a question they wanted to know the
answer to,93,94,96 making it easier to understand the ﬁndings and their implications.The acceptability of a trial in practice
There were four articles that focused on the acceptability of the trial rather than the intervention in
practice. We undertook detailed data extraction on all four articles (Table 16). One study was undertaken
at the pre-trial stage. Interviews and focus groups were used.Potential value of qualitative research for exploring acceptability of a trial in practice
One of these studies was undertaken in the context of a feasibility trial, for which the researchers wanted
to know whether or not it was feasible to run a trial in a busy emergency environment.101 The main trial
was not feasible owing to difﬁculties recruiting, ability to consent in a busy ward and emergency situation
and ethical issues of carer consent when patients were frail. The other three were undertaken in the
context of the main trial, for example to consider the acceptability of the trial design to researchers
because the control arm offered a service which the researchers believed did not contain the active
ingredient but could have offered what they term placebo effects.98 It was not clear whether or not this
was prompted by the trial results, whereas Thorstensson et al.100 undertook the qualitative research in
response to something going wrong with the trial because a large number of participants were movingNIHR Journals Library www.journalslibrary.nihr.ac.uk
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56from one arm to the other and there was a need to understand why Jonvallen99 did not present an explicit
motivation for her study. Using qualitative research to consider the acceptability of a trial in practice felt
like a useful thing to do. It identiﬁed why the trial was not feasible in a busy emergency situation,101
questioned whether or not some controls offer interventions in themselves,98 identiﬁed lessons for future
trials of interventions that were likely to have strong user preferences100 and questioned whether or not
ensuring compliance with trial protocols could cover up the lack of compliance with the intervention.99
Suggestions for good practice and maximising value (acceptability of a trial in practice)
i. Make the implications for different audiences clear.
l All the articles would have beneﬁted from making the implications for different audiences clear in
both the abstract and the conclusions. This was certainly an issue for Thorstensson et al.,100 for
which conclusions could have been directed at triallists to help them deal with strong preferences
for treatments by perhaps using different designs in this situation. In other articles, there was
opportunity to maximise the value of the qualitative research by going beyond description of the
results in the abstract and including implications. For example, Beal et al.98 could have discussed
whether or not triallists should use a control comparison comprising large amounts of education,
what other types of controls might be more appropriate and what types of trials and interventions
their ﬁndings were applicable to. Instead, it was framed as a general inquiry about placebo effects
and trial participation.
ii. Do more of this at the pre-trial stage.
l Only one of the four studies was undertaken at the pre-trial stage so that lessons were for future
trials rather than the speciﬁc trial with which the qualitative research was undertaken.Ethical conduct in a trial
Informed consent for participating in trials is a well-researched area.73,102 Participant concerns about
informed consent can be a barrier to recruitment.73 Interventions to improve participant understanding of
trials have had limited success, with the exception of someone offering one-to-one information sessions.102
Qualitative research has been used to reﬁne trial consent procedures to ensure an ethically acceptable trial
design.103 We found 16 articles that focused on the ethical conduct of the trial, with most of the
qualitative studies (n = 14) undertaken during the main trial and very few at the pre-trial stage. We ordered
them alphabetically and selected every second one for detailed data extraction (Table 17). Three of these
six articles made use of observation as well as interviews and focus groups.
Potential value of qualitative research for exploring ethical aspects of a trial
Researchers appeared to be driven by concerns that informed consent for participation in trials was
problematic in practice. Some were driven by concerns about therapeutic misconception – the conﬂation
of research with clinical care105,108,109 – and whether or not it was actually occurring in a trial. For example,
Wasan et al.109 seemed to be concerned about whether patients joined the trial for clinical beneﬁt when
there was no likely beneﬁt. Others were concerned about complicated informed consent processes that
appeared to pay no attention to important communication issues relevant to different groups.107 Gikonyo
et al.104 were part of a Social and Behavioural Research Group independent of the trial, funded to consider
a wide range of issues around the trial. They were interested in whether or not everything was working as
planned, including informed consent. They produced multiple articles about how to help RCTs work in
low-income or diverse communities. Mangset et al.106 were funded by an ethics group and focused on
people who had just had a stroke and for whom informed consent was difﬁcult.
This appeared to be a valuable contribution to the trial endeavour because it challenged ethical
assumptions by both ethicists and triallists, showing that informed consent could be more complicatedNIHR Journals Library www.journalslibrary.nihr.ac.uk
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DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38than ethicists present. For example, people do not participate in trials for one simple reason but for a mix
of altruism, desire for clinical beneﬁt, access to treatments they do not have access to, or to help health
professionals who are there to help patients.105,108,109 They identiﬁed that a beneﬁt of participating in a trial
could be better health care when trials are undertaken in contexts in which people pay for health care.104
This body of research also showed that gold standard informed consent procedures could be problematic
and that a simpler informed consent process, which paid attention to language and communication, could
improve people’s understanding and, therefore, access to trials.107 This research also showed that emphasis
on formal information giving procedures rather than attention to building relations with a low-income
community could be problematic104 and showed the need for individualised rather than standardised
informed consent.106 There was an overlap here with the next subcategory of adaptation of the trial
conduct to the local context. As well as considering how to improve informed consent, researchers
focused on making trials work for diverse groups, paying attention to local rules and appropriateness104,107
and respect for communities.104
Suggestions for good practice and maximising value (ethical conduct in a trial)
i. Consider undertaking an in-depth analysis.
l Many of these articles undertook an in-depth analysis108,109 and beneﬁted from using observation107
or ethnography105 to show insights about complex ethical issues.
ii. Be explicit about learning for the trial endeavour.
l The message for the trial endeavour was very clear in these articles. There was only one example in
the six articles where the researchers failed to offer direction and recommendations for that type of
trial with that type of patient.
iii. Be prepared to challenge standard practice and accepted beliefs.
l One strength of this set of articles was that the authors were prepared to challenge ethicists’
theories using empirical evidence as well as challenge what is considered to be gold standard
ethical practice in trials.Adaptation of trial conduct to local context
Interventions may be community based and targeted at ‘hard-to-reach’ communities that are vulnerable or
stigmatised. A trial may only be viable within such communities if attention is paid to adapting the trial to
the complex context in which it occurs. We found two articles in this subcategory and both used
participatory or community action research (Table 18). One of these was undertaken at the pre-trial stage.
Both articles reported using a range of methods within this methodological approach: focus groups,
interviews, community forums, community councils and participatory mapping. Only some methods
were qualitative research and it was difﬁcult to disentangle the contribution of the qualitative research
from the community/participatory action research. It is likely that we are discussing the contribution of the
latter here.
Potential value of qualitative research for adaptation of trial to local context
The core activity in both articles appeared to be the establishment of a liaison network and a council/
committee of local people to facilitate two-way communication about the trial. The key driver appeared to
be ensuring the trial was feasible in the local context. Other aims were at play, with speciﬁc reference to
increasing participation within the trial,111 empowerment of a community, dialogue between community
and researchers so that research is undertaken with people and not on people,110,111 reduction of the
probability of negative reactions to the trial111 and good participatory practice.11159
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thing to do for community-based trials in ‘hard-to-reach’ communities. Shagi et al.111 made the point that
this was not only essential to the successful conduct of their feasibility study for the trial and would also
be used in the main trial. Balcazar et al.110 reported that the process helped disseminate to the community
the need for the trial. The two-way communication seemed key to improving the trial quality and trial
sensitivity to human beings.
Suggestions for good practice and maximising value (adapting trial to local context)
i. Consider the utility of an action or participatory research paradigm/methodology.
l Researchers used participatory research rather than qualitative methods to improve local
appropriateness. This approach could be used in community-based trials as a matter of course.
ii. Measure success of participatory approaches.
l Participatory approaches may be expensive and cost-effectiveness must be considered.
Balcazar et al.110 felt that it was important to take that approach but also say ‘unfortunately,
speciﬁc data to measure success of this interaction were not collected’. Shagi et al.111 did collect
quantitative data on the goal of the action research, for example, 1600 women were recruited and
follow-up rates > 80% were achieved for all routine clinics, but the authors could not attribute this
to their participatory approach. If people use a participatory approach they may wish to provide
evidence of its success to convince others to use it.Impact of trial on staff, researchers or participants
Trials can affect staff delivering the intervention or collecting data for the trial as well as those participating
in the trial. We found ﬁve articles in this subcategory and extracted data for them all (Table 19). There was
potential overlap between the subcategory Trial participation: the experience of being in a trial and articles
in this subcategory, which focused only on trial participants. The articles included in this subcategory went
beyond experiences of participation and explored the impact of being in the trial (rather than having the
intervention) on participants’ treatment or wellbeing. Only one study was undertaken pre-trial. The
qualitative methods were interviews, focus groups and two used a longitudinal design.
Potential value of qualitative research for understanding impact of trial on stakeholders
Researchers were not explicit about why they used qualitative research for this purpose. It seemed to be
driven by concerns about the viability of the speciﬁc trial and future trials: concern that the practitioner
community had little experience with trials and thus might be burdened by the trial,112 concern about the
viability of trials in the context of the closure of trials in a particular community,115 or concern that
practitioners might not be able to practice normally within a trial.113 A different concern was that trials
might impact on the content of the very treatment they were trying to test.114 It appeared to be useful work
for both the speciﬁc trial and future trials. For example, Grbich et al.112 reported that the qualitative research
improved communication so that adversaries of the trial turned into advocates, sorted out problems at an
early stage, resulted in improvements in some trial procedures and identiﬁed issues about neglecting
non-trial patients to offer extra care to trial patients. There was also evidence of challenging assumptions.
Kyle and Marks-Maran113 challenged what appeared to be strong concern within a community about RCTs
and with empirical evidence showed that although that concern existed, there were other positive aspects
of RCTs. Paterson et al.114 challenged the assumption that treatments offered in RCTs reﬂect practice.61
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DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Suggestions for good practice and maximising value (impact of trial on stakeholders)
i. Be clear about the rationale for the research.
l These articles had very helpful messages for trials, but these were not necessarily clear because the
rationale for the research question was not clear.
ii. Balance the needs of the speciﬁc trial and the stakeholders.
l Grbich et al.112 had to pay attention to what they could change within the speciﬁc trial and what
needed to stay the same. They could not change the intervention too much within their trial by
dispensing with case conferences because staff did not like them but could change some issues
around the delivery of the intervention.
iii. Be explicit about the implications for trials.
l Grbich et al.112 paid attention to the implications of the qualitative research for both the speciﬁc
and futures trials, detailing these in a large section in the discussion. Other articles in this
subcategory could have been clearer about this.Category 3: outcomes
The third broad category of qualitative research focused on the outcomes of the trial. It was a very small
category, with only ﬁve articles, accounting for 1% of the 356 uses of qualitative research. This was
surprising given that this use of qualitative research is included in other frameworks.6,8 None of the
qualitative research was undertaken at the pre-trial stage. There were two subcategories:
1. breadth of outcomes
2. variation of outcomes.Breadth of outcomes to be measured in the trial
It is usual to have a number of outcomes measured within a trial. These outcomes may be selected by the
intervention developers or the triallists, based on a theoretical model of how the intervention is intended to
work, with identiﬁcation of a pathway of expected outcomes. For example, someone receiving a healthy
eating intervention may be expected to eat less fat in order to reduce their weight, which would result in
measurement of both fat intake and weight within the trial. Alternatively, qualitative research can be used
to determine the range of outcomes relevant to the intervention. One might expect this to be used at
the ﬁrst two stages of the MRC framework for developing and evaluating complex interventions. As the
intervention is being developed, or a feasibility study or pilot trial is being undertaken, the target group for
the intervention can participate in qualitative research to describe the outcomes they perceived they gained
after using the intervention and this can be used to consider the outcomes to be measured in the main trial.
We identiﬁed one article with this focus (Table 20). It differed from the articles focusing on ‘perceived value
and beneﬁts of the intervention’ because of the focus on challenging the outcomes which were actually
measured in the trial. This article was a candidate for exclusion because the data collection of using an open
question on a data collection instrument in the trial was not qualitative. We included it as a ‘grey’ article
because the analysis and reporting of the ﬁndings was more in-depth than other articles using open
questions on surveys.
Potential value of qualitative research for understanding the breadth of trial outcomes needed
The researchers did not appear to set out to address the breadth of outcomes best measured in the main
trial. As part of the main trial, they collected data on the patient experience of the intervention and
identiﬁed the opportunity to consider the breadth of outcomes used in the trial compared with the
perceived beneﬁts identiﬁed within the open comments.117 They asked all 127 trial participants receiving
acupuncture for menopausal symptoms to complete a written statement about changes they attributed to63
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TABLE 20 Example of the use of qualitative research to facilitate understanding the breadth of outcomes valued
by patients
Paper Country Trial
Aim of
qualitative
research
Qualitative methods
and sample
Value of qualitative
research to trial and
the trial endeavour
Alraek and
Malterud 2009
(grey article:
open questions
in survey)117
Norway Pragmatic RCT
of acupuncture
to reduce
symptoms of
the menopause
(DD)
To describe
changes in
health in
acupuncture
arm of trial
Written answers to
open question on
questionnaire to
127 patients in
intervention arm
Range of outcomes in
the trial was not
comprehensive.
Ensures right outcomes
measured in future trials
DD, drug or device.
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64the intervention. The participants identiﬁed a variety of health changes that the authors were concerned
may not be revealed by limited outcome measures in acupuncture studies. The utility felt high in terms of
questioning whether trials could be missing beneﬁts important to patients or perceived as being achieved
by patients,117 although the potential value was for future trials.
Suggestions for good practice and maximising value (breath of outcomes to be measured)
i. Consider timing in the context of the MRC framework for Evaluation of Complex Interventions.
l Alraek and Malterud117 took advantage of a data set to explore this issue. However, the utility of
using qualitative research for this purpose lies at the early stages of the MRC framework to ensure
that an optimum set of measures is used in the full trial.
ii. Consider the value of perceived outcomes identiﬁed.
l This approach has the potential to identify many possible outcomes. Alraek and Malterud117 asked
respondents to identify ‘even issues that might be considered as less important’. Qualitative
research could consider the problem of respondent burden during data collection in trials and give
attention to the value of perceived outcomes by participants so that only outcomes valued by
participants were measured.
iii. Be explicit about the message for the current trial or future trials.
l Articles could do more than problematise the outcome measurement of the trial and identify
explicitly what outcomes trials should measure, or what important outcomes they failed to measure
and the implication of this for the conclusions of the trial.Variation of outcomes
Qualitative research can be used to explore variation in the health outcomes of individuals receiving an
intervention within a trial, or variation in outcomes for different clusters in a trial. We found four articles
published between 2008 and 2010 that used qualitative research to explore variation in outcomes within
a trial (Table 21). We expected these to be undertaken with the main trial and, indeed, all four were
undertaken at that stage. Two of the articles addressed variation explicitly, exploring variation in outcomes
between the clusters in cluster trials.39,118 The article by Hoddinott et al.39 also described an explanatory
model and appears in Table 6 because it is such an excellent example of both subcategories. The other
two articles addressed variation between individuals in a trial and also ﬁt elsewhere in the framework.
In one article, the trial was an opportunity to explore a research gap and was treated as so peripheral to
the qualitative research that this article might belong in Experience of the disease, health behaviour or
beliefs.120 In another article, successful outcomes were the focus, with unsuccessful outcomes included inNIHR Journals Library www.journalslibrary.nihr.ac.uk
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66the sample in a minor way and the article might better ﬁt under Development of the trial intervention.119
We included them here because they helped to illustrate the potential and practice of using qualitative
research to explore variation in outcomes.
Potential value of qualitative research for explaining variation in the outcomes of a trial
Variation in outcomes measured is likely to occur in any trial. Some variation will be random but some may
be explained by differences between individuals receiving the intervention or differences between groups
or communities in a cluster trial. Researchers from the two cluster trials were driven to explore variation in
outcome because they expected it to occur39 or identiﬁed the variation and wanted to understand why it
had occurred;118 they used qualitative data collected during the trial. We wondered if this would be driven
by null trials but this was not the case because Hoddinott et al.39 planned to do their analysis prior to the
trial and the trail reported by Aagaard et al.118 trial was positive. The researchers seemed aware of the
different contexts in which the intervention operated within the different clusters. Understanding the
effect of context on outcome could then lead to understanding the transferability of ﬁndings to different
contexts, offering textured conclusions from the trial rather than a simple ‘yes/no’ answer.118 The utility of
exploration of variation in outcomes for individual patients was less obvious in the two articles included
here and this may have been because they did not absolutely ﬁt this subcategory.119,120 Both had useful
messages for future intervention developers and interestingly, both identiﬁed the importance of the
individual’s context to making or maintaining successful lifestyle change. The ﬁndings could also have been
used to interpret the trial results but were not.
Suggestions for good practice and maximising value (explaining variation in trial outcomes)
i. Pay attention to validity and credibility.
l Blinding was identiﬁed as an important issue in the two cluster trials for which the outcomes
of a small number of clusters were compared with qualitative ﬁndings from each cluster.
Hoddinott et al.39 undertook seven ‘embedded case studies’ using the clusters as cases and
emphasised the importance of building their model of how organisations used the intervention
prior to knowing the trial outcomes ‘to minimise bias’. Aagaard et al.118 identiﬁed the importance
of blinding the researchers to the seven emergency departments in their study when analysing the
qualitative data, but stated it was not possible, and this, therefore, was a limitation of the study.
For individual-level studies, it was blinding of individuals during the interviews to their
categorisation of ‘beneﬁted from intervention’ that researchers identiﬁed as important.119,120
l There was a need for transparency when deﬁning an individual as having beneﬁted from the
intervention or when producing ratings based on outcomes and processes, stating how this was
done and who was involved. Aagaard et al.118 used their qualitative research to produce a
‘qualitative rating’ on three key issues, including leadership of quality improvement. Then they
compared scores on outcomes with scores on processes across the seven clusters. They
hypothesised the direction of effect for their three process variables and found it for one, found
nothing for another, and found the opposite to the hypothesised direction in the third. The authors
drew due attention to the limitations of doing this, rightly reporting that their results were
formative, but perhaps still drew too ﬁrm a conclusion based on the data they had.
ii. Clarify implications for practice.
l Penn et al.,119 Peterson et al.120 and Hoddinott et al.39 were clear about the implications of their
ﬁndings, although Aagaard et al.118 could have considered the implications for transferability of
ﬁndings and mechanisms of action and Peterson et al.120 could have considered implications for
the speciﬁc trial.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38iii. Consider using ethnography.
l Hoddinott et al.39 produced an in-depth and convincing analysis, highlighting the strength of
ethnography for that the outcomes would vary and planned to investigate this. This prospective
the work they were doing.
iv. Plan for variation.
l Hoddinott et al.39 expected approach was likely to ensure they had the information and resources
they needed to explore any variation.Category 4: measures used in a trial
The fourth broad category focused on the measures used within the trial. Leidy and Vernon121 reﬂect on
the role of qualitative research for ensuring the clarity and content validity of patient reported outcomes in
clinical trials. They focus on the instruments used to measure outcomes and identify the role of qualitative
research in selecting the right instrument, ensuring the selected instrument matches issues important to
patients, constructing a new instrument or adapting an existing one and considering the validity of using
validated outcome measures in different groups. We identiﬁed 10 articles focusing on the measures used
in the trial, accounting for 3% of the 356 uses of qualitative research. One-third of the articles (3/10)
reported qualitative research undertaken at the pre-trial stage. There were three subcategories which
aligned to some extent with those of Leidy and Vernon121 but which focused on process as well as
outcome measures:
1. accuracy of measures
2. completion of measures
3. development of measures.Accuracy of measures
We identiﬁed seven articles related to assessing the accuracy of both process and outcome measures used
in the trial and selected six for data extraction (Table 22). Three studies were undertaken at the pre-trial
stage and interviews were the main approach used, including cognitive interviews.
Potential value of qualitative research for addressing accuracy of measures used in a trial
Researchers did not necessarily plan to explore the accuracy of measures as the aim of their qualitative
research pre-trial. It appeared to occur in response to problems arising during data collection and analysis
of the trial. An exception was an exploration of the performance of a validated instrument for a particular
patient group in a pilot trial in preparation for the main trial.122 In other studies, issues occurred within the
trial and qualitative research was established to explore them, for example, during the trial the research
assistants were being asked to clarify how a key outcome measure should be completed.124 The reason for
undertaking the qualitative research was not always clear,123 with some suggestion that a team member
had a particular interest and explored it using the trial as opportunity.126
Even though there was only one example of the planned use of qualitative research on the measures used
in the trials prior to the main trial in our six extracted articles, and three in total in this subcategory, there
appeared to be merit in making this the planned objective of future qualitative research with trials. The
utility felt high by providing extra instructions to allow valid completion of validated measures,126 not using
an inappropriate instrument in the full trial,122 and facilitating the development of accurate measures
using quantitative data in the full trial.123 The potential value was improving the internal validity of the
speciﬁc or future trials.67
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DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Suggestions for good practice and maximising value (accuracy of measures used in a trial)
i. Increase depth of qualitative research.
l Sometimes the qualitative research was reported brieﬂy in a mixed methods article123,125,127 or was
extremely descriptive – almost like a mini-survey.126 This did not damage the utility of the research
but did generate concerns about its credibility.
ii. Reﬂect on the relationship between the qualitative and quantitative research.
l There was disagreement about two approaches to ensuring accurate measures were taken in RCTs.
The ﬁrst was that having explored accuracy using the qualitative research, then quantitative
measures could be used.123 The second was that qualitative research should be used to collect
difﬁcult to measure processes and outcomes within the trial, even if numbers were large and it was
time consuming and expensive.124,125 The best option might be dependent on the situation, with
attention needing to be paid to the trade-off between efﬁciency and accuracy.
iii. Link with the current trial or future trials.
l Messages for future studies and trials were sometimes explicit in the abstract.123,124,126,127 For example,
Penman-Aguilar et al.123 was clear that they had learnt a lot for the main trial using the qualitative
research in their mixed methods study in their pilot trial and developed a measure for the main trial.
Farquhar et al.122 concluded that they would not use the instrument in the main trial, although the
abstract focused more on the learning for people using the instrument in general.
iv. Timing of research: more pre-trial work needed.
l In an ideal world, all of this type of work would occur at the pre-trial stage and there were examples
of this.122,123 However, some of the articles used qualitative research during or after the main
trial,124–127 so that lessons learnt were relevant only to future trials rather than the speciﬁc trial.Completion of process and outcome measures
We identiﬁed only one article exploring completion of outcome measures (Table 23). This was related to
retention of participants within a trial (see earlier subcategory Trial recruitment and retention) but here
retention was affected by how the outcome measures were administered. This study was not undertaken
at the pre-trial stage and used interviews with trial participants.TABLE 23 Examples of the use of qualitative research for completion of outcome measures
Study Country Trial
Aim of
qualitative
research
Qualitative methods
and sample
Value of qualitative
research to trial and
the trial endeavour
Nakash et al.
2008128
UK RCT of mechanical
supports for severe
ankle sprains (DD)
To examine
factors affecting
response and
non-response
Interviews with
22 participants,
eight of whom
did not respond
Identiﬁed reasons for
non-response such as
not understanding
trial and fully recovered.
Improves internal and
external validity
of future trials.
Helps interpretation
of specific and
future trials
DD, drug or device.
69
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70Potential value of qualitative research for the completion of trial outcome and process measures
Non-completion of outcome measures affects the internal and external validity of a RCT. Nakash et al.128
undertook a useful study exploring why some participants did not return their postal survey within the
RCT. They argued that the usual methodological issues about survey response might not apply within a
RCT. Indeed, they found that a lack of understanding of the trial resulted in non-return of questionnaires,
identifying ways of improving completion of measures in future trials.
Suggestions for good practice and maximising value (completion of trial measures)
i. Timing of research: more pre-trial work needed.
l Nakash et al.128 undertook this useful work during the main trial with lessons for future
trials, when it would have been more beneﬁcial at the pre-trial stage in order to impact
on the speciﬁc trial.Development and validation of measures
When reading abstracts and full articles, we identiﬁed a subcategory of the use of qualitative research
for developing and validating instruments for use in trials. They were identiﬁed by our search strategy
because they explicitly reported that the instrument was being developed for use in trials and they used
secondary analysis of data from a trial to test the quantitative psychometric properties of a newly
developed instrument.
We identiﬁed two articles that described the development of an instrument for measuring a secondary
outcome in a trial (Table 24). These studies were not completed prior to the start of trial to allow the use
of the instruments to measure processes or outcomes in the trial. Both articles used mixed methods
research, with the qualitative research undertaken prior to the trial to develop the instrument and the
quantitative research undertaken during the trial. Focus groups or interviews were used to identify items
for a questionnaire and cognitive interviews to explore content and face validity of that questionnaire. We
found other articles doing this work but excluded them because the qualitative research was not described
in enough detail. There are likely to be more articles describing the development of an instrument for use
within a future trial, but these two were included because some of the quantitative psychometric testing
took place using trial participants.
Potential value of qualitative research for developing measures for a trial
Trials need validated measures and these are not necessarily available for secondary outcomes in a trial.
Resources may not be available to develop validated secondary measures prior to the main trial. The two
articles included here faced this situation and used a mix of qualitative research before the main trial and
quantitative psychometric testing during the main trial to develop validated outcome measures. The
potential value was to ensure validated instruments were available for future trials, or to improve the
credibility of the trial ﬁndings by being able to report that these were based on validated instruments.
Suggestions for good practice and maximising value (development of measures)
i. Describe the qualitative research in more detail.
l These articles reported mixed methods studies. Articles reporting mixed methods research have
space limitations that affect the reporting of details of methods and ﬁndings. The authors here
chose to limit the space given to reporting the qualitative research, but this can be problematic
when the basis of the instrument is the qualitative research.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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72ii. Explicitly consider the utility of instruments beyond the speciﬁc trial.
l Some instruments may be useful for a range of interventions or may be very speciﬁc to the
intervention for which it was developed. Researchers should be more explicit about the utility of
their instrument beyond their speciﬁc trial and the extent to which an instrument has been shaped
by the needs of a trial, which might make it difﬁcult to use in other trials.129Category 5: target condition
The ﬁfth broad category focused on the condition that the intervention was aimed at within the trial,
for example depression, with 33 articles accounting for 9% of the 356 uses. Only 6% (2/33) articles
reported qualitative research undertaken at the pre-trial stage. We identiﬁed only one subcategory within
this category:
l experience of the disease, behaviour or beliefs.Experience of the disease, health behaviour or beliefs
For detailed data extraction, we put the 33 articles in alphabetical order and selected every sixth article.
These focused on a range of health issues: the meaning of a service to users, help-seeking behaviour,
health service utilisation, the nature of a symptom and self-management (Table 25). The topics were
always related to the trial intervention in some way, either exploring the issue that the intervention was
attempting to affect or something related to that issue. All the studies used interviews or focus groups
with patients participating in the trial, carers of trial participants, or health professionals who were trial
participants or service providers within the trial.
Potential value of qualitative research for exploring the experience of the disease, health behaviour
or beliefs within a trial
The authors did not offer an explicit rationale for using trial participants to explore wider health issues. This
appeared to be an opportunistic endeavour, with researchers taking advantage of an identiﬁed group of
people with a disease, or experiencing a health service, to address a research gap. In some studies, the
intention was to collect data on the intervention and other interesting issues arose during the interviews,
which then became the focus of an article.132 In other studies, we could see that the trial offered access to
a group of people that might otherwise be hard to identify for qualitative research,135 that the data
collected in the trial were rich enough to allow secondary analysis to explore issues of concern to carers133
and that researchers had an unanswered question when the trial ended which was addressed by returning
to trial participants.134
There was no doubt that researchers were attempting to address research gaps and made convincing
arguments for the need for their research. These articles contributed to the wider knowledge base in terms
of understanding more about users’ experiences of a service136 and offering implications for clinical
practice.132,135 There was even an indication in one article that drawing on the trial as a sampling frame for
the qualitative research strengthened the research because of the ability to use the large geographical
spread of trial participants which would not be feasible in a separately funded qualitative study.132 Some
articles also offered contributions to the trial endeavour by identifying other potential interventions for
testing134 and understanding more about a health problem that was important but was not being
measured in clinical trials.133
The authors themselves often drew attention to concerns, within the discussion section of their articles,
related to the generalisability or transferability of their ﬁndings beyond the trial. First, health professionals or
patients in a trial might not be representative of those in the real world; for example, clinicians in a trial may
have had more of an interest in smoking cessation than the general population of clinicians134 or areas
participating in the trial may have done so because they had poorer services.132 Second, being in a trial may
have affected the views of participants.132 Third, the need to ﬁt in with a trial may have affected dataNIHR Journals Library www.journalslibrary.nihr.ac.uk
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74collection; for example, the need to collect qualitative data after the last trial outcome measurement may
have introduced recall issues for the qualitative research.132 It was extremely helpful to read researchers’
reﬂections on the strengths and limitations of this approach to identify suggestions for good practice.
Suggestions for good practice and maximising value (experience of the disease, health behaviour
or beliefs)
i. State clearly whether or not the intervention and control group are included in the qualitative study
and consider the implication of this sampling strategy.
l In some of the articles, the qualitative research had been undertaken with participants from both
arms of the trial whereas, in others, only those offered or completing the intervention had been
included. Some authors stated their sampling frame clearly in their methods sections131–133 whereas
in other articles we had to work this out ourselves because it was mentioned only in passing in
later parts of the article. This information was important for interpretation of ﬁndings because
experiences in different arms of a trial may not be the same. It may also be important to reﬂect on
sampling from different arms of the RCT both when planning the best sampling strategy for the
study and when analysing the qualitative data because one group of authors who used both
intervention and control participants expressed concerns about having two groups within their
sample with very different experiences.136
ii. Consider the inﬂuence of the trial on the ﬁndings.
l In some articles, the researchers described the trial and its participants in some detail.132–134,136 This
offered an in-depth description of the context of the research participants, which is important for
the credibility of qualitative research. The detail of the inclusion and exclusion criteria for the trial,
by Bair et al.,131 was particularly helpful because of the degree to which this shaped the qualitative
sample. Description of the content of the intervention and the control was also important because
this affected interviewees’ recent experiences of health care and treatment. The discussion section
of these types of articles would beneﬁt from an explicit subsection considering the inﬂuence of the
trial on ﬁndings and interpretation.
iii. Consider implications of the ﬁndings for the trial endeavour.
l We acknowledge that the articles considered here may be one of a number written from the
qualitative research undertaken with the RCT and that relating ﬁndings to the trial endeavour may
be better undertaken within other articles. Even so, we think it is important to consider inferences
for the trial endeavour because the qualitative study participants were sampled from trial
participants. Holtrop et al.134 did this by showing that the intervention in the trial was one of many
inﬂuences on the behaviour they wished to change and they were able to identify other future
interventions that might be more useful. Some researchers discussed this issue as a brief point
in the discussion section of their article rather than in the abstract or conclusion. For example,
Cook et al.133 point out in their discussion that clinical trials are not measuring an important
outcome for carers because they do not understand how to measure it. This was an important
message for triallists that could have been made more explicitly within the article.
iv. Pay attention to the clarity of the key message for different audiences.
l More attention could have been paid to implications of the ﬁndings for different audiences. This
seemed to be more important for articles in this category because of the opportunity for confusion.
Authors had to describe the RCT and the intervention within these articles and then go on and
describe qualitative ﬁndings that related to neither of these issues. This could lead to problemsNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38understanding the message of the article because it might be unclear if the implications were for the
trial intervention or the health condition.The potential value of qualitative research with trials
We considered the lists of potential value of the qualitative research for the trial endeavour documented in
the ﬁnal column of the tables describing examples from each subcategory in Detailed description of
framework subcategories with examples. We listed and grouped them into categories of potential value
(Table 26). The range of potential values was impressive, from improving the science and ethics of trials to
reducing the costs of trials and making trials more sensitive to the people who participate in them.TABLE 26 A summary of the potential value of qualitative research to the trial endeavour
Category Potential value Examples
Bias Avoids measurement bias Helps test face and content validity of instruments in the
relevant patient group
Efﬁciency Ensures faster recruitment Uses observation and interviews to identify problems with
recruitment in a speciﬁc trial
Saves money Stops attempts at full trials of poor or unacceptable
interventions, or unacceptable trials designs
Ethics Ensures sensitivity of trials to human
beings in trials
Ensures that recruitment and communication strategies can
pay attention to health professionals and patients so that
the experience is positive for them
Improves informed consent Challenges current assumptions about gold standard
informed consent, or value of information vs. value
of communication
Implementation Facilitates replicability of intervention
in the real world
Describes components of the intervention so that others can
make use of the full intervention in the real world
Facilitates transferability of ﬁndings in
the real world
Identiﬁes contextual issues important for success
Interpretation Explains trial ﬁndings Explains why trials were null; this may prevent another
trial of a similar intervention. Contextualises results of
successful trial to support dissemination and transferability in
real world
Relevance Ensures interventions meet the needs
of health professionals and patients
Identiﬁes value of intervention to important stakeholders.
Ensures intervention is culturally appropriate
Success Makes a trial successful, feasible,
viable
Engenders stakeholder support for the trial. Makes a trial
locally appropriate to cultural needs
Validity Improves internal validity Ensures the correct measures are used to measure the
correct outcomes
Improves external validity Helps to understand how to broaden recruitment to include
hard-to-reach groupsGeneral suggestions for good practice and maximising valueThe trial article
By studying the qualitative article only, we realised that we were missing a crucial part of the picture – the
article reporting the trial. This trial article might include the actual impact of the qualitative research
on the speciﬁc trial, for example optimising the intervention, explaining the trial ﬁndings, addressing
implementation in the real world; therefore, we took a 1 in 10 sample of our qualitative articles by
randomly selecting 30 of our 296 articles and searched for the related trial article in order to summarise
the actual value of the qualitative research for a speciﬁc trial as documented in the trial article. We found75
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76the trial article for only 20 out of 30 studies. Two qualitative articles were in our ‘grey’ area and used more
than one trial, for two the trial was still in progress, for two the study was a pilot/feasibility and we could
not locate the full trial, for one the trial had been abandoned and the qualitative research undertaken to
understand why and, ﬁnally, we had three for which we could not locate the article or we were unsure if
the trial article we found was the same trial as described in the qualitative article. For a further article we
could not access the trial article, leaving 19 trial articles for analysis. Only 4 out of 19 (21%) of the trial
articles identiﬁed the impact the qualitative research had on the trial (Table 27).TABLE 27 How trial articles describe the impact of the qualitative research
Impact of the research described in the qualitative article Number of trial articles
Trial article DID NOT reference qualitative research 9
Trial article published BEFORE qualitative article 4
Trial article published same year as qualitative article 4
Other 1
The trial article DID reference the qualitative article 8
Mentions it but no impact 6
(Mentions qualitative research to be published) 3
Explicit impact 2
(Explained ﬁndings) 1
(Developed intervention) 1
A mixed methods article of both the trial and qualitative research 2
Explicit impact 2
Explained/modiﬁed ﬁndings 1
Lack of feasibility of main trial 1Good practice
We identiﬁed some issues repeatedly and bring these together to consider good practice and ways of
maximising value for this whole body of research.
i. Be clear about the impact on the current trial or about the implications for future trials.
l Given that qualitative research was undertaken in the context of a speciﬁc trial, we expected
it to impact on that trial in some way by optimising the intervention, improving recruitment within
the trial, explaining ﬁndings, identifying the most appropriate set of outcomes, or facilitating
transferability of trial ﬁndings by considering contextual issues important to effectiveness. We found
some evidence of this reported in the qualitative research articles but generally our expectation was
not met. This was related to two issues, ﬁrst, some of the contribution that qualitative research can
make requires that it is undertaken at the pre-trial stage in order to have an impact on the main
trial and much of it was undertaken with the main trial in practice. Second, qualitative research
undertaken with the main trial, which had the potential to impact on the trial, did not appear to do
this in the qualitative article. A key example of this was the lack of evidence of qualitative research
explaining trial ﬁndings. We acknowledge that this may have been reported elsewhere, such as the
trial article but could not see much evidence of this in our small sample when we explored this.
l The learning from this body of work was largely for future trials but this learning was rarely explicit
within articles. Researchers need to be explicit about the implications of their qualitative research
for the trial endeavour. The abstract of an article is the window to the article and is read by moreNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38people than the full article so we recommend that researchers report this in the abstract as well as
the conclusion of the article. Implications may exist for different stakeholders and it is worth being
explicit about whether the implications are for the triallists, intervention developers, policy-makers,
patients or service providers who may be designing new interventions or trials, or attempting to
implement trial ﬁndings in the real world.
ii. Undertake qualitative research at the pre-trial stage if possible.
l Almost three-quarters of the qualitative research in our sample was undertaken with the full trial
rather than pre-trial, even in situations in which we would expect it to be undertaken only at a
pre-trial stage, such as the acceptability of the intervention in principle, recruitment, diversity of
participation, acceptability of the trial in principle, breadth of outcomes, accuracy and development
of measures. We understand that some of the issues that emerged from qualitative research were
unexpected and that researchers were taking the opportunity to identify these for future trials.
However, qualitative research undertaken at the feasibility/pilot stage of a trial can impact on the
full trial as well as on future trials so we recommend that researchers consider how to optimise
interventions and recruitment prior to undertaking expensive full trials. We recognise that obtaining
funding for pre-trial research might be challenging and that changes may be necessary to how
research is funded.
iii. Consider depth of analysis.
l As a team, we value both descriptive and explanatory qualitative research. Describing interventions
as practised, for example, may be very important for replicability of interventions in the real world.
However, some of the articles we read were like reports of mini surveys and, although useful for
identifying lists of issues, did not generate understanding. Some researchers went beyond studying
what happened and considered why it happened. This appeared to be facilitated by considering a
single focus within an article rather than attempting to describe a whole dataset and the use of
observation and ethnography (see next point, Make use of the range of qualitative methods
available). Qualitative research can also challenge as well as describe and explain and some of the
in-depth analysis we read here challenged beliefs, for example about good ethical practice.
iv. Make use of the range of qualitative methods available.
l The most usual approaches taken within these articles were interviews with a sample of trial
participants and focus groups with intervention deliverers. The use of diaries and recorded
consultations, which were part of the intervention, proved useful to researchers. Observation and
ethnography was rarely used and seemed a powerful approach when used. This may be related to
the fact that anthropologists are more likely to use observation and they might be interested in
‘what is really going on here’ types of questions that lead to explanatory analyses. We are not
recommending that researchers without experience undertake more observation when doing this
research, but that they consider the beneﬁts of observation or a disciplinary perspective on the
quality of research produced.
v. Consider utility of participatory or ‘dynamic’ approaches.
l There were a few examples of researchers working at the pre-trial stage who focused on the
viability of a trial, either focusing on recruitment for a challenging trial or making trials in complex
and challenging contexts locally appropriate. Public health trials are likely to fall into this
‘challenging’ category because they focus on difﬁcult behaviour changes or are based in vulnerable
communities. These participatory or dynamic approaches, which are open to adapting the trial
conduct and intervention at the feasibility phase so that full trials are successfully completed, may
facilitate viability of these complex trials.77
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78vi. Improve reporting of articles.
l We read some excellent articles and highlighted the best of these when describing examples of
subcategories in Detailed description of framework subcategories with examples. We felt that
some articles could have reported the research more clearly and we identify ways in which this
could be done (Table 28).TABLE 28 QUAlitative Research with Trials: Excellent Reporting (QUARTER)
Aspect of the research Guidance
Research question Explain the origin of the analysis focus/research question. Why was it important, how did
it emerge and when did it emerge in relation to the trial? Articulating the origin of the
research question contextualises the ﬁndings
Do not be afraid to select a focus rather than try to report all the ﬁndings. A single
message powerfully told can have more meaning that 20 issues described in broad brush
Be clear about the aim of the analysis in the abstract and main paper. Sometimes
research starts with a broad aim of ‘exploring the views of patients’ but the focused
analysis for the paper is the feasibility of the intervention. Making this clear helps the
reader to understand the ﬁndings
Framing Place the research within an evaluative framework such as the MRC framework for the
development and evaluation of complex interventions
Describe the trial, considering the information that is relevant to the qualitative research
Data collection and analysis Be clear about when the qualitative data collection AND analysis was undertaken – after
trial data collection was complete? When the trial results were known?
Be clear about whether the research was undertaken with participants experiencing the
intervention or the control or both of these groups
Balance Give the qualitative research space in mixed methods articles
Conclusions and implications Report implications for the speciﬁc trial and future trials in both the abstract and the
discussion
Make the implications for different stakeholders clear: triallists, intervention developers,
service providers, patientsDrug trials versus trials of complex interventions
We classiﬁed interventions in the data extraction articles as drug or device, or complex. We found that
researchers used qualitative research with RCTs for drugs or devices as well as complex interventions within
each of the ﬁve categories of the framework (Table 29). Bearing in mind that articles for data extraction were
selected purposively for the ‘intervention’ category of our framework and by systematic random sample for
other categories, the use of qualitative research with a focus on the intervention tended to be undertaken
on complex interventions (only 15% of data extracted articles were for drugs or devices). When the focus
was the category ‘design and conduct of trial’ and ‘measures’, the interventions were much more likely to be
drugs or devices (65% and 67%, respectively). A total of 38% (40/104) of data extracted articles focused on
drugs or devices, but this percentage cannot be extrapolated to the full 296 articles. A crude estimate for the
296 articles, based on applying percentages of drug or device data extracted articles within each category
and then summing totals across categories, is that 27% of interventions were drugs or devices.
It is interesting to consider why researchers used qualitative research to explore the intervention in a drugs
or devices trial given that this was a minority event. These studies were about adherence to drugs or
devices, different settings for administering drugs or devices, or there was acknowledgement that the use
of the drug or device required behaviour change. Across all categories, qualitative research was used in
drugs or devices trials undertaken in complex environments (e.g. the community rather than hospital) or
complex patient groups (e.g. substance abuse).NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 29 Type of intervention a drug or device (data extracted articles only)
Category Subcategory
n focused on DD/n
data extracted (%)
Intervention Intervention development, N = 48 0/6 (0)
Intervention components, N = 10 3/6 (50)
Models, mechanisms and underlying theory development, N = 23 0/6 (0)
Perceived value and beneﬁts of intervention, N = 42 0/6 (0)
Acceptability of intervention in principle, N = 32 0/6 (0)
Feasibility and acceptability of intervention in practice, N = 83 1/6 (17)
Fidelity, reach and dose of intervention, N = 12 2/6 (33)
Implementation of the intervention in the real world, N = 4 1/4 (25)
Trial design, conduct
and processes
Recruitment and retention, N = 11 2/6 (33)
Diversity of participants, N = 7 3/6 (50)
Trial participation, N = 4 4/4 (100)
Acceptability of the trial in principle, N = 5 5/5 (100)
Acceptability of the trial in practice, N = 4 2/4 (50)
Ethical conduct, N = 16 6/6 (100)
Adaptation of trial conduct to local context, N = 2 1/2 (50)
Impact of trial on staff, researchers or participants, N = 5 2/5 (40)
Outcomes Breadth of outcomes, N = 1 1/1 (100)
Variation in outcomes, N = 4 0/4 (0)
Measures Accuracy of measures, N = 7 3/6 (50)
Completion of measures, N = 1 1/1 (100)
Development of measures, N = 2 2/2 (100)
Condition Experience of the disease, behaviour or beliefs, N = 33 1/6 (17)
Total N = 296 40/104 (38)
DD, drug or device.
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Summary of findings from the systematic mapping review
We found a large number of articles based on qualitative research undertaken with a speciﬁc trial. Numbers
appeared to be increasing between 2001 and 2010, although, when exclusion criteria were applied, there
was no evidence of an increase over the shorter time period of 2008–10. The range of contributions was
extensive, with more activity in some areas than others, for example exploring the feasibility and acceptability
of an intervention in practice. This body of work had the potential to offer a wide range of value to trials but
this appeared to be potential value rather than actual value because of the lack of explicit attention within
these articles to how the research impacted on the speciﬁc trial or the implications for future trials. Value
could be maximised by being clear about the impact of the qualitative research on the speciﬁc trial or its
implications for the trial endeavour, including future trials, doing more of this work at the pre-trial stage,
undertaking in-depth analysis with an explanatory or challenging focus that attends to ‘what is really going
on here’, making more use of non-participant observation, considering the use of participatory or dynamic79
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80approaches in pre-trial research for challenging trials and better reporting of the qualitative research.
Qualitative research was undertaken with trials of drugs or devices as well as trials of complex interventions.The systematic mapping review in the context of other research
Lewin et al.8 detail how qualitative research can contribute to the development and evaluation of complex
interventions and then go on to identify how it actually contributes in practice. The list of ways in which it
can be used overlapped with ours to a large extent to develop and reﬁne the intervention, to develop or
select appropriate outcome measures, to examine whether or not the intervention was delivered as
intended (including describing the intervention as delivered), to unpack processes of implementation, to
explore delivers’ and recipients’ responses to the intervention, to explore reasons for ﬁndings of the trial,
and to explain variations in effectiveness within the sample. Our research looked beyond complex
interventions and by doing so added a new category of the design and conduct of the trial. The
framework Lewin et al.8 used, of qualitative research undertaken before, during and after the trial, did not
ﬁt well with our ﬁndings because we found that researchers used qualitative research with the same focus
at different times of the trial process. For example, qualitative research undertaken at the same time as the
main trial was used to explain trial ﬁndings, whereas Lewin et al.8 report that this occurred after a trial.
Lewin et al.8 also identiﬁed issues we did not, for example the use of qualitative research to generate
hypotheses. Their objectives of the qualitative research in practice aligned much more with our ﬁndings:
developing the intervention, experiences of the intervention, reasons for refusing participation, developing
outcome measures and illness experience. Creswell et al.6 list 20 reasons for including qualitative research
with a trial using the before, during and after the trial framework. Again, the items overlap with our
subcategories: understand impact of intervention, understand mechanisms, ﬁdelity of implementation,
develop recruiting and consent practice, validate outcome measures, develop an instrument and explain
variation in outcomes. As with Lewin et al.,8 the framework did not reﬂect what happens in practice in
terms of when the qualitative research is undertaken. Creswell et al.6 also identiﬁed issues we did not,
for example, to document the need for an intervention, identify mediating and moderating factors
and understand how participants view the trial results. This means that our framework is unlikely to
be comprehensive.
Lewin et al.8 found reports and publications of 30 trials of complex interventions that used qualitative
research. They found that in the trial and qualitative publications, most had no evidence of integration at
the level of interpretation and few qualitative studies were used to explain the trial ﬁndings. Our ﬁndings
concurred with this; however, they also found something that was contradictory to our ﬁndings: there was
more use of qualitative research before than during the trial. We found the opposite but this may have
been because Lewin et al.8 included unpublished qualitative research whereas our review used only
published qualitative research. Finally, Lewin et al.8 also identiﬁed problems with reporting the qualitative
research, as authors could have been more explicit about how qualitative research explained ﬁndings or
developed the intervention. In the wider literature, there are ‘trial articles’ reporting how the qualitative
research explained the trial ﬁndings.137 The message that emerges from both our own research and that
of Lewin et al.8 is that this may be something researchers expect to happen more than it actually happens
in practice.
Noyes et al.138 discuss the relevance of qualitative research for systematic reviews in The Cochrane
Handbook for Systematic Reviews of Interventions. They highlight the importance of qualitative studies
undertaken with trials to add value to systematic reviews rather than simply the speciﬁc trial, including
research about the intervention implementation and the illness experience. They identify the value of this
research in enhancing the relevance and utility of the systematic review of trials to potential research users
and in explaining heterogeneity of ﬁndings in a review; however they also highlight the problem of
retrieving these articles. Our research shows that they will be able to locate some of these articles but
systematic reviewers themselves will have to do the work in terms of thinking about the relevance of these
articles to the trial-based evidence because the authors themselves may not have been explicit about this.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The strengths of this part of the study were twofold. First, it was grounded in published research that is
available for other researchers and research users to utilise. Second, there was a considerable amount of
team discussion to ensure clarity and consistency of decision-making. However, there were eight
limitations. First, this component includes only part of the picture and some qualitative research
undertaken with trials is not published. In addition, we did not include some terms in our search strategy
that may have identiﬁed qualitative research, for example documentary analysis and participatory research,
although some articles based on these approaches were identiﬁed using other terms. Second, the impact
of the qualitative research on the trial may be published elsewhere, particularly the ﬁnal report of the
study or the trial article. We did a small substudy of trial articles and were not convinced that the impact of
the qualitative research was published there either, a ﬁnding supported by other researchers.8 Third, our
review was based on publications between 2008 and 2010 and is unlikely to be comprehensive. We had
originally planned to identify articles over the much longer time period of 2001–9 but changed our
strategy when our more comprehensive search strategy identiﬁed many more articles than indicated by our
pilot search in our research proposal. The short time frame used may have limited the range of aspects of
a trial we identiﬁed in our framework. We acknowledge that the framework is not comprehensive and
present it as likely to evolve in the future. Fourth, our search identiﬁed journal articles explicitly connected
to a trial. Some qualitative research undertaken with a speciﬁc trial in mind may not mention the trial and
this may occur more with some contributions than others, for example developing interventions,
developing outcome measures and implementation in the real world. Therefore, we may have
underestimated the use of qualitative research for some purposes. Fifth, although we tried to be consistent
in our decision-making about inclusion of articles, we struggled to draw a clean line around some
decisions such as ‘Is it qualitative research according to our deﬁnition that both qualitative data collection
and analysis were used’. Sixth, we did not apply a quality assessment checklist to articles to consider the
relationship between quality and maximising the value of qualitative research for RCTs. Seventh, we made
judgements here from a narrow perspective and did not necessarily give suitable recognition that when
researchers write a stand-alone article based on qualitative research, they also have to make a stand-alone
coherent story. Also, researchers do not necessarily start out with the intention of exploring some of the
issues that they focused on here. Rather they may take advantage of the trial as an opportunity to do this
research or the issue emerges unexpectedly during the trial. Eighth, this review was based on published
research and this may not reﬂect the breadth of qualitative research that is undertaken in practice.Conclusions and implications of the mapping review
A considerable amount of qualitative research undertaken with trials has been published in the past few
years, carried out in relation to trials of both drugs or devices and complex interventions. Qualitative
research may be undertaken with trials but not published, so we have addressed here only part of the
work undertaken by qualitative research with trials. Based on what is published in peer reviewed journal
articles, qualitative research is undertaken for a wide range of purposes with implications for the speciﬁc
trial, future trials and the endeavour of generating evidence of effectiveness of health interventions. There
are excellent examples of this qualitative research and a wide range of beneﬁts it can offer. However, our
review suggests that this value is more about potential rather than actual impact and there is a need to
improve the reporting of this research so that stakeholders with an interest in trials and the evidence
produced from trials can learn from this extensive body of work. We published the framework in a
journal article.13981
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studies combining qualitative research and trialsAimNot all qualitative research undertaken with trials is published;8 therefore, simply focusing on journal
articles offers a limited view of how qualitative research is used and the impact it has on the speciﬁc trial.
The aim of this component was to identify studies that combined qualitative research and RCTs and
explore how qualitative research was used and ways of maximising its value. We aimed to consider this
using two key study documents: proposals to funders and ﬁnal reports to funders. We limited this part of
the study to the UK in order to identify lessons for UK-based funding bodies.Methods
Identifying trials with qualitative research
The mRCT located at www.controlled-trials.com/ was set up in 1998. It is an international searchable
database containing information about the study hypothesis, design, funders, sponsors and contact details
of predominantly ongoing trials. UK funding bodies have their own subregisters within the mRCT. In 2011,
we searched for UK-based RCTs that used qualitative research and were ongoing between 2001 and
2010. We searched four active registers: UK Trials, MRC, National Institute for Health Research (NIHR) HTA
and the Wellcome Trust. The search terms used to identify qualitative research are listed in Appendix 5.
Owing to the limited search facility in this database, we entered each term individually and then removed
any duplicate studies identiﬁed.
A total of 122 studies (3%) from the 3812 trials listed in the four UK subregisters appeared to use
qualitative research. From these 122, we excluded seven trials that were too old (end date before 2001)
and 26 for which the search terms we had used, for example ‘qualitative’ did not relate to qualitative
research, leaving 89 trials with qualitative research. Of these 89 trials, most (n = 69) were identiﬁed from
the subregister UK Trials with the rest from HTA (n = 10), MRC (n = 7) and the Wellcome Trust (n = 3). The
lead researcher of each study was contacted via email and a request made for the full proposal, the ﬁnal
report and a list of any relevant publications in peer-reviewed journals. One reminder was sent.Data extraction and analysis
SJD read the proposals and formally extracted data using a data extraction form that consisted of general
information about the proposal, such as the funder and the year it was written; the type of RCT; the type
of intervention; the stated aim and the rationale given for undertaking the qualitative research; the
qualitative design, methods, and participants; and information about how the qualitative research was
described within the structure of the proposal (e.g. which section of the proposal the qualitative research
appeared in, how much space was given to the description, details of costings and resources, and the type
of language used to describe the relationship between the qualitative research and the trial). Space for
open comments was available when the assessor (SJD) recorded any aspects of the proposal that seemed
interesting or unusual. The structured aspects of the data were entered into IBM Statistical Product and
Service Solutions (SPSS) Statistics v20 (IBM Corporation, Armonk, NY, USA). The main analysis was
descriptive, displaying the proportion of proposals within each category of each item. The chi-squared test
or Fisher’s exact test was used to compare different types of proposals. Some sections, such as the aim
and rationale of the qualitative research, required verbatim extraction and SJD grouped these extracts into
categories using a process similar to thematic analysis.83
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84AR read the reports to identify whether the authors reported how the qualitative research had an impact
on the speciﬁc trial, making written notes on the type of impact described. We had planned to undertake
a more thorough analysis of these reports but had limited time owing to the unexpectedly large size of the
systematic mapping review in Chapter 3.Findings
Description of studies
We obtained proposals for 41 out of 89 studies (46%). The proposals had start dates between 1999 and
2010, with three studies commencing prior to 2001, 17 studies between 2001 and 2005 and 21 studies
between 2006 and 2010. The proposals addressed a wide variety of topics including cancer, mental
health, complementary medicine, public health issues such as obesity and diabetes, and the delivery of
health care. We had requested ‘proposals’ from lead researchers rather than specifying that we wanted
the original proposals sent to funders, and we received 53 different documents: 36 proposals to funders
and 17 published protocols.
We obtained reports for 22 out of 76 studies (29%) that had been completed at the time we requested
study documentation.Proposals
Further exclusions
We excluded 17 published protocols because they were written after researchers obtained the funding.
On further reading of the remaining proposals, we excluded 4 out of 36 because they did not describe
qualitative research. Of these, three were qualitative follow-up studies added into the mRCT database after
the registration of the trial and one study used the term qualitative in the database, but it used neither
qualitative methods nor qualitative analysis and was thus excluded, leaving a sample of 32 proposals.
The studies were funded by HTA (n = 19), the MRC (n = 5), the Department of Health (n = 3) and others
including the Scottish Executive Health Department and the Wellcome Trust (n = 5).Stated aim of the qualitative research
Statements relating to the aim of the qualitative research were extracted from the proposals and subjected
to a thematic analysis shaped by the framework of the focus of qualitative research (see Table 4) from the
systematic mapping review in order to identify the intended focus of the qualitative research for the trial
(stated aim). All proposals stated at least one aim of the qualitative research and some proposals stated
more than one aim, for example, different aims for the start-up and main phase of the trial. We identiﬁed
68 aims in total from 32 proposals (Table 30). These aims ﬁtted our framework in Chapter 3 with the
exception of a large subcategory (n = 11) related to obtaining the experiences and views of the
intervention in which it was difﬁcult to identify anything more speciﬁc than general experiences of
different groups about the intervention. Similar to our framework in Chapter 3, the majority of stated aims
focused on the intervention, with 39 of the 68 relating to the intervention either solely (24 aims) or in
combination with other categories (15 aims). Most intervention-related aims were about acceptability and
implementation of the intervention either speciﬁcally (10 aims) or more generically (six aims) including
feasibility and usefulness of the intervention. Two of the aims were unclear about which aspect of the
intervention they would focus on. Other stated aims addressed trial design, conduct and processes
(15 aims); the outcomes being measured (ﬁve aims); measures used in the trial (two aims); and the disease
or target condition (two aims).NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 30 The stated aim of qualitative research described in proposals
Framework
categorya Framework subcategory Examples of stated aims of the qualitative work from proposals
Intervention
(39)
Intervention development (3) Develop [intervention]
Focus group to identify range of possible interventions
Intervention components (2) Subsidiary aim is to ﬁnd out what ‘support as usual’ means
Describe ‘usual care’ for this patient group
Models, mechanisms and
underlying theory
development (2)
To better understand women’s decisions about [intervention] and
build a conceptual model of preferences
Develop theoretical framework regarding subjective experiences of
service users
Feasibility and acceptability of
intervention in practice (8)
Examine acceptability of [intervention] for those > 75 years and to
ascertain the views of various stakeholders
Treatment acceptability and usefulness of intervention
Assess the acceptability of the intervention to patients and healthcare
providers
Explore factors associated with success or failure of the intervention:
feasibility, acceptability of different models of [intervention]
Intervention ﬁdelity, reach and
dose (3)
Identify patients’ reasons for completing or not completing [intervention]
Establish patient costs and how they affect adherence, gain insights
into reasons for poor uptake and lack of adherence
Compliance with intervention
Intervention implementation (2) [Healthcare professionals]: experiences of applying new intervention,
impressions of ‘climate’ in group and impact on wider service.
Managers: understanding of service policies and practices for
[treatment group] – perceived inﬂuence of [this type of trial] on
clinical practice
Assess the impact of the new [intervention] on the workforce, other
key stakeholders and national leads
Generic acceptability/
implementation (6)
Identify factors (organisational, professional and patient related) that
inﬂuence successful implementation
Views of [healthcare professionals] concerning implementation of the
service. Understand how the intervention is delivered in practice
Experiences and views about
the intervention (11)
Main trial: assess experience of receiving [intervention]
To qualitatively explore participants’ experiences of the two
[interventions]
Explore patients’ views and experiences of [intervention]
Patient experiences about the process and effects of [intervention]
Unclear (2) Identify additional factors inﬂuencing the uptake of [intervention] and
the way it is used
Explore how [intervention] inﬂuences beliefs and behaviours
Trial design,
conduct and
processes (15)
Recruitment and retention (4) Improve trial recruitment ‘to recommend recruitment strategies most
likely to promote recruitment into the main trial’
Process evaluation will see barriers to recruitment
Start up: assess parent and clinician attitudes to recruitment methods
Reasons for rates of recruitment on trial
continued
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TABLE 30 The stated aim of qualitative research described in proposals (continued )
Framework
categorya Framework subcategory Examples of stated aims of the qualitative work from proposals
Trial participation (5) What it is like to take part in a trial
Start up: assess parent and clinician attitudes to participation
Understand why some men consent to randomisation
Acceptability of trial in
principle (1)
Explore attitudes towards possible trial; focus groups with patients
to explore attitudes towards proposed trial, initial suggestions
around participation
Acceptability of trial in
practice (1)
Understand the reasons for acceptance and refusal of randomisation’
Ethical conduct (2) Ethical and practical issues of consent and assent, for example
feasibility and acceptability of different consent models, views on
participation, merits of conducting a trial
Consent and assent
PPI (1) Phase 1: develop qualitative methods for main study to engage
service users and carers in driving the research process and to elicit
views of NHS services
Unclear (1) The empirical investigation of the social organisation, production and
effects of the RCT in practice
Outcomes (5) Breadth of outcomes (2) Ensure that the most relevant [outcome] factors are assessed by the
questionnaires
To access important aspects of care not available from standardised
clinical outcome measures
Variation of outcomes (2) To examine the implementation process in order to understand and
explain any differences in outcome between intervention sites
Phase 2: determine users’ and carers’ views on the process and
effects of [intervention] compared with the views of those who
received the control
Unclear (1) Start-up: assess parent and clinician attitudes to outcomes
Measures (2) Completion of measures (1) Ensure the feasibility of daily assessment
Development of measures (1) Look at ways of asking about [outcome measures]
Target
condition (2)
Experience of the disease,
health behaviour and
beliefs (2)
Main trial: explore parent and clinician attitudes and knowledge to
[health behaviour]
Explore issues related to [disease]
Unclear (5) Non-attendance (1) Provide insights about non-attendance
Unclear (4) Understanding of processes underlying changes in patients’ beliefs
and attitudes
To provide a richer understanding of patient and carer perceptions to
complement quantitative data
Differences in experience between two treatment groups
Process evaluation (monitor effect on outcomes)
a Numbers in brackets represent the number of incidences that this category or subcategory was mentioned in out of the
proposals we analysed.
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Statements relating to the rationale for undertaking the qualitative research were extracted and subjected
to an inductive thematic analysis to identify why researchers felt it was important to undertake the
qualitative research (we call this the stated rationale). Only 19 out of 32 proposals (59%) included some
statement about the value for the trial of doing the qualitative research. Of those 19 proposals, 14 (74%)
gave one rationale and ﬁve gave more than one rationale. Rationales included interpreting the trial
ﬁndings (n = 7), optimising implementation into clinical practice (n = 5), optimising the trial process (n = 3),
improving recruitment and consent procedures for the main trial (n = 3), and generating theories and
models to guide future interventions (n = 3) (Table 31). These mapped onto the potential value weTABLE 31 The stated rationale for doing the qualitative research described in proposals
Rationalea Statements from proposals
Patient voice or engagement (2) Engage service users in driving research process
Bring together the views of different research participants
Optimise the trial process/develop
the best processes to maximise the
success of the trial (3)
Optimise overall trial process
Develop qualitative model to understand perceptions and inform strategies for full trial
Modify procedures and documentation in feasibility phase
Improve recruitment and consent
procedures for main trial (3)
Develop training programme to improve recruitment strategies for main trial
Develop consent procedures for main trial
Generate theory of attendance at [intervention site]
Generate theories and models to
guide intervention development (3)
Build conceptual model of preferences for intervention
Provide new insights into patients’ views and experiences of [intervention] and
usual care
Develop theoretical framework regarding subjective experience of service users
Generate theories to guide the trial
and health community (2)
Provide generalisable information for wider health community about acceptability
Develop theoretical model of HTA practice/develop critical understanding of social
processes and practices implicated in development, implementation and
dissemination of RCT in ﬁeld of HTA
Optimise implementation into
clinical practice (5)
Inform future development of services of this intervention
Inform roll out of intervention to wider community
Inform commissioners and service providers to contribute to maximisation of quality
and uptake
Assess feasibility of/learn lessons for delivering [intervention] in NHS
Interpret trial ﬁndings (especially
unexpected ﬁndings) (8)
Understand and explain differences in outcomes between intervention sites
Provide a richer understanding of patient and carer perceptions to complement
quantitative data
Help interpret post-trial ﬁndings
Insight into/possible explanations for differential success of intervention
Interpret trial results to understand why intervention did work/work to further
interpret and illuminate the ﬁndings from the trial itself
Inﬂuence interpretation of trial ﬁndings (especially unexpected ﬁndings)/identify
unexpected outcomes
Other (2) Understand, as well as quantify, the process and outcome of care
Explore range of resource use for economic analysis
a Numbers in brackets represent the number of incidences that this category was mentioned in out of the proposals we analysed.
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88identiﬁed in the journal articles in Table 26. Other rationales for doing the qualitative research included
engaging users in driving the research process, giving a voice to trial participants, understanding the
process and outcomes of care, exploring the range of resources for economic analysis and generating
theory to guide the trial and health community.
Space allocated to the qualitative research
Proposals ranged from 4 to 73 pages long, with a mean of 23 pages. From reading each of the proposals,
the amount of space dedicated to the qualitative research in the proposal was categorised as one
sentence, more than one sentence but less than a paragraph, more than one paragraph but not in its own
section, or having its own section with its own heading. In 8 out of 32 proposals (25%) in which
qualitative research occupied less than a paragraph, the same information or sentence was often repeated
in several sections of the proposal. In four proposals (13%) there was more than one paragraph about the
qualitative research, while in 20 of the proposals (63%) there was a section dedicated to the qualitative
research, although the quality of what was written varied across proposals. This was not simply that short
proposals had short descriptions – the shortest proposal had a section on the qualitative research.Type and size of qualitative study
Methods were described in 30 out of 32 proposals (94%). Interviews were the most common method,
used in all but one study, followed by focus groups, sometimes in combination with interviews.
Two studies also used observations and one study also used diaries. Only 21 studies (66%) included any
information about how many interviews or focus groups were planned. Of these, 10 proposals stated up
to 50 interviews, nine studies proposed between 50 and 100, and two studies intended to undertake
between 150 and 200 interviews. For those combining interviews and focus groups, two studies
proposed up to six focus groups and 15–30 interviews, while one study proposed 24 focus groups and
60 interviews.
Analysis was described in 23 out of 32 (72%), simply stating the type of analysis they would use. These
included constant comparative analysis (19%), thematic analysis (19%), content analysis (13%), framework
analysis (9%), with interpretative phenomenological analysis mentioned in one proposal. The eight
proposals that gave less space to the qualitative research (less than one paragraph) were less likely to
include an analysis section (Fisher’s exact test, p = 0.002).Expertise and resources
A total of 75% (24/32) of proposals included some information about who would do the research.
However, only nine proposals (28%) stated that they would use qualitative researchers, with another
11 (34%) stating that they would use researchers but not specifying whether or not they were qualitative
researchers, or stating that the trial or project managers or the lead researcher would do the qualitative
research. Four proposals (13%) did not provide any information. One proposal stated that the researchers
would train community advisers to do the qualitative research. In terms of resources, 19 out of 32
proposals (59%) included information about resources to undertake the qualitative work. These included
transcription (53%), travel (47%), equipment (26%) and training (21%).Language used to identify the relationship of the qualitative research to
the trial
A total of 20 proposals (63%) described the relationship between the qualitative research and the trial:
10 described a relationship in which the qualitative study was subordinate to the trial, represented by
language such as embedded, incorporating, nested, sample from, and substudy. Six proposals positioned
the qualitative study on a par with the trial, using language such as alongside, concurrent, in combination
with, linked, and parallel. Four did not use speciﬁc terms, simply saying that they would also carry out
semi-structured interviews or a RCTwith a qualitative evaluation. Studies with less than one paragraph for
the qualitative research were less likely to describe this relationship (Fisher’s exact test, p = 0.01).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The 22 ﬁnal reports varied in length, ranging from 2 to over 220 pages. Some reports required by funders
only address a list of activities and outputs rather than detailed information about the research project. Ten
of the reports were HTA reports, some of which we included as peer-reviewed articles in the systematic
mapping review (see Chapter 3). Three reports did not mention qualitative research. We had the proposal
for one of these and it described qualitative research. The lead researcher informed us that the study
design had changed after initial funding had been agreed. Fourteen of the reports (64%) explicitly
identiﬁed that the qualitative research had impacted on the speciﬁc trial (Table 32). The type of impact
mapped onto the uses of potential value of qualitative research to trials identiﬁed in Chapter 3.TABLE 32 Qualitative research in ﬁnal study reports
Impact Number
Yes, impact on the trial 14
Facilitated recruitment or explained why poor 3
Identiﬁed lack of acceptability or acceptability of intervention 2
Identiﬁed lack of acceptability of trial design 2
Qualiﬁed or explained trial ﬁndings 6
Modiﬁed way intervention was implemented 1
Impact unclear 1
Report too short 4
No mention of qualitative research 3
Total 22DiscussionSummary of findings from review of studies
Around 3% of UK trials on the mRCT database reported using qualitative research. In proposals to
funders, we recognise that researchers are often constrained by the necessity of providing detailed
information about how the trial will be conducted and the lack of space available on application forms.
That being said, there were still some concerns about how the qualitative research was described. The
stated aim and rationale for using qualitative research in proposals broadly aligned with our ﬁndings in
Chapter 3. The framework of uses of qualitative research was sometimes difﬁcult to apply because of the
vagueness of statements in some proposals. In terms of stated aims, we identiﬁed an additional category
of patient and public involvement that was not found in the systematic mapping review and more generic
statements about the acceptability and implementation of the intervention, and the experiences and views
of participants that we were unable to categorise more speciﬁcally. We did not ﬁnd examples of the
following subcategories found in the systematic mapping review: perceived value and beneﬁts of the
intervention, acceptability of the intervention in principle, diversity of participants, adaptation of the trial to
local context, impact of the trial on staff, researchers and participants, and the accuracy of measures.89
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90Suggested improvements to proposals include giving an explicit rationale for using the qualitative research,
giving space to describe the sample size and analysis and resources, and specifying the use of experienced
qualitative researchers. The number of interviews or focus groups planned in some of the proposals
seemed extremely high, highlighting a potential feasibility issue for some studies in completing the
planned data collection or analysing a large volume of data successfully. It may be important for funders to
question whether or not the qualitative data is being subject to quantitative criteria when large samples
are proposed. If the trial or project manager and general researchers on the trial are to undertake the
qualitative work, this suggests that there may be a lack of training and expertise for the qualitative work,
indeed, particularly in the case of the trial manager the qualitative research risks being subsumed by the
trial. Even though all the proposals we included were funded, we suggest that the lack of information
about costs and resources means that it may be difﬁcult for funders to see that the qualitative research is
adequately resourced, whether or not it is feasible to complete, or if it provides value for money.
The impact of the qualitative research on the trial was much more obvious in ﬁnal reports than in
qualitative articles reported in Chapter 3. This component of the study also highlighted the complex
context of doing qualitative research with trials, showing how some qualitative research is added after the
trial is funded, some is not conducted as planned and some qualitative research is not published in the
ﬁnal report.Review of studies in context of other research
Lewin et al.8 concluded from a review of reports and publications of 100 trials of complex interventions
that few used qualitative research. Their study found qualitative research for 30% of trials, which was
much higher than our study. This may be explained by their focus on complex interventions because
qualitative research may be more commonly undertaken with these types of trials than clinical trials, or
because they undertook more strategies to identify the qualitative research compared with our electronic
search of a database. Our low percentage of 3% was much more similar to Flemming et al.,7 who found
that less than 1% of 146 trials in palliative care in a systematic review used qualitative research.
Research commissioners make decisions about funding studies based on application forms with detailed
proposals. A search of the literature revealed few articles related to writing proposals for qualitative
research in general or speciﬁcally related to qualitative research combined with trials. Sandelowski and
Barroso140 refer to the process of writing qualitative research proposals as ‘artful design’ that requires
‘reﬂexivity, elegant expression, imaginative rehearsal, and strategic disarmament’ in order to neutralise any
anticipated concerns reviewers may have. They argue that the proposal must demonstrate the researchers’
knowledge of the methods and ﬁeld while demonstrating awareness and respect for their audience. They
point out a tension between the emergent nature of the qualitative research and the planning of the
research, with the need to show the signiﬁcance of the research to be undertaken. That is, they put store
by the rationale for doing the work. Connelly and Yoder141 identify a number of common failings in
qualitative proposals which we also found in the proposals in our study such as inadequate explanation of
methodological techniques and lack of rationale for the use of qualitative methodology. The lack of
description of sample size and analysis has been found for mixed methods research more generally,142
highlighting the difﬁculties research commissioners may face when deciding on the quality of
qualitative research.Strengths and limitations of review of studies
It is unusual to assess the research proposals submitted to funders. Yet the proposal is the starting point of
any study and shapes the utility of the research. We assessed the proposals of funded studies and cannot
say how they compare with those of unfunded studies but would suggest they are likely to be superior.
Our study had three limitations. First, qualitative research undertaken with trials may not be identiﬁed on
the database we used, underestimating the amount of this type of research that occurs. Second, our
response rate was poor, particularly for the ﬁnal reports, leaving us with small numbers and the likelihood
of non-response bias. Third, requesting full application forms with proposals would have given us a more
comprehensive and consistent set of documents for use in our study.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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A proposal without a solid rationale for undertaking the qualitative research with the trial suggests that
the qualitative research and its relationship to the trial have not been properly thought through. All the
proposals included in our study were successful in that they were funded. However, we would still suggest
that it is insufﬁcient to state the aims and rationale of the qualitative research without reference to the
details of who will carry out the qualitative research or how it will be conducted and resourced, all of
which are important to enable reviewers and research commissioners to make a conﬁdent decision about
whether or not to fund the trial with qualitative research. We summarise our ﬁndings here to offer
guidance for researchers and research commissioners for the content of proposals relating to the
qualitative research undertaken with trials (Table 33).TABLE 33 Guidance for researchers and commissioners on writing proposals for qualitative research and trials
Aspect of design Recommended details
Aim and rationale Describe the aim of the qualitative research and its rationale. Include a statement addressing the
ways in which it ‘adds value’ to the trial
As far as possible, make aims speciﬁc to the trial, for example ‘to explore patient views on
adherence’ rather than general, for example ‘to explore patient experiences’
Methods Provide a clear account of the proposed methods of data collection including the location and
timing of data collection, the skills and seniority of the person who will undertake data collection
and the process of obtaining consent from participants
Describe the status and scale of the proposed qualitative research including a clear rationale for
the sampling method, sample size and how participants will be selected
Describe and reference the proposed analysis methods and give a clear rationale for the approach
to be taken
Integration with trial Identify the skills and seniority of the person who will undertake the analysis and write-up
Outline suggestions for integrating and synthesising qualitative data/ﬁndings with the trial results
Costs Describe the broad marginal costs of the qualitative research and highlight any dedicated
equipment, software, staff and transcription costs
Leadership Identify which of the co-applicants will take overall responsibility for the qualitative research and
describe their role in the design, data collection, analysis and write-up of the study
91
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qualitative research undertaken with randomised
controlled trialsAimIn Chapter 3, we reported on qualitative research undertaken with trials and subsequently published in
peer-reviewed journals. In Chapter 4 we reported on studies that used both qualitative research and trials
to understand how these studies are proposed and reported to funders. We identiﬁed these studies using
abstracts on a trials database. These abstracts may not have reported the use of some qualitative research
so we undertook a survey of lead investigators of studies registered in the mRCT database, which we had
not identiﬁed as using qualitative research in our review in Chapter 4, in order to measure the amount of
qualitative research which is ‘invisible’ when searching trials databases and thereby gauge how much of
the picture we missed in Chapter 4.MethodsWe undertook two email surveys of lead investigators of studies registered on the mRCT database
www.controlled-trials.com/. The ﬁrst was a survey of a random sample of lead investigators and the
second was a survey of lead investigators of trials identiﬁed as likely to be of complex interventions
because we hypothesised that qualitative research was more likely to be used with trials of complex
interventions. Both samples were identiﬁed by applying a random number generator formula to record
numbers in the mRCT database.Random sample
To obtain a random sample of 100 studies, we identiﬁed 120 records, from which we excluded 18 studies
that we had identiﬁed as using qualitative research (see Chapter 4) or with an end date prior to 2001. We
excluded a further 13 studies without a valid email address for the lead investigator, which left 89 studies.
We did not apply further exclusion criteria.Complex interventions sample
It proved impossible to apply a formal deﬁnition of a complex intervention5 to the brief abstracts on the
mRCT database; therefore, we had to ﬁnd a way of only using the limited information in an abstract to
screen for trials which were of complex interventions. We identiﬁed trials with patient-reported primary
outcome measures as a proxy for trials of complex interventions. This removed clinical trials, to create a
sample likely to be ‘rich in complex intervention trials’. To identify a sample of 100 studies, it was
necessary to generate 400 random records. SJD excluded studies that had used qualitative research and
applied our deﬁnition of complex intervention to abstracts, discussing any ambiguous entries with the
wider team. We identiﬁed 104 studies and excluded a further ﬁve studies without a valid email address
for the lead investigator, which left 99 studies.Data collection
We developed a short questionnaire to ﬁnd out whether or not any qualitative research had been
undertaken, or was being undertaken, with the trial (see Appendix 6). We piloted the survey with six
colleagues who had led trials and made some minor modiﬁcations to the survey process and questionnaire
based on their feedback. The questionnaire asked if any qualitative research was undertaken with the trial
and, if so, to describe the objectives and methods of the research. Two further questions were included for93
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94completed trials only about details of reports and publications from the qualitative research. Finally, an
open question asked for ‘any other comments’.
We sent an email and attached electronic questionnaire to the lead investigator. If we had no response
after 2 weeks, we sent a reminder email. We entered the answers to structured questions into IBM SPSS
v20 to produce descriptive statistics and undertook a descriptive thematic analysis of comments to the
open question.Results
Response rates
We received 38 completed questionnaires from the random sample, giving a response rate of 43%
(38/89). We excluded a further ﬁve questionnaires in which respondents reported that the trial had not
been undertaken, leaving 33 responses. From the complex intervention sample, we received 34 completed
questionnaires, giving a response rate of 34% (34/99).Prevalence of qualitative research
For the random sample, 8 out of 33 respondents [24%, 95% conﬁdence interval (CI) 10% to 39%] reported
that qualitative research was conducted with the trial and described methods that we classed as qualitative
research. Three respondents reported using qualitative research but described interview-administered surveys
or meetings and e-mails with researchers and we classiﬁed these as trials not using qualitative research. For
the complex intervention sample, 15 out of 34 respondents (44%, 95% CI 27% to 61%) reported that
qualitative research was used and described methods that we classed as qualitative research.Methods used
Interviews were the most common method used. Of the eight random sample studies, three used
interviews only, two used interviews and focus groups, one used interviews and non-participant
observation, one used only focus groups and one used only non-participant observation. Of the
15 complex intervention studies, seven used interviews only, three used interviews and non-participant
observation, four used interviews and focus groups, and one used only non-participant observation.Focus of the qualitative research
The qualitative research focused on a range of issues that we were able to classify using the framework
described in Chapter 3, with the intervention as the most common focus. Of the eight random sample
studies, six focused on the intervention in terms of developing the intervention, acceptability of the
intervention, how the intervention was implemented and treatment ﬁdelity. One focused on participation
in the trial and one did not give enough information to classify the focus of the research. Of the
15 complex interventions sample studies, nine focused on the intervention in terms of developing the
intervention, acceptability of the intervention and treatment ﬁdelity. Other uses included trial design
(n = 1), recruitment (n = 1), ethical issues (n = 1) and the target condition (n = 2).Reporting the qualitative research
Most of the studies had submitted a ﬁnal report by the time of completing the questionnaire: 6 out of 8 of
the random sample and 10 out of 15 of the complex intervention sample. Of the eight random sample
studies, ﬁve reported that the qualitative research had been, or would be, reported in a PhD thesis (n = 3)
or a peer-reviewed journal (n = 2). Ten of the 15 complex intervention sample responded that the
qualitative research had been or would be reported in a PhD thesis (n = 1) or peer-reviewed journal (n = 8)
or the ﬁnal report (n = 1). One participant stated that the qualitative work would not appear in the
ﬁnal report.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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We identiﬁed three themes from the comments of all respondents (numbers of respondents in brackets):Funding
Different points were made by different respondents relating to funding: there was a bias against funding
qualitative research with trials (n = 1), the qualitative research was unfunded (n = 1) and qualitative
research had been undertaken prior to the trial and funded separately (n = 1).Publishing
With regards to publishing the qualitative research, it was stated that the research assistant/PhD student
would publish it (n = 1), they would not publish because they ran out of time and money and the research
assistant had moved on to another study (n = 1), they did not publish it but the authors report that the
interviews were exceptionally valuable in understanding the results of the trial (n = 1), they do not bother
to publish applied qualitative research because it is not valued academically (n = 1), it was not part of the
core message and would distract from it (n = 1) and the qualitative research was still ongoing when the
trial ﬁnished (n = 1).Perceived value of the qualitative research
Four respondents did not include qualitative research because they felt it was unscientiﬁc (n = 1),
unnecessary (n = 1), the study was designed a long time ago (n = 1) or they had learnt about qualitative
research since getting the study funded (n = 1). Two respondents who had undertaken qualitative research
had recommended in the ﬁnal report that more qualitative research was needed or had undertaken more
of it in relation to the original trial. Three respondents described the utility of the qualitative research for
the trial in explaining the trial ﬁndings (n = 2) or making a limited contribution (n = 1).DiscussionThe surveys were small with low response rates but nonetheless offered useful data for estimating the
prevalence of the use of qualitative research with trials in conjunction with ﬁndings reported in Chapter 4
and identifying perceptions of researchers that can be viewed in conjunction with ﬁndings from our
interview study reported in Chapter 6. The surveys showed that our review of studies in Chapter 4
considerably underestimated the percentage of trials with qualitative research, particularly for trials of
complex interventions. Of 3812 UK trials, we identiﬁed 3% (122 trials) that appeared to include qualitative
research. Our random sample survey found 8 out of 38 respondents had used qualitative research with
their trials. If we assume that non-respondents did not use qualitative research then 8 out of 89 trials (9%)
of trials used qualitative research without recording this fact in the trials database. If this is combined with
recorded qualitative research rates, we estimate that at least 12% of UK based trials in the mRCT database
ongoing in the time period 2001 to 2010 used qualitative research. As we anticipated, the same
calculation applied to complex intervention trials suggests a higher rate of qualitative research use (18%).
However, this is still lower than the 30% reported by Lewin et al.8 Our estimates are likely to be
conservative because we assumed that all non-responses were negative and the wording on the
questionnaire about the use of qualitative research – ‘when conducting your trial’ – may have encouraged
responses about concurrent rather than sequential use of qualitative research.
The surveys offered some insights into why the qualitative research was not included in the trials database:
because it was unfunded, was funded separately or was perceived as peripheral to the trial because it was
an opportunity for researchers to obtain their PhDs. Although the qualitative research was invisible in
the trials database, some of it was published in peer-reviewed journals so could have been included in
Chapter 3 if it was explicitly linked with the trial and published between 2008 and 2010. The objectives of
the qualitative research described in the surveys aligned with those described in our framework based on95
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96our systematic mapping review in Chapter 3 and did not identify new categories or subcategories. The
surveys did however identify another value of the qualitative research – helping researchers obtain further
degrees – albeit not a value to the trial endeavour. Researchers mainly used interview studies and this
concurs with ﬁndings in Chapter 3. Some of the issues arising in the open comments are similar to
ﬁndings from the interviews with researchers reported next in Chapter 6.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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qualitative research and trials: a qualitative telephone
interview studyAimTo explore researchers’ perceptions of how to maximise the value of qualitative research undertaken with
speciﬁc trials.Methods
Design
We undertook a qualitative telephone semistructured interview study of researchers with experience of
working on studies combining qualitative research and trials. We used telephone rather than face-to-face
interviews for practical reasons. The strengths of this was that they are less time-consuming to undertake
across a wide geographical area, and their main weakness – difﬁculty in generating a rapport with an
interviewee – was minimised because researchers are likely to be comfortable with this medium as they
use telephones in their daily work.Sample
We wanted to explore the views of researchers with a wide range of experience. We sampled from the
sources described earlier in the report: authors of articles reporting qualitative research undertaken with
trials, researchers of studies from the mRCT database and researchers from our survey of ‘invisible’
qualitative research. We limited our sample to UK-based researchers because facilitators and barriers may
differ by country and we wanted to gain a more in-depth picture that was relevant to the UK. We
undertook purposive sampling of chief/principal investigators and qualitative researchers because we felt
they would offer different perspectives. We attended to maximum variation by including researchers who
had worked on studies covering the range of uses of the qualitative research in relation to the trial (see
Table 3). We used an iterative approach for selecting potential interviewees: we selected 10 interviewees,
invited them for interview and interviewed the six that agreed; then we selected another set of potential
interviewees to complement the ﬁrst six interviewees. We read transcripts after each interview and met as
a team to discuss sampling. After the ﬁrst 15 interviews, we paid attention to data saturation for the aim
of our study. At this stage we felt that we were hearing similar issues and decided to interview another
three to six researchers in order to ﬁll the gaps within our sample. We were particularly keen to ensure we
addressed all the framework categories (see Table 3) and, wherever possible, authors of the most recently
published articles in our framework to ensure we included researchers’ more recent experiences.Interviews
The interview guide was semistructured, focusing both on the speciﬁc study we had used to select
interviewees and on more general views based on wider experiences of doing this type of research (see
Appendix 7 for ﬁnal interview guide). The interview guide addressed the objectives of the qualitative
component within their study and how these arose, how the qualitative research was undertaken in
conjunction with the trial, what made it successful (asking interviewees for their understanding of
‘success’) or how it could have been more successful, the visibility and status of the qualitative component,
decisions about reporting ﬁndings, and perceptions of whether or not it was worth doing the qualitative
research. We viewed our ﬁrst interview as a pilot and reﬁned the interview guide, continuing to do so as
we read transcripts of early interviews. For instance, for later interviews we added a more direct question97
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98about what constituted ‘success’ for the qualitative research. The interviews were conducted
during 2011 by AR and lasted between 39 and 81 minutes. They were digitally recorded with permission
from interviewees.Analysis
Interviews were transcribed verbatim and checked for accuracy by AR. Transcripts were returned to
interviewees to allow them to identify extracts they preferred were not used in verbatim quotes. For the
analysis, we followed stages of the ‘framework’ approach22 because we had a priori issues to explore as
well as wanting to allow for emergent issues. Our team read transcripts for familiarisation, developed an
initial thematic framework based on the interview guide and early transcripts and AR coded all transcripts
to this thematic framework using NVivo 9 (QSR International, Warrington, UK). Our team discussed the
content of codes and connections between codes, returning to read some transcripts to ensure that we
kept a case focus while thinking about themes. The analysis was continued by JG who wrote up the
themes for discussion within the team. The ﬁnal analysis and write up was undertaken by AO in discussion
with KJT and SJD. We selected quotes to evidence and illustrate our ﬁndings and we identify interviewees
by the roles they had within the research team of the study they were selected from.
Our focus within these interviews was on how the value of qualitative research is maximised for the
speciﬁc trial with which it has been commissioned. As we reported earlier, this was the focus of our whole
study but we widened it for the systematic mapping review (see Chapter 3) because so many articles had
implications for future trials.Findings
Description of interviewees
We approached 26 researchers and interviewed the 18 who agreed. The interviewees were researchers
who may be known by readers of this report and we have taken care throughout the presentation of
ﬁndings to protect anonymity. For this reason, we do not present a table of characteristics with a row for
each interviewee, but simply summarise characteristics. We sampled interviewees from the mapping review
(n = 9), review of studies (n = 6) and surveys (n = 3), and selected them as the lead researcher (n = 11) or
the qualitative researcher (n = 7) on the selected study, although two lead researchers identiﬁed
themselves as both. They were male (n = 5), female (n = 13) and had worked on trial designs such as
cluster (n = 6), early phase (n = 2) and pragmatic trials (n = 7), and had undertaken qualitative research to
address the intervention (n = 11), the trial conduct (n = 6), outcomes (n = 1), measures (n = 1) and the
target condition of the trial (n = 2). Interviewees described themselves as a quantitative researcher (n = 4),
qualitative researcher (n = 5), mixed methods researcher (n = 1), principal/chief investigator (n = 6) and both
lead investigator and qualitative researcher (n = 2).Overview of themes
Our focus was on how to maximise the value of the qualitative research for the speciﬁc trial in terms of
the impact it had on the intervention, trial conduct, outcomes and measures used, interpretation of trial
ﬁndings or implementation of the trial ﬁndings in the real world. The focus was different from the focus in
Chapter 3, which considered the value to the more general trial endeavour of producing evidence of
effectiveness of health interventions.
Interviewees were clear that qualitative research could, and did, have value to the speciﬁc trial. Maximising
that value required two things: that high-quality qualitative research was undertaken and that integration
of the quantitative and qualitative components of these studies occurred. As we analysed the data, we
developed and tested the ‘theory’ that the value of the qualitative research to the speciﬁc trial was
dependent on how it was valued by the lead investigator, the team and prevailing research structures.
Consequently, the presentation of ﬁndings shows how aspects of the social organisation andNIHR Journals Library www.journalslibrary.nihr.ac.uk
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integration with the trial.Theme 1: the value of qualitative research to the specific trial
Interviewees were clear that qualitative research did have, or could have, value to the speciﬁc trial. We
describe here the range of ways in which the interviewees articulated this value and the extent to which
our deﬁnition of success for the qualitative research had an impact on the speciﬁc trial aligned with
interviewees’ views. First of all, we describe how interviewees deﬁned qualitative research because this
shaped their beliefs about its value in this context.Different ways of defining qualitative research
Implicit within the interviews was that qualitative research does not comprise a single approach but a
number of different approaches employed by a number of different disciplines. Interviewees referred to a
range of methods used within their studies. The variety of methods was matched by the variety of ways in
which they described how they analysed their qualitative data: thematic analysis, inductive thematic
analysis, interpretive phenomenological analysis, realist evaluation, using an iterative process, using NVivo,
interrogating the data using key words, or using a combination of techniques that made deﬁnition
difﬁcult. Some attempts at deﬁnition involved reference to a set of qualitative skills, including conceptual
and interpretive skills. Others approached deﬁnition in terms of highlighting the purposes or functions
served by qualitative research which are not ﬁt for quantitative approaches. Qualitative research addressed
‘how’ and ‘why’ questions, with some qualitative interviewees suggesting that these were more complex
than questions addressed by RCTs and that, consequently, qualitative research was much more difﬁcult
to undertake.© Que
Health
provid
addres
Park, SWe expect RCTs to come up with an answer, don’t we? We always expect that, you know, this trial
will be able to solve the answer to this question, and I don’t think that’s what qualitative research is
about. I think it’s more about trying to gain a broader understanding . . .
T16, qualitative researcherQuantitative research is . . . much easier because it is much more logical, structured, rule-bound, I
suppose, and not as conceptual, and I think qualitative research is much more difficult, because it’s
more conceptual, because the theoretical frameworks are less well developed and there are
conflicting . . . theories . . .
T6, lead investigatorA belief in the complexity and depth of qualitative research, illustrated by the quote above, was contrasted
by some interviewees who described their research colleagues’ belief of qualitative research as simply the
use of closed questionnaires, or in fact anything that was not a trial. Finally, interviewees deﬁned
qualitative research by its quality of flexibility to emergent situations – that it could be undertaken with
one speciﬁc purpose in mind but end up producing unanticipated ﬁndings, or that it may reveal useful
things in relation to the particular intervention under study but also illuminate phenomena in a way that
could shape future interventions or services. They also described the need for qualitative research to evolve
over time within a study rather than be constrained by the original research design, for example, in order
to incorporate additional interests or to address difﬁculties that arise within the wider study. This
openness, ﬂexibility and responsiveness to needs was discussed as the reality, and as a strength, that was
different from qualitative research that was unplanned and not thought through.The value of qualitative research to the specific trial
Examples were cited in which qualitative research was not seen to have any potential to add value to a
trial, for example, drug trials or trials with clinical rather than behavioural outcomes. For trials of complex
interventions, interviewees described a variety of ways in which qualitative research did add value to the99
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100trial and in some cases described it as best practice, citing the MRC guidance for developing and
evaluating complex interventions. The ways in which interviewees described qualitative research adding
value to the speciﬁc trial aligned with our framework based on our systematic mapping review (see
Chapter 3). Interviewees described using qualitative research to identify problems and solutions prior to
the main trial by exploring trial feasibility, informing the intervention or developing data collection
instruments. This was seen as much more routine practice than in previous years, addressing problems that
had occurred previously with trials. It was described as saving the effort of undertaking trials which proved
unfeasible, making viable a trial by ensuring its ability to recruit or retain participants, or optimising
interventions, instruments and procedures to ensure the best RCT of the best intervention. Therefore, the
language was both overcoming barriers faced by RCTs and improving RCTs.NIHRIt’s a given really that we ought to consider using qualitative research methods to uncover the barriers
for trials etc. in advance, before trying to do them . . . that’s quite routine now that people are really
into . . . looking at the feasibility of whether interventions are acceptable to the users before you
actually try and implement them in an experimental setting. So I think the value of qualitative
research in trials is, there are many, but certainly (1) looking at the barriers of actually undertaking
a trial, (2) looking at the acceptability of interventions and procedures, are, through qualitative
methods, enormously useful.
T2, lead investigatorThe qualitative research was also used with the main trial to understand the intervention implementation
and context in order to facilitate use of the evidence in the real world. This was described sometimes, but
not frequently, as process evaluation. The use of the qualitative research to understand context was
valuable because it increased the utility of the evidence generated by the trial for changing practice in the
real world. It was seen to be invaluable not only in relation to the speciﬁc trial, but for future interventions,
trials and clinical practice.. . . the qualitative side will always be successful in helping you to contextualise the findings. Without
the qualitative side, the context is always going to be much more poorly described. In some types of
trial that may not matter hugely, in other types of trial it may be absolutely essential to understand
more about the context of those delivering the intervention, those receiving the intervention, how
they have experienced it, in order to understand the feasibility of wider use of the intervention . . .
let’s say we had demonstrated that the [X] intervention was effective, there would still be lots of
questions – ‘well how would you successfully roll it out, how would you apply it widely across the
NHS?’ . . . so in terms of success – how can you tell whether it’s been successful? I suppose that that
for me is one of the key things, is it helping an audience, whoever’s trying to understand what the
trial has shown . . . is it helpful in terms of explaining the context within which the implications of a
trial can be considered.
T12, lead investigatorQualitative research was also valued for explaining trial results that were null, disappointing, surprising or
confusing. In one study, the researchers were puzzled as to why an intervention that had been highly
valued by many members of the group receiving it was not effective. The qualitative data revealed
variability in the quality of the intervention provided, which may have contributed to the unexpected trial
result. Explanations could be pragmatic and speciﬁc to the trial or be more generalisable through use of
theory. It was not simply about explaining trial results, but also offering complementary ﬁndings which
supplemented or modified the conclusion of the trial, for example by identifying beneﬁts of the
intervention that had not been measured quantitatively in the trial, or identifying that although theJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38intervention proved effective within the trial, it would meet implementation difﬁculties that would limit its
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Park, S. . . some of the findings were coming out that were perhaps difficult to understand, and it allowed
us to work out why those findings, what was behind those [. . .] there might be more similarity
between the control site and intervention site than you actually anticipated, because people change
the practice and they take on different methods over time. So the qualitative methods could tease out
that kind of information and allow us to look more deeply into why the findings might not be
so different.
T1, qualitative researcherIt was pretty much informed by a grounded theory approach all the way through, in that what we
wanted to do was to develop theory about why the intervention outcomes were as they were.
T9, lead investigator and qualitative researcherIn addition to the qualitative research being a problem solver, explainer and translator of evidence into the
real world, there were also some unexpected beneﬁts of using qualitative research. Some interviewees
highlighted the importance of the qualitative research in securing stakeholder engagement to ensure trial
viability. In relation to the issue of ‘buy in’, interviewees described how those responsible for delivering the
intervention felt that being interviewed or taking part in workshops to discuss the eligibility of potential
trial participants had ‘given them a voice’ and created a positive relationship with the trial researchers
which helped them to remain enthusiastic about the trial. This had not been an explicit aim of the
qualitative research but was what may be termed a ‘secondary gain’.Impact on the specific trial is not what it is all about
A key belief held within our research team was that qualitative research should have an impact on the
speciﬁc trial and we explored this explicitly within the interviews. We asked interviewees to reﬂect on how
successful the qualitative research had been and deﬁne success from their perspective. Some interviewees
equated success with impact on the speciﬁc trial (see The value of qualitative research to the specific trial)
but felt that there were other beneﬁts to using the qualitative research. They discussed the value to future
trials by informing the researcher’s future practice in developing and evaluating complex interventions. The
qualitative research could also offer benefits to the research team rather than the speciﬁc trial by offering
an opportunity for a junior researcher to undertake his or her PhD. They described success in terms of it
having ‘answered the question that it’s addressing’, having valued the participants by incorporating and
representing their experiences faithfully and having achieved publications. Success for them included
offering insights into ‘patient experience’ that had the potential to improve service delivery generally.It depends what you’ve set out to do, if you’ve set out to enrich your data from your main trial, and
you’ve been able to achieve that then that would be success. If you get publications out of it,
obviously that is, we’ve all got to think about that, that’s success. If you’ve managed to enrich the
experience of people taking part – I mean certainly my experience is that people who were taking
part in the main trial really valued having the qualitative research because they liked talking about
their story, and it was more personal for them and enriched their experience of taking part in the
main trial – so I think that’s success as well. And I think probably if their experiences then being
adequately written up and adequately recognised and not, you know, it is then getting put on a back
burner, which is unfair to the participants . . . being seen as, like, secondary or less important to the
main findings, that probably is not successful . . . I think qualitative research as part of RCTs is a very
valuable thing to do, and that I think it’s happening more and more, which is a good thing, and I
think a mixed methods approach is happening more, which is again a good thing, and I think
everybody benefits from it, particularly the participants. And at the end of the day that’s why we are
doing research, isn’t it? It’s to help benefit people.
T16, qualitative researcher101
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102There were also negative views about the qualitative research having an impact on the speciﬁc trial.
Qualitative research directed at assessing the feasibility of a trial, which resulted in the trial not proceeding,
may be viewed by some as a success but viewed by others as a failure because the triallist could not
proceed along their planned route of undertaking the main trial. Our early interviews, when we asked
about impact on the trial the question, were sometimes met with denial that impact had occurred because
this was considered to be problematic. One interviewee was insistent that allowing the qualitative research
to have any impact at all on the trial would constitute ‘contamination’. This was brought about partly
through how we expressed the question but also highlighted the fear that qualitative researchers should
be careful not to damage the trial as an experiment. As well as this reaction of fear, there was genuine
concern about the potential for qualitative research to offer a therapeutic effect and thereby damage the
RCT experiment, particularly if the interviews and observation were more intensive than the intervention
under study: ‘. . . particularly where the intervention you’re evaluating has got a psychosocial component,
you do worry a little bit about interviewer effect . . . a therapeutic effect which can water down the impact
of the actual intervention within the trial.’ (T17, qualitative researcher.)Theme 2: there is value but it needs to be maximised
Even though the position of our interviewees was that qualitative research was valuable and many of them
perceived it to have been successful within their studies, they identiﬁed problems with attaining full value
from it and identiﬁed solutions required to do so. They expressed concerns about the quality of the
qualitative research undertaken and the integration between the qualitative research and the trial.
Attention to both of these issues was required to maximise the value of the qualitative research to the
speciﬁc trial.Do ‘proper’ qualitative research
Interviewees rarely offered speciﬁc quality criteria but were, instead, critical of what they perceived to be
poor-quality qualitative research undertaken in this context, identifying a lack of conceptual thinking,
analytical thinking or what the interviewee below describes as ‘intellectual intensity’. These criticisms were
made by both quantitative study leads and qualitative researchers.NIHRI think one of the problems that we face with qualitative research is that it is talked up a lot, but
quite often the product that is delivered isn’t nearly as good as the aspirations for the discipline [. . .]
I would say that most of it falls very far short of this sort of conceptual framework, real contribution
to understanding that we think it will be, so that a very common process is for people to use
expressions like, ‘we did a phenomenological analysis,’ ‘we extracted the themes and I’m going to
present them to you’ and then they present to you four themes, each of which is named, and then
they give some quotes, in a box or in the text, and you come out the other end and you think, ‘I
don’t know if I’ve learnt anything from this’. And when you meet really good qualitative research,
you know what [. . .] we can achieve with it, but so often, I think, the intellectual intensity that’s
required to do it well isn’t applied.
T8, lead investigatorInterestingly, this interviewee, who identiﬁed himself or herself as ‘not a specialist qualitative researcher’,
described a process of undertaking qualitative research that contributed to poor quality, i.e. large numbers
of interviews, a lack of an iterative approach and overly optimistic expectations of what it could deliver. It
felt like a model that this interviewee worked hard to resist, although they did not explicitly indicate exactly
who or what was imposing this model:I’m becoming much more directive about not saying ‘well, let’s interview 40 people’, but say, ‘let’s
just start with one and . . . then do another and do another, that that would be a better way to do it’,
so what we tend to do now is much less quantity of qualitative interviews . . . what is also better
practice, which is really look at them as we go along . . .
T8, lead investigatorJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Although some interviewees discussed the need for ‘proper’ qualitative research, they also identiﬁed the
problem that qualitative researchers from different disciplines have different understandings of the
meaning of quality. One of the consequences of a lack of consensus of the meaning of quality was that
qualitative research might be criticised and labelled as poor, damaging its ability to obtain funding, or its
credibility and, by means of this, its utility. This was in contrast with the general acceptance of the
meaning of a quality RCT. Of course, there are debates about quality criteria for RCTs, but researchers
were working in the context of combining two contrasting methodologies of the ‘varied and contested’
qualitative research and the ‘singular and accepted’ RCT.Integrate the qualitative research and trial: essential to the study
or an ‘add-on’?
When interviewees perceived a lack of impact of the qualitative research on the speciﬁc trial, they
explained it in terms of a failure of the two methods to be integrated.© Que
Health
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Park, S. . . it can be used in much more creative ways than it is being I think, or it has been doing, because I
think there’s still this idea that it’s just something on its own whereas it can be integrated.
T1, lead investigatorThere were various descriptions of the integration or separation of the qualitative research and the trial.
A few interviewees described the qualitative research as essential to the study and as essential as the trial:I think the key to it is using qualitative methods because you really need to. [. . .] Sometimes
qualitative methods get put in because they feel qualitative methods ought to be in there these days
. . . so I think it very important that the qualitative methods are actually needed, so there is a research
question there that qualitative methods would answer . . . So, having them there for the right reasons
T17, qualitative researcherThree of our interviewees who described integrated studies were driven by the need to undertake research
that was applicable to the complex world in which health care operated and could not conceive of
undertaking a trial of the types of issues they were interested in without using qualitative research. A sign
of how integral the qualitative research was to the study was never more telling than when the trial
publication waited for the delayed qualitative research.. . . for example, we’ve had the quantitative data pretty much ready [. . .] for about 6 months, but
because of various delays the qualitative has lagged behind a bit, so we’re only just catching up with
that now. So you could argue that we could have published 4 or 5 months ago, but we’re making it
wait for the qualitative, which has not been a problem in the team, but I could imagine in another
team where they weren’t so keen or so understanding of qualitative methods and what it does bring
to the final paper, that could be a challenge.
T17, qualitative researcherThe clearest expression of the essential status of the qualitative research to the study came from a lead
investigator who viewed the trial as embedded within the qualitative research rather than the more usual
description of the qualitative research embedded within the trial:It’s a qualitatively motivated trial really . . . I don’t know whether ‘motivated’ is the right word there,
but, as I said, I very much see the qualitative as coming – the trial as being embedded within
qualitative research, so it’s very, very visible.
T9, lead investigator and qualitative researcherMuch more common was a description of the qualitative research as important to the study rather than
essential, with the qualitative research ‘embedded’, ‘nested’, ‘integral/integrated/integration’ and ‘built
into’ the study. This contrasted with other interviewees who described ‘the trial’ and the qualitative103
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104research as an ‘added extra’ using terms such as ‘separate’, ‘bought in’, a qualitative ‘element’, ‘detached
from’, an ‘adjunct’ to, ‘secondary/second tier’, not ‘joined up’, an ‘added extra rather than core’. More
ambiguous descriptions sought to describe a degree of separateness but with an attempt to keep the two
in juxtaposition: ‘in parallel/on a parallel track’, ‘side by side’, and ‘alongside’. More clearly pejorative
descriptions referred to qualitative research being ‘bolted on’, ‘squeezed in’ or as constituting ‘tokenism’.Theme 3: the significance of research teams for maximising the value
of the qualitative research
The quality and integration of the qualitative research and trial were dependent to a large extent on the
structural composition and social organisation of research teams for these studies. Important aspects of the
team included who was part of the team prior to obtaining funding and during the study, the stability of
team members, the status of different team members, the distribution of resources within the team,
communication within the team and how differences within the team were handled.Who is in the team?
Both the quality of the qualitative research and the integration with the trial were affected by who was in
the team from planning through to completion. The integration of the qualitative research and the trial
was dependent on how essential the qualitative research was perceived as being to the study. If qualitative
research was perceived as essential or important then it was designed in the original research proposal,
with senior qualitative expertise on the team from the outset. One interviewee suggested that locating
someone committed to qualitative research permanently within a clinical trials unit could facilitate this early
understanding of the need for qualitative research and expertise in designing it. In practice, the qualitative
researcher mirrored the status of the qualitative research by being a key member of the team, such as the
joint principal investigator with a quantitative colleague, or by being an ‘add-on’. An interviewee had been
the ‘added on’ junior team member in the past:NIHRI was brought in to help finish off those interviews and then I led the focus groups [. . .] Because I was
brought in at a late stage, and I basically came in, finished off a bit of a job and then wrote the
sections for the report, but didn’t really bring it together, I’m not sure how the links were made
between the two.
T13, qualitative researcherOn another study, they felt themselves to be a ‘full’ team member, which they felt enhanced the quality
of research produced by contributing to better research proposals. The risk of failure to integrate the
qualitative research and the trial could also be exacerbated by what social scientists refer to as
‘Taylorisation’ in which externally appointed qualitative researchers were only around for discrete ‘bits’
of the work rather than being in a position to have an overview of the relation of the parts to the whole.
They arrived on the study when it was designed and left the study prior to publications being written.Interviewer: . . . there’s no mention of the qualitative component in the trial results paper . . .T16, qualitative researcher: That’s right, linking the trial results with the qualitative, that just hasn’t really
happened at all, and I think that’s probably because the discussions about having some sort of
qualitative component to the trial [. . . ] wasn’t the PI’s [principle investigator’s] main interest, because
he’s a clinician . . . when I became attached to a different project, given the kind of, not so much
lack of communication, that’s probably the wrong way to describe it, but if you’re still on the same
site as the people running the trial, you can keep in touch better and remind each other that we
should be meeting up and discussing how everything fits together . . . it was harder to keep that going.
And so it got written up as my qualitative sub-study (laughs).Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Status of team members
The trial was often described as the primary aspect of a study, which also included qualitative research.
This status of qualitative research as an ‘add-on’ inevitably set up an organisationally hierarchical structure
in which, characteristically, the lead researcher was a ‘quantitatively oriented’ professor who ran the trial
and qualitative researchers were co-applicants or on ﬁxed term contracts. When this was not the case, it
was seen as being atypical: ‘I was the PI [principle investigator] and I’m a qualitative researcher, so it’s
quite unusual in that most complex intervention trials are designed by the quantitative person and the
qualitative researcher is sort of bought in.’ (T9, lead investigator and qualitative researcher.) Another
interviewee who described a very integrated approach to their study was a quantitative lead investigator
who shared the study leadership with a qualitative lead investigator.
In other studies, the presence of senior qualitative researchers could ensure good-quality qualitative
research was undertaken by facilitating in-depth analysis and write-up. Problems could occur when there
were only junior researchers on the team, without the support of experienced qualitative researchers. The
qualitative research could have a very quantitative approach imposed on it to make it acceptable to the
team, for example, the topic guide being highly structured and resembling an interviewer-administered
questionnaire. Even when senior researchers were on the team, supervision may not be available to junior
researchers owing to time constraints.© Que
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Park, S. . . there certainly are an awful lot of grant applications I see where it is quite clear that the little bit
on process evaluation is just there as a bit of a token, maybe got a junior qualitative Research
Assistant from a sociology department down the road to write a paragraph to go in the bid and then
they cost it in for a few hours a week for the duration of the trial and clearly they are not an integral
and powerful part of the study team
T18, lead investigatorResources available indicates value of qualitative research and affects quality
There was certainly an issue about resources within the team, with the value of a study component
evident through the resources it attracted. Some studies had senior qualitative researchers as applicants
with enough of their time funded to ensure good-quality research was undertaken and qualitative
researchers to undertake the research rather than trial managers doing it alongside running the trial:
‘That’s the ideal situation – where the work is properly funded’ (T3, qualitative researcher). Time as well
as staff was an important resource, with enough time allocated to allow for an in-depth analysis.. . . allowing adequate time for analysis of qualitative data is important because it does take much
longer than analysing quantitative so therefore there is a cost implication, so that’s the only thing that
could be challenging when working with people who are from a more quantitative background is
helping them understand the process of qualitative analysis and the time that it takes.
T17, qualitative researcherTeamworking: the importance of communication in integration and
feeling valued
In addition to the way teams were structured, the way they operated on a day-to-day basis and how
members communicated with each other was seen to contribute to the way qualitative research could add
value to the trial. Engaging the whole team and working in a collaborative way was described as
facilitative to integrating different parts of the study. Leadership was identiﬁed as important for bringing
people together: ‘it did take a strong leader to bring everybody together [. . .] he did bring people together
and had a big discussion’ (T15, lead investigator). The meetings encouraged communication and often
involved everyone attending all the team meetings, especially at the beginning of the project, so that good
relationships could be forged from the start. There was also a cost to communication, therefore,
researchers described getting the balance right by having task-oriented groups of staff in between ‘full’
meetings and bringing people together at certain stages in the project. Key stages were ‘the beginning,
the results, what do they mean especially, and dissemination.’ (T6, lead investigator.) What seemed to be105
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106important was that some thought was given to how meetings and other forms of communication could be
designed to make inclusiveness and team integration more effective. Importantly, this contributed to
qualitative researchers feeling that their work was valued, particularly if they were part of the highest
meeting in the hierarchy of meetings: ‘I think we felt valued because the trial steering group valued that
work stream’ (T3, qualitative researcher).NIHR. . . the main thing was openness of communication, fostering an environment that everybody’s views
counts and everybody’s methodology is on the same level, and about each member of the team
facilitating qualitative or quantitative research to be done, at the time that it was required, so our
team meetings were very open, we all knew we didn’t know everything, so we were very open about
asking questions from each other, because none of us could cover the full spectrum that everybody
else had, and, keeping those channels of communication open was seen to be very good.
T4, lead investigatorSo I think that’s why I would say it did work . . . because maybe people felt part of that whole process
of bringing the qualitative together.
T13, qualitative researcherTeams could be close or distant in their working practices. Close teams did not necessarily occur by
accident – some qualitative researchers could, and did, choose to work with respectful colleagues who
would be collaborative team members. The team could also be bound by shared values around the
intervention and context of the research. Closeness could develop over time, for example, as a colleague
who was described as not ‘overly impressed’ with the qualitative research became more interested once
the qualitative ﬁndings came in (T10, qualitative researcher). However, communication and team interest
did not automatically result in integration:More quantitatively oriented triallists [. . .] might be interested in the qualitative results in their own
right, but I don’t know how interested they’re going to be in thinking about what it tells us about the
trial. [. . .] They provide a path of least resistance, if you want
T11, qualitative researcherOther researchers described an experience of distance being created by colleagues perceiving their
research as unimportant in comparison with the trial.. . . there wasn’t a high degree of interest in the qualitative study in the wider research group, but it
had to happen so it did, and I would even say that some of the key researchers involved in the wider
study just wanted to distance themselves from it [. . .] ’well that’s over there, that’s something soft
that you’re doing, but we’re important and we’re over here and we’re doing all this important stuff
T10, qualitative researcherDisciplinary backgrounds and differences
The disciplinary background of team members and the associated research paradigms were seen to be
signiﬁcant for the value placed on the qualitative research. Some clinical specialties were seen to be more
sympathetic to qualitative research than others – palliative care, public health and primary care – for which
one might argue the complexity of interventions is more obvious than in other specialties. A lack of
expertise in qualitative research by the quantitative researchers could not only affect the quality of the
qualitative research by imposing quantitative ideals on it, for example, wanting large numbers, but could
also affect the conﬁdence clinicians had in the quality of the qualitative research and therefore their
willingness to consider interaction with the trial. For an interviewee who felt that both the trial manager
and trial co-ordinator were receptive to emerging qualitative ﬁndings and willing to take them on board,Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38the fact that these colleagues had some qualitative experience of their own was seen to be a signiﬁcant
contributory factor (T11, qualitative researcher).© Que
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Park, SIt was clear to me that [name of professor] didn’t know a great deal [about how the qualitative
investigation would be undertaken] and he was looking to me to say, ‘is this methodologically sound,
am I going to get panned when I go to X conference or Y conference, because you haven’t done
something?’ [. . .] They want the qualitative research to be of a standard that they feel able to defend,
but they’re not familiar enough with qualitative approaches to know that you can actually defend
something completely different if you know how to make the argument
T10, qualitative researcherThese differences were due to a lack of understanding of qualitative research by quantitative researchers,
or a lack of understanding that there was anything to understand. A qualitative interviewee pointed out
that in contrast with discussions about sample size, for which people will defer to the statisticians or
triallists who are seen as the experts in this respect, ‘when it comes to the qualitative stuff, everyone’s got
an opinion, even if they’re informed or not’ (T11, qualitative researcher). The effect of not having
expertise, or constraining that expertise, on the quality of the qualitative research was not necessarily
evident until too late, as in a case for which, despite a ‘few workshops to do with training’ with
interviewers beforehand, transcripts of in-depth interviews ‘read like clinic interviews’ in which the
participant ‘only got the choice of saying “yes” or “no”.’ (T15, lead investigator.)Theme 4: how structural issues shape practice: what is valued in academia does
not necessarily facilitate the value of the qualitative research for the trial
Our interviewees presented a number of structural issues as barriers to producing good-quality applied
qualitative research, which, in turn, reduced the value of the qualitative research for the trial. What was
valued within academia and traditional disciplines, what they perceived funding agencies were willing to
fund, research governance structures and the current culture of learning could limit the quality of the
qualitative research. Structural issues were also barriers to integrated research and publishing qualitative
research was presented as a particular problem.The drive to pursue academic careers and, therefore, the value placed on some
journals and articles
The qualitative research was described as integral to some studies, driven by the need to ﬁnd effective
treatments and increase patient beneﬁt. However, a qualitative researcher reﬂected on how trials could
also be vehicles for the career progression of some researchers rather than ways of identifying effective
treatments for patients: ‘They are not driven to ﬁnd a treatment that is acceptable to patients, are they?
They are essentially driven by the task of undertaking a highbrow RCT, getting publications on it and
moving on to the next big thing’ (T10, qualitative researcher). However, interviewees who spoke with
passion about the essential contribution of qualitative research to producing evidence of use in the real
world were also driven by the need to be seen within their own institutions as someone doing ‘valuable
research’. Valuable research produced high-impact papers, termed ‘three-star’ papers by the current
national exercise within the UK, which allocates resources based on research quality. If the qualitative
research could not produce these valued papers then it was viewed as less valuable, or even worthless,
within academia.. . . if it’s not a three-star paper, which they define as something like obviously high impact and is top
10% of Web of Science categories, then it doesn’t count for anything at all, and you’re literally in
their eyes wasting your time writing it. So, it’s difficult for me to justify the time writing up
qualitative papers for minor journals when I could be writing high impact papers or getting more
grant money in.
T5, lead investigator107
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108Pursuit of an academic career within current structures also included the need to bring in more funding
and move on to the next project, resulting in teams breaking up before ‘non-priority’ papers were written,
which, in this case, were the qualitative papers unlikely to be published in three-star journals. Given that
we found 97 examples of UK publications in less than a 3-year period (see Chapter 3), we could see that
our interviewees were making these points about maximising value rather than attaining any value.
Nonetheless, there was evidence that more of this research was happening and perceived to be of value
than was being published:NIHR. . . our priority now, at the moment, is just to get the trial paper published. [. . .] I’m being honest
here, there is an issue of will here. Because we have learnt a lot by doing this, including by doing the
qualitative research and we’ve moved on to new projects, and we’ve just started another massive
project, and so the question is where is the appetite when we’ve moved on. Who in our team is
going to develop the qualitative publications from the work that we did before?
T8, lead investigator, underlines indicate interviewee emphasisThe value of applied qualitative research within academic disciplines
The academic career is shaped by academic discipline. Combining qualitative research and trials is a
multidisciplinary endeavour and the qualitative research can be undertaken by researchers from disciplines
such as psychology, sociology, anthropology and subdisciplines such as public health or health services
research. Qualitative and mixed methods researchers described the tensions between applied research and
their academic discipline. Qualitative research, applied research or applied qualitative research may not be
valued within a discipline, making it difﬁcult to publish in a high-impact journal within their discipline or
a ‘decent qualitative journal’ (T5, lead investigator). The option available for publication here was a
lower-status applied journal because high-status applied journals valued the trial publication rather than
the qualitative research publication.The challenges are more to do with [. . .] convincing traditional triallists and traditional medics who
think in terms of experimental designs only, and really don’t think that qualitative research is any
more than something that is a bit woolly. So that the latest challenge is presenting and selling the
importance of doing qualitative research and what it actually achieves
T2, lead investigatorFunding agencies: do triallists value it enough to ask them to pay for it?
Interviewees noted that qualitative and mixed methods researchers were now on research commissioning
panels, which they perceived as creating a favourable condition for obtaining funding. The MRC
framework for the evaluation of complex interventions was identiﬁed as shaping the environment within
which researchers worked, promoting the value of qualitative research to funding agencies to the point
that they would sometimes request that qualitative research was included within a bid.I think the commissioning process has really changed quite significantly since this was set up [. . .] now
the MRC has its famous complex trials framework. And that’s just been part of the general change
across the whole community with the interdisciplinary understanding of applied health researchers
coming to bear on the broader community to show that qualitative research is important, has
important roles to play in trials . . . And so the commissions have improved dramatically.
T2, lead investigatorHowever, the availability of funds clearly exercised interviewees. One interviewee described the funder’s
commitment to the qualitative research as integral to the trial and their willingness to fund it fully as a key
contributing factor to maximising its value. They then went on to say that ‘to get a donor who’s willing to
put the extra money in is exceptional’ (T15, lead investigator) and indeed another regarded having
dedicated staff to undertake the qualitative research as ‘quite a luxury’ (T3, qualitative researcher). It was
not clear to what extent the funding agencies were contributing actively to this perceived lack of funding
for fully resourced qualitative research and to what extent lead applicants were contributing to it by tryingJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38to keep the costs of a bid down, either by ‘second-guessing’ their chances of securing a large enough
grant to fund the qualitative research properly or by trading on the goodwill of qualitative researchers to
‘squeeze it in’ without proper funding. This ‘minimal cost’ approach was felt to compromise the depth and
quality and, therefore, the value of the qualitative research:© Que
Health
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Park, SBecause it wasn’t that the funder said you cannot have this money, but we underestimated in
order to keep the costs of the study down, and hence didn’t have the time or the resource in terms
of the researcher to gather the data and to analyse the data as fully as you would have liked.
So I suppose that’s the take-home message really [laugh], [. . .] we shouldn’t have been quite so
ambitious in the original proposal and should have tried to seek more funding.
T12, lead investigatorThis contrasted with a lead investigator who felt that qualitative research was central to the study and
believed so much in the research that they made sure it was properly funded.
Related to this was a sense that applicants were not necessarily communicating the worth of the
qualitative research by not being sufﬁciently explicit about the aims and objectives that the qualitative
research would fulﬁl for the trial. This was perceived as problematic if a large amount of money was
requested from funders because it raised the question of value for money:. . . it’s a difficult one for funders because you know, I sit on funding panels, and I sometimes think
you can look at proposals and see that they just squeeze something in and it’s not really clear what
the linkages are and the value, so I think researchers have a real job to sell the value of these different
methods in their proposals … and then funders make a decision of whether to fund it or not,
don’t they?
T13, qualitative researcherOverall, there was a sense that a range of parties needed to change their approach to funding qualitative
research and trials to maximise the value of this endeavour. If the funder and the applicants viewed the
qualitative research as an ‘add-on’ then this determined its value in terms of impact on the trial. This
meant that the space in the funding application form was used to give detail about the central
endeavour – the trial – with the recognition that if this was not detailed fully then funding would not
occur. Interviewees suggested that funders could change application forms to offer explicit space for the
qualitative research:The quantitative side tends to take predominance very often in terms of the application [. . .]
and the qualitative side is much often less fully described, because there’s less space left on the
application form.
T12, lead investigatorAs a grant reviewer, you tend to get very tired of people saying ‘Oh yes, we’ll do a mixed methods
evaluation, including a process evaluation, because it’s very important, blah blah blah’ and then they
say absolutely nothing about what exactly they’re going to do [. . .] there are very few applications
you get where they can say a lot because of the fact that the forms aren’t helpful to support that.
T18, lead investigatorThis contrasted with an example in which the qualitative research was far from ‘add-on’. Funding for the
full trial was dependent on the qualitative research at the development stage of the trial, which focused
the applicant’s mind on ensuring that this phase of the project followed the best possible practice
(including, in their view, publishing a mixed methods paper).109
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110Research governance: not conducive to emergent qualitative research
Research in the NHS takes place within a governance structure. The demands of research governance, in
relation to ethics committees and research and development permissions, were cited by some interviewees
as representing an indirect barrier to maximising the value of the qualitative research by reducing the
strengths of the qualitative research. This was due to such demands not being compatible with the
requirements of some approaches to qualitative research. Topic guides needed to change iteratively during
a study but some ethics committees required notiﬁcation of change to any documentation:NIHRQuite a few of the ethics committees asked to see the in-depth interview guides and the focus group
discussion guides and it meant if we wanted to change anything, we’d have to go back and
resubmit all of these again.
T15, lead investigatorThe time taken to secure approval meant that insufﬁcient time was left towards the end of the project to
complete the planned number of qualitative interviews and to do justice to the qualitative data that had
been collected. The time taken to complete what were described as bureaucratic procedures was felt
particularly acutely in studies for which the qualitative research had not been incorporated in the
original proposal.Gaining expertise and developing a culture of learning
A number of interviewees drew attention to the importance of the quality of the qualitative research and
the extent to which this could depend on the calibre of the researcher. As well as expertise in qualitative
research, expertise was also required in relevant evaluative frameworks and in combining RCTs and
qualitative research. Reach, Efﬁcacy, Adoption, Implementation, and Maintenance (RE-AIM), MRC and
realist evaluation frameworks were mentioned as useful by some interviewees. There was a view that the
literature on qualitative methods in health services research is very broad in its focus and that it could be
adapted to be applicable to RCTs. There were also suggestions that concrete examples of good practice in
the form of case studies would be helpful (showing not only how qualitative methods were used but also
the insights that would have been unavailable from the trial alone). Helpful literature, was cited, for
example from the Cochrane group and Jenny Donovan and colleagues, University of Bristol. However, this
was not just about availability of relevant literature but about a culture of learning from this literature and
the value given to such learning: ‘I used to say, “when you started this project, how many other people’s
things like that did you read?” And the answer is none.’ (T8, lead investigator.) This contrasted with the
learning that occurred within some experienced teams, members of which felt that they undertook more
sophisticated studies as they learned from previous experience. There was a sense that this whole
endeavour needed more guidance, networking and proﬁle in order for learning to occur within the
research community.Publication structures do not facilitate integration
As described earlier, interviewees felt that more integration of the quantitative and qualitative components
of studies was necessary to maximise the value of the qualitative research for the speciﬁc trial. However,
regardless of the degree of integration of the two during the trial, capitalising on the value of the
qualitative research to trials at the publication stage seemed to present a ﬁnal challenge that proved
insurmountable for many. Typically, two separate sets of journal articles were published. Publishing the
quantitative and qualitative ﬁndings separately mirrored the social organisation of the teams more
generally. However, it was also the case when qualitative and quantitative researchers worked closely
together because of publication ‘norms’:So that’s going to be just purely qualitative spin-off papers if you like. I would be very, very surprised
if we willfind ourselves in a situation where the trial results didn’t go out in a paper which was just
the trial results, in the normal way that you would expect, in a main journal . . .
T11, qualitative researcherJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Note the use of the terms ‘spin-off’ and ‘main’ in this quote, continuing to emphasise the trial as the main
endeavour and the qualitative research as ‘add-on’. A barrier to publishing integrated results was word
length for journal articles. Alternatives were found such as publishing quantitative and qualitative ﬁndings
alongside each other in the same issue of a single journal or writing an integrated article after publication
of the qualitative and trial results separately in order to ‘bring it all together’ (T7, lead investigator and
qualitative researcher). Some researchers were ‘very keen to have the qualitative integrated with the
quantitative, rather than just publish them separately’ (T17, qualitative researcher) and wanted the ‘norm’
to be integrated papers.© Que
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Park, S. . . ideally we would have put more stuff from the process evaluation in the main trial paper but we
didn’t . . . because of the word length, you know, word count restriction meant that just by reporting
all the usual stuff for the primary and secondary outcome analyses, there wasn’t really room for
much else.
T18, lead investigatorHowever, this was not about simply changing publishing practices. There were several factors militating
against ‘integration’ within publications: the fragmentation of teams which leaves the lower-priority paper
unpublished, the demands of qualitative data analysis sometimes meant that the production of the
ﬁndings of the qualitative and the quantitative research got ‘out of synch’, and other priorities and
pressures on academics, for example, to publish in high-impact journals unsympathetic to qualitative
research or to generate further income, both of these resulting in the ‘down-grading’ of the qualitative
ﬁndings to the status of ‘minor’ articles which are then never written.. . . the thing that’s difficult is the integrating the two at the end and trying not to just publish them
separately, and I don’t think that’s necessarily been done that successfully so far. There are some good
examples of where it’s been done very well, but not all trials, it doesn’t always happen, I mean, there
can be a lot of qualitative data that doesn’t make it into publication, as we found with our own work,
and partly that’s to do with time.
T17, qualitative researcherTheme 5: an improving climate but action is required for further improvement
Interviewees who had been engaged in combining RCTs and qualitative research for many years felt that
the climate for the endeavour had become more facilitative: ‘Every statistician who I work with now has a
mutual respect for qualitative research . . . thirty years ago they would have said “Well, that’s not science,
so what are you doing that for? It’s just story-telling” ’ (T2, lead investigator). This progress was in part
attributed to changing priorities in health-care research, in which RCTs were being used for more complex
or behavioural interventions. A major funding body, the MRC, had also contributed by showing the value
of qualitative research within an evaluative framework for these complex interventions. However,
interviewees who were less experienced researchers, who found themselves in lower-status positions
within teams, had experiences that indicated that progress may be patchy and that there is still room for
improvement. This patchiness was evident in more experienced voices too. One interviewee expressed the
view that it is less frequent these days to come up against overt antagonism towards qualitative research
because there is more of a climate of acceptability, but that, nevertheless, some funding agencies and
researchers are not convinced:[Two named boards] have got quite a lot of mixed methods people in, so . . . kind of quite well
attuned to it really . . . but my perception is that across the whole (wider funding landscape)
it’s probably not quite very well appreciated.
T18, lead investigatorSome structural issues are also changing in ways that may facilitate maximising the value of qualitative
research undertaken with trials. For example, the progression of electronic journals with no word
limitations may encourage more integrated reporting of studies, as might the increasing use by the NIHR111
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112of publishing ﬁnal reports within peer-reviewed journals. However, some interviewees wanted to see more
agency from individual researchers, for example, they wanted the research community to actively learn
from practice rather than continuing to do more of the same.Discussion
Summary of findings from interview study
The value of undertaking qualitative research with trials was considered to be high by researchers engaged
in this endeavour but this did not necessarily equate to the QUART team deﬁnition of value to the speciﬁc
trial. Impact on the speciﬁc trial was not viewed as essential by some researchers. It was described as
central and essential for some studies but as an ‘add-on’ to the trial for other studies. Lead researchers
who described their focus as undertaking research to change practice in the real world, who were highly
aware of the complexity of their interventions, the environment the intervention would be tested in and
the environment the intervention would need to operate in outside the context of a trial, viewed
qualitative research as essential and its impact on the trial as necessary. For other studies, the qualitative
research was an ‘add-on’ to the trial, sometimes viewed as an interesting but ultimately separate
endeavour, or sometimes as a distant ‘something funders like to see’, which could result in
under-resourced qualitative research that would not impact on the trial. Structural issues supported the
trial as the most valued component of these studies.Interview study in the context of other research
The ﬁndings of this interview study were similar to ﬁndings from interviews with researchers from
mixed methods studies. Researchers valued mixed methods research and saw integration of the qualitative
and quantitative ﬁndings as a mark of quality but tended not to engage in it because of dysfunctional or
multidisciplinary teamworking142 and structural issues such as publication norms.143 Our ﬁndings were also
similar to issues raised in a discussion of a methodological paper about the use of mixed methods in
palliative care in which the authors identiﬁed a lack of skill mix and experience in mixed methods research,
problems obtaining funding and under-resourced studies resulting in poor quality and difﬁculties in
publishing integrated ﬁndings.7 An editorial about health services research also highlighted the need to
develop skills and train people in qualitative research and mixed methods and the need for structural
changes in journal publications, such as longer word lengths and skilled reviewers, to facilitate qualitative
research.144 Simons145 reported her personal experience of being a trial co-ordinator and carrying out a
qualitative case study within the trial for a PhD, offering a different, but complementary, perspective.
Simons145 highlighted the difﬁculties of both being engaged with a trial and undertaking qualitative
research that challenged the trial, taking care not to damage the experiment while doing the qualitative
research, being very rigid in her interviewing technique compared with a sociologist she worked with. The
author reported how publishing the trial took precedence and the inability to show the impact of the
qualitative research on the trial because the qualitative research was not complete at the time of
publishing the trial. Her work identiﬁed a view that was expressed by one of our interviewees and perhaps
did not receive much attention in our write-up. This view challenged the basic assumptions of trials and
identiﬁed the naivety of some trials of socially complex interventions that work under the assumption that
context can be controlled.11Strengths and limitations and reflexivity of interview study
This interview study drew on the range and depth of experience of researchers. The sample was taken
from three sources to ensure we had the views of researchers currently undertaking this endeavour, who
had seen projects through to completion and who had worked on projects for which the qualitative
research was not necessarily visible. The sample was drawn from the UK, where the use of qualitative
research with trials is acceptable to signiﬁcant funding bodies such as the NIHR and MRC but may be less
acceptable to other funders of more clinical research. Researchers from other countries will have to
consider the transferability of these ﬁndings to their speciﬁc contexts. The interview topic guide and the
analysis and interpretation were shaped by the QUART team’s belief that qualitative research undertakenNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38with a speciﬁc trial should have an impact on that trial. We were open to the possibility that researchers
would disagree with this position, and indeed researchers offered other reﬂections on value, but our
presentation of the ﬁndings has been shaped by our research question and stance. The QUART study
grant holders have undertaken trials themselves and are supportive of trials for generating evidence of
effectiveness. We are critical of how some trials have been undertaken, including our own research, but
do not challenge the need for trials. Again, this stance shaped our research question, sampling, analysis
and interpretation.Conclusions and implications of the interview study
One conclusion that could be drawn from this research is that all trials should be undertaken with
qualitative research that has equal status with the trial and is viewed as essential to the generation of
evidence of effectiveness. The conclusion we draw, as the QUART study team, is different, however.
We do not necessarily want to see an increase in the use of qualitative research but rather an increase in
thinking about whether and how it can be of use within a particular study and how it can be resourced to
maximise its value. We would like to see trial teams thinking about the problems their interventions and
trials are likely to face and the value of qualitative research in addressing problems such as poor
recruitment, a lack of understanding of why interventions work or not, a lack of use of evidence generated
by trials in practice, or the failure of interventions and trials in complex environments. Where these
problems are likely to be signiﬁcant, well-resourced and expertly executed qualitative research may
enhance the production of evidence of effectiveness as well as enhance its relevance and usability in the
real world. The issue that appeared to be at play within our interviews was the sense that some qualitative
research is being undertaken in the UK research community because it’s the ‘done thing’, without valuing
its potential to impact on the speciﬁc trial. If that impact is important to the research lead, this shapes the
team structure, team communication, resources and dissemination strategy. There was also an indication
that impact of the qualitative research occurs within some studies but is invisible to others owing to
structural constraints, such as publishing norms, which limits its value to other researchers working on
similar interventions or in similar environments.113
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DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Chapter 7 Integration of ﬁndings from different
componentsAimThe aim was to bring together the ﬁndings from the different study components to help to draw
meta-inferences from the study.MethodsWe identiﬁed ﬁndings from each method: systemic mapping review of articles, review of studies, survey
and interviews. We identiﬁed themes within these ﬁndings and displayed them together on a grid
(Table 34). We undertook a partial ‘triangulation protocol’ approach.146 Within each theme we considered
where ﬁndings from different components of the study converged, offered complementary information,
were contradictory or did not exist. Then we drew conclusions or meta-inferences within each theme.147
During this process, we paid attention to overlap in the samples of different components, for example we
had interviewed people who had published articles or undertaken studies so some convergence between
components was expected.115
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DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Chapter 8 DiscussionSummary of ﬁndingsQualitative research is used with trials. At least one in eight trials funded in the UK and ongoing in the
2000s used qualitative research, increasing to at least one in ﬁve for trials of complex interventions. A
large number of articles reporting qualitative research undertaken with trials, almost 300, were published
between 2008 and 2010. We used these articles to develop an empirically based framework of the aspects
of trials addressed by qualitative research. This framework consisted on ﬁve broad categories (intervention,
trial design and conduct, outcomes, measures, and target health condition), with 22 subcategories.
Qualitative research was used with both trials of drugs or devices and trials of complex interventions.
When the focus of the qualitative research was the intervention or outcomes, the trial intervention was
likely to be a more complex intervention than a drug or device. This qualitative research had implications
for the speciﬁc trial it was undertaken with, future trials and the endeavour of generating evidence of
effectiveness of health interventions. There were excellent examples of this qualitative research and a wide
range of ways in which it could bring value to the trial and trial endeavour; however, this value was likely
to be potential rather than actual value. This was partly to do with how researchers do this work and
partly to do with how they publish it. Researchers work within structures that encourage obtaining less
value from this approach than is likely to be possible. Researchers driven by the need to provide evidence
of effectiveness for real-world application have overcome some of these structural barriers.Comparison with other researchEach of the study components has been considered in the context of relevant research at the end of each
chapter. Here, we summarise the unique contribution of our study and how it supports or contradicts
previous research. Both Lewin et al.8 and Creswell et al.6 identiﬁed lists of uses of qualitative research with
trials within a temporal framework. Our research complements these studies by presenting an empirically
developed framework based on different aspects of a trial. By studying what researchers have actually
published, we show that some of the contributions that qualitative research can make are not occurring in
practice and that much of the endeavour occurs during the trial, even when ideally it should occur before
the trial. Lewin et al.8 took a complementary approach of studying trial and qualitative research articles as
well as unpublished research for 30 trials of complex interventions. Their conclusions of a lack of
integration between the trial and the qualitative research, and methodological shortcomings of the
qualitative research, were largely supported by our ﬁndings, with details of differences discussed in
Chapter 3. The ﬁndings from our qualitative research largely concurred with a similar study of mixed
methods researchers in health services research,142,143 although this is not too surprising given that some of
those interviewees in the earlier study had worked on studies of trials and qualitative research and the
research was undertaken by the same lead researcher. Its added value to the evidence base was
identifying how the ‘add-on’ status of qualitative research to trials limits its ability to impact on trials and
how the way in which research is published contributes to this.
Some literature reﬂecting on this methodological development takes a more challenging stance than our
study. It addresses the philosophical differences between RCTs and qualitative research,148 the tensions
between undertaking qualitative research and delivering a RCT,145 and the practical challenges of
undertaking qualitative research in the context of a RCT.149 Munro and Bloor149 express concern that the
burden of expectation on process evaluations may be too great. They cite the range of questions that
process evaluations could address to show that much can be expected and that this may lead to too much
data being collected within them. Indeed, our framework might add to this problem by identifying the
wide range of ways in which qualitative research can be used with trials. We think that Munro and121
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122Bloor149 make an important point and that researchers will need to consider the most important aspects
of an intervention or trial to be addressed by any qualitative research. Munro and Bloor’s149 experience of
a process evaluation alongside a feasibility trial highlighted two problems: the timing of the process
evaluation compared with the trial and the challenges of generalisation of ﬁndings. First, the
process evaluation data collection may be complete when unexpected ﬁndings emerge from the
outcome evaluation, which the process evaluation is then asked to explain without the option of further
data collection. Interviewees in our study did not identify this speciﬁc issue but did raise the wider
challenge of the trial and qualitative research ﬁndings being available at different times. Second, they
highlight the tension between the inductive nature of the qualitative research and the expectation that the
process evaluation will pronounce on generalisability. They recognise the value of process evaluation but
highlight the need to attend to some problems emerging from practice. The reﬂections of Munro and
Bloor149 bring to mind the debates about the challenges of identifying causal relationships with qualitative
research.150 Qualitative researchers will need to balance attending to the uncertainties in their research and
the claims being made, while also attending to the strengths of qualitative research to facilitate
understanding of complex issues.Strengths, limitations and reﬂexivityOur study has three key strengths. First, it is timely in that a considerable amount of this research has been
undertaken without much methodological reﬂection of this rapidly developing area. Second, the study
focuses on what researchers are actually doing rather than debates about what can be done in theory.
Third, it combines evidence that is based on the lasting end products of research – publications – and
researchers’ views of this ﬁeld. Our study has four main limitations. First, the review focused on
publications from 2008 to 2010, which arose from studies that may have begun as early as 2000. Thus,
they reﬂect recent history rather than current practice. However, the interviews were undertaken in 2011
with researchers who discussed their current work as well as their past work, so recent practice is included.
Second, although the review was international, the rest of the study focused on the UK. Third, each
method had its own limitations, which we discussed at the end of each chapter. It is worth bearing in
mind that the mapping review was based on published research and that this might not reﬂect all the
ways that qualitative research is used with trials. Fourth, our study focused on the value to the trial with
which the qualitative research was undertaken. The assessment of potential value in our mapping review
was subjective but did concur with views expressed by our interviewees. The researchers we interviewed
and our PPI participants identiﬁed a further value of qualitative research for bringing patients and health
professionals into the picture, a value that we identiﬁed in some parts of our values framework (that is,
a potential value of ensuring the trial was sensitive to human beings) but perhaps on reﬂection did not
fully appreciate.
The study focus, methods and inferences are shaped by our research team. Three of the authors (AO, KJT
and JH) are the grant holders on the original bid for this study, they are (or have been) members of
research commissioning boards in the UK, have undertaken studies combining trials and qualitative
research and would call themselves health services researchers. Three of the authors are qualitative
researchers who have not worked on trials (SJD, JG and AR). Disciplinary backgrounds of the team include
psychology (JH and SJD), sociology (KJT, AR and JG) and health services research (AO). A driver for
undertaking this study was a belief that qualitative research can be an important addition to trials and the
evidence produced from trials, and concerns that the value was not being maximised. A different set of
researchers might have been less accepting of the utility of trials or of qualitative research and may have
developed a different framework from the one we present in Chapter 3.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Generalisability and transferabilityThe review was based on international publications written in English between 2008 and 2010 and its
geographical transferability will be to countries that publish academic research in English. Publications in
later years may be different, but, given that researchers in the UK identiﬁed publishing as a major
structural barrier, one might surmise that the same picture would emerge from a review of 2012–14
unless researchers make a conscious effort to change practice. The only issue that may affect temporal
transferability is the increasing use of electronic publication and its accompanying tolerance of longer
articles. The interview study was UK based and undertaken in 2011 and, therefore, has geographical and
temporal speciﬁcity. The context was one of combining qualitative research and trials being a generally
accepted endeavour. Researchers from outside the UK may wish to consider the ﬁndings from the
UK-based components of our study in the context of how health research is undertaken in their own
countries. As our study focused on health research, its ﬁndings may not be transferable to trials
undertaken in social, educational and other ﬁelds of research. However, it is interesting to note that the
2010 paper by Spillane et al.151 from education describes using qualitative research with a trial in ways that
are very similar to those found in our study: to monitor the ﬁdelity of treatment implementation in the
trial, identify variables that mediate relations between treatment and outcomes, and validate measures
and instruments.A rapidly developing ﬁeldResearchers are developing strategies for undertaking qualitative research with trials. This involves
qualitative research being included in procedures and practices associated with trials, for example having
standard operating procedures within clinical trials units152 and publishing protocols for the process
evaluation as well as the trial.153 These developments highlight the growing status of combining qualitative
research with trials and its establishment as a normal and acceptable practice. These developments are
welcome if they attend to maintaining the emergent and ﬂexible aspects of qualitative research in contrast
to the highly protocolised world of RCTs. Established trial methodology may also be affected by
accumulated understanding from qualitative research about how interventions and trials operate in the
real world. A very helpful contribution to the literature is researcher reﬂections on undertaking this type of
research, based on personal experience145,149 or methodological perspective.154 Finally, systematic reviewers
interested in explaining the heterogeneity of trial results want to study the qualitative research undertaken
with included trials.155Conclusions and recommendations for different stakeholdersIf qualitative research is undertaken with speciﬁc trials, should we not expect that research to impact on
the trial in some way by optimising the intervention or trial conduct, explaining trial ﬁndings or facilitating
transferability of trial ﬁndings in the real world? In Chapter 3, we identiﬁed detailed suggestions for good
practice and how to maximise value for each of the 22 ways in which qualitative research was used with
trials. In Chapters 4–6, we identiﬁed further ways of maximising value when writing proposals, reporting
and conducting this type of research. In Chapter 6, we explored how wider structural issues affect the
value gained from qualitative research undertaken with trials by supporting and valuing the trial as the key
endeavour. Below we offer summary recommendations to maximise the value of undertaking qualitative
research with trials:123
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124Researchers
Plan the qualitative research
It is not possible or necessary to use qualitative research to address all the aspects identiﬁed in our
framework in the context of a single trial. Researchers will need to think about the problems and challenges
their planned trial is likely to face and design the qualitative research to address these, while allowing for a
degree of openness and ﬂexibility to address possible emerging issues as the trial progresses.Design and implement studies not trials
Some lead researchers we interviewed identiﬁed the qualitative research as essential to their desire to
produce evidence relevant to the real world, whereas others described it as an addition to the trial and
even as peripheral to the trial. When it was perceived as essential to the trial, impact on the trial was
central to the team’s thinking. Powerful examples in the literature have embedded the trial in the
qualitative research and ‘contravened conventional approaches by being driven not by the RCT design
but by the qualitative research’9 or viewed their research as an integrated methods approach.1Use qualitative research at the feasibility and pilot stage of randomised
controlled trials
Qualitative research undertaken at the feasibility or pilot phases of a RCT can impact on the main trial by
optimising the intervention, improving the conduct of the trial, or identifying the appropriate outcomes and
measures. This can result in successful and efﬁcient trials that, we would argue, would be more likely to have
positive results if shown to be feasible. At the pre-trial stage the research can be iterative, feeding into the
feasibility trial and seeing improvements in recruitment or the intervention during this time. Bradley et al.1
and Donovan et al.9 took this approach and the latter describes it as a ‘sociological iterative approach’.Think about the impact on the trial and implications for the trial endeavour
One of the most problematic things we came across here was the lack of explicit articulation of the effect
of the qualitative research on the trial or the lessons for that trial or future trials. We do not think that the
qualitative research and the trial have to be published in the same article for this to happen. Some authors
show that these lessons can be articulated in the qualitative article. There is an issue about the timing of
the two components working against this.
A related ﬁnding was researcher concern about the contamination of the experiment by the qualitative
research, with concern that some intensive techniques, such as diary keeping and interviews, can offer a
therapeutic effect.156 This requires thought at the planning stage so that intensive qualitative data
collection on a large proportion of the trial participants can be undertaken after the collection of important
outcome data. There is also the potential for bias for some endeavours, for example using qualitative
research to study variation of outcomes when the outcomes are already known. Again, the potential for
this bias can be considered at the planning stage. There is some evidence in the wider literature that the
qualitative research can take on procedures associated with trials, such as having a published protocol for
the process evaluation or qualitative research,153 which would ensure planning and thinking about
contamination and bias and how to minimise these in the context of a speciﬁc study.Undertake depth qualitative research
Sandelowski and Barroso,140 in the context of the synthesis of qualitative research, describe articles that
present summaries of data organised as themes rather than presenting ﬁndings in the form of a model or
integrating concept. They did not want to discard this research because of its utility for health-care
practice. We felt the same about some of the research we included here, which was descriptive and
sometimes read as a list of issues. We felt that some of these studies were useful, for example list of
solutions to the problem of trial recruitment in a deprived community. Yet other research required a more
explanatory approach with in-depth analysis (e.g. asking why the trial ﬁnding was null or positive) and this
could be lacking.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Some researchers propose the need to attend more to the epistemological roots of qualitative research to
maximise its potential.157 There are concerns in educational evaluation that qualitative research has been
assigned to second-class status when used with RCTs, with undermining of its epistemological roots. We
found some evidence of this in our interviews in which some researchers described implicit pressure to
undertake large samples and structured interviews. We recommend that researchers engage expertise in
qualitative research and resource the qualitative research in terms of the time, money and stafﬁng
required. There is a lot of activity in this ﬁeld yet researchers present their ﬁndings without necessarily
building on learning in the ﬁeld. May158 presents the ‘normalisation process model‘ to facilitate service
providers and researchers in understanding the factors that help or hinder the embedding of complex
interventions in routine practice. He constructs this model using qualitative research, some of which was
undertaken with RCTs, and then suggests that it can be used as a framework for prospective qualitative
research. This approach to building a conceptual framework from existing qualitative research can help
learning from disparate qualitative research undertaken with trials. There may be other opportunities to
develop such models or make use of existing ones.Allow qualitative research to take a challenging role
We identiﬁed qualitative research as a describer, explainer and translator of evidence, with some evidence
for qualitative research as a challenger of current practices. There are examples in the wider literature of
qualitative research challenging the underlying theory of the intervention,1 challenging whether or not the
trial should continue159 and being used to provide evidence for discontinuing a trial.160Develop a learning environment about this issue
Some researchers have developed considerable expertise in undertaking qualitative research with trials and
could share this expertise by running training courses and writing about how to undertake this work well.
Researchers new to the ﬁeld of combining qualitative research and trials – both qualitative researchers and
triallists – would beneﬁt from attending these courses and reading some of the exemplars we identify in
this report.Funders
Some of our interviewees identiﬁed funding application forms as a structural barrier to giving a detailed
description of the qualitative research to be undertaken with a trial. These application forms could include
requirements for the detail of the qualitative research, for example specifying the rationale for its use and
detail of methods, sample size, analysis and resources required.Ethics committees
Some of our interviewees identiﬁed the practice of ethics committees as a barrier to the iterative approach
often taken with qualitative research. Ethics committees could recognise the need for qualitative research
to evolve throughout studies without the need for submission of substantial amendments.Journal editors
Publication norms were identiﬁed by some of our interviewees as a barrier to continuing to publish applied
qualitative research and to addressing the impact of the qualitative research on the trial within journal
articles, for example explaining trial results. Journal editors could consider the importance of applied
qualitative research to their readership and, where it is undertaken with a trial, request that the lessons for
trials are made explicit. Electronic publication, with its associated longer article length, may facilitate this.125
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randomised control$
trial$.mp
qualitative research.mp. OR
qualitative research/
clinical trial.mp OR
clinical trial/
(qualitative ADJ3 method$).mp
pragmatic trial.mp ((qualitative ADJ3 study) OR (qualitative
ADJ3 studies)).mp
complex intervention.mp (focus group$ OR focus-group$).mp
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controlled-trial$).mp
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audio-recorded)).mp
case studies (EXCLUDED) (qualitative case study OR qualitative case
studies OR qualitative case-study OR
qualitative case-studies).mp
(descriptive case study OR descriptive case
studies OR descriptive case-study OR
descriptive case-studies).mp
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action research.mp
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qualitative case-study
qualitative case-studies
qualitative inquiry
qualitative exploration
qualitative intervention
qualitative
semi structured interview(s)
semistructured interview(s)
semi-structured interview(s)
in-depth interview(s)
interview(s) AND theme(s)
interview(s) AND audio recorded
interview(s) AND audio-recorded
descriptive case study
descriptive case studies
focus group(s)
focus-group(s)
mixed method(s)
mixed-method(s)
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process evaluation
ethnography
ethnographic
ethno methodology
ethnomethodology
phenomenological
action research
content analysis
narrative analysis
grounded theory
thematic analysis
conversation analysis
discursive
discourse analysis
social constructionist
social construction
social constructionism
APPENDIX 5
192
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Appendix 6 Questionnaire193
© Queen’s Printer and Controller of HMSO 2014. This work was produced by O’Cathain et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
APPENDIX 6
194NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38195
© Queen’s Printer and Controller of HMSO 2014. This work was produced by O’Cathain et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
APPENDIX 6
196NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18380 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 38Appendix 7 Topic guide
Introduction: Thank the interviewee for agreeing to the interview and to the recording of the interview.
Check consent and if it is OK to record the interviews. Ask them if they have any questions before the
interview begins.
Say that you are here to talk to them because of their involvement in a trial with qualitative research:
[STUDY A].Interview topics to be covered during the interviewThe interviewee’s role in the trial (PI or qualitative researcher)
The qualitative components of their trial and the interviewee’s perceptions of the objectives for
undertaking each component if more than one (Prompt: Pick up on any elements of the trials that we
have not yet identiﬁed and explore in more depth)
The reasons why qualitative research was undertaken with this trial
The rationale for qualitative research addressing the objectives above
The success of the qualitative research with this trial from the interviewee’s point of view (explore their
meaning of ‘successful’)
The interviewee’s perceptions of the impact of qualitative research on the trial itself (Prompts: Did it do the
right ‘work’, status of qualitative components, visibility of qualitative components, reporting of qualitative
components, worth having a qualitative component)
Challenges and opportunities for the successful use of qualitative research in the interviewee’s study
(Prompt for unintended consequences, both positive and negative)
Challenges and opportunities for the successful use of qualitative research in trials more generally
Issues related to the commissioning of the qualitative research for the trial and more generally
The interviewee’s perceptions of qualitative research in generalEnding the interview:Is there anything else you’d like to say?
What is the message you’d like me to really take away today?
What would you like to see coming out of our study?
Close the interview and thank the interviewee for their participation.197
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